货号:A210874
同义名:
ICI 47699; trans-Tamoxifen
Tamoxifen是一种选择性雌激素受体调节剂(SERM),竞争性阻断雌激素受体(ER)α转录活性,抑制乳腺细胞增殖。通过激活ERβ介导的TGF-β信号诱导凋亡,并干扰CDK4/cyclin D1复合物形成,阻遏G1/S期转化。用于ER+乳腺癌辅助治疗,兼具骨组织雌激素激动效应。
规格 | 价格 | 会员价 | 库存 | 数量 | |||
---|---|---|---|---|---|---|---|
{[ item.pr_size ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解
产品名称 | Autophagy ↓ ↑ | 其他靶点 | 纯度 | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
SBI-0206965 |
+++
ULK2, IC50: 711 nM ULK1, IC50: 108 nM |
95% | |||||||||||||||||
Hydroxychloroquine sulfate | ✔ | 99% | |||||||||||||||||
Valproic acid sodium | ✔ | HDAC | 97% | ||||||||||||||||
PFK-015 |
++
PFKFB3, IC50: 207 nM |
99%+ | |||||||||||||||||
MRT68921 HCl |
++++
ULK2, IC50: 1.1 nM ULK1, IC50: 2.9 nM |
99%+ | |||||||||||||||||
ROC-325 | ✔ | 99%+ | |||||||||||||||||
Autophinib |
+++
Autophagy, IC50: 40 nM |
99% | |||||||||||||||||
Lys05 | ✔ | 99%+ | |||||||||||||||||
1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。 |
靶点 |
|
描述 | Tamoxifen is an antagonist of the estrogen receptor in breast tissue via its active metabolite, hydroxytamoxifen. |
细胞系 | 浓度 | 检测类型 | 检测时间 | 活性说明 | 数据源 |
518A2 cells | Cytotoxicity assay | 96 h | Cytotoxicity against human 518A2 cells after 96 hrs by SRB assay, IC50=7.62 μM | 22749392 | |
850C cells | Cytotoxicity assay | 96 h | Cytotoxicity against human 850C cells after 96 hrs by SRB assay, IC50=11.09 μM | 22749392 | |
A253 cells | Cytotoxicity assay | 96 h | Cytotoxicity against human A253 cells after 96 hrs by SRB assay, IC50=8.92 μM | 22749392 | |
A2780 cells | Cytotoxicity assay | 96 h | Cytotoxicity against human A2780 cells after 96 hrs by SRB assay, IC50=7.77 μM | 22749392 | |
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
NCT00041080 | Fallopian Tube Cancer ... 展开 >> Primary Peritoneal Cavity Cancer Recurrent Ovarian Epithelial Cancer Stage III Ovarian Epithelial Cancer Stage IV Ovarian Epithelial Cancer 收起 << | Phase 3 | Completed | - | United States, Pennsylvania ... 展开 >> Gynecologic Oncology Group Philadelphia, Pennsylvania, United States, 19103 收起 << |
NCT00041080 | - | Completed | - | - | |
NCT03011684 | Infertility | Phase 3 | Recruiting | December 2019 | United States, California ... 展开 >> University of California at San Francisco Recruiting San Francisco, California, United States, 94143 Contact: Mitchell Rosen, M.D. Mitchell.Rosen@ucsf.edu Contact: Joseph Letourneau joseph.letourneau@ucsf.edu Principal Investigator: Mitchell Rosen, M.D. 收起 << |
计算器 | ||||
存储液制备 | ![]() |
1mg | 5mg | 10mg |
1 mM 5 mM 10 mM |
2.69mL 0.54mL 0.27mL |
13.46mL 2.69mL 1.35mL |
26.92mL 5.38mL 2.69mL |
CAS号 | 10540-29-1 |
分子式 | C26H29NO |
分子量 | 371.51 |
SMILES Code | CC/C(C1=CC=CC=C1)=C(C2=CC=C(OCCN(C)C)C=C2)\C3=CC=CC=C3 |
MDL No. | MFCD00010454 |
别名 | ICI 47699; trans-Tamoxifen; ICI 46474; (Z)-Tamoxifen |
运输 | 蓝冰 |
存储条件 |
In solvent -20°C:3-6个月-80°C:12个月 Pure form |
溶解方案 |
DMSO: 25 mg/mL(67.29 mM),配合低频超声,并水浴加热至45℃助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO 无水乙醇: 50 mg/mL(134.58 mM),配合低频超声助溶,注意:无水乙醇开封后,易挥发,也会吸收空气中的水分,导致溶解能力下降,请避免使用开封较久的乙醇 |
Tags: Tamoxifen/他莫昔芬 |Tamoxifen/他莫昔芬 | ICI 47699 | trans-Tamoxifen | ICI 46474 | (Z)-Tamoxifen | 10540-29-1 | 自噬 | 热休克蛋白 | 凋亡 | 细胞凋亡诱导剂 | ERR | Tamoxifen/他莫昔芬 纯度/质量文件 | Tamoxifen/他莫昔芬 亚型比较 | Tamoxifen/他莫昔芬 生物活性 | Tamoxifen/他莫昔芬 细胞研究 | Tamoxifen/他莫昔芬 临床数据 | Tamoxifen/他莫昔芬 实验方案 | Tamoxifen/他莫昔芬 技术信息
请填写此表格索取QC报告。我们很快就会发送到您的邮箱。您的信息在我们这里是安全的。*是必填项.
靶点 | 数值 |
Estrogen receptor |
需要的总药量: mg
您需要配制的工作液浓度为:mg/mL
细胞系 | 浓度 | 检测类型 | 检测时间 | 活性说明 | 数据源 |
518A2 cells | Cytotoxicity assay | 96 h | Cytotoxicity against human 518A2 cells after 96 hrs by SRB assay, IC50=7.62 μM | 22749392 | |
850C cells | Cytotoxicity assay | 96 h | Cytotoxicity against human 850C cells after 96 hrs by SRB assay, IC50=11.09 μM | 22749392 | |
A253 cells | Cytotoxicity assay | 96 h | Cytotoxicity against human A253 cells after 96 hrs by SRB assay, IC50=8.92 μM | 22749392 | |
A2780 cells | Cytotoxicity assay | 96 h | Cytotoxicity against human A2780 cells after 96 hrs by SRB assay, IC50=7.77 μM | 22749392 | |
A549 cells | Cytotoxicity assay | Cytotoxicity against human A549 cells assessed as cell viability by MTT assay, IC50=8.4 μM | 26079090 | ||
DLD1 cells | Cytotoxicity assay | 96 h | Cytotoxicity against human DLD1 cells after 96 hrs by SRB assay, IC50=4.78 μM | 22749392 | |
DU145 cells | Proliferation assay | 48 h | Antiproliferative activity against human DU145 cells after 48 hrs by MTT assay, IC50=5.5 μM | 23287057 | |
EL4 cell | Proliferation assay | Inhibition of [3H]thymidine incorporation into EL4 cell proliferation, ic50=0.535 μM | 1573630 | ||
GBM1 cells | Proliferation assay | 72 h | Antiproliferative activity against human GBM1 cells assessed as reduction in cell viability incubated for 72 hrs by WST-1 method, IC50=7.5 μM | 26355532 | |
GBM2 cells | Proliferation assay | 72 h | Antiproliferative activity against human GBM2 cells assessed as reduction in cell viability incubated for 72 hrs by WST-1 method, IC50=3.5 μM | 26355532 | |
GBM3 cells | Proliferation assay | 72 h | Antiproliferative activity against human GBM3 cells assessed as reduction in cell viability incubated for 72 hrs by WST-1 method, IC50=4.7 μM | 26355532 | |
HEK293T cells | Function assay | Antagonist activity at Gal4 DBD-fused human ERalpha LBD expressed in HEK293T cells assessed as inhibition of estradiol-induced transcriptional activation after 20 hrs by luciferase reporter gene assay, IC50=0.039 μM | 23786452 | ||
HeLa cells | Function assay | Inhibition of 17-beta-estradiol mediated luciferase transcription in HeLa cells expressing human estrogen receptor alpha; ERE assay, IC50=0.622 μM | 15658851 | ||
HepG2 cells | Proliferation assay | 48 h | Antiproliferative activity against human HepG2 cells after 48 hrs by MTT assay, IC50=6.3 μM | 23287057 | |
HepG2 cells | Cytotoxicity assay | 24 h | Cytotoxicity against human HepG2 cells after 24 hrs by CellTiter-BlueCell viability assay, IC50=23.4μM | 20545334 | |
HL60 cells | Cytotoxicity assay | 72 h | Cytotoxicity against human HL60 cells after 72 hrs by WST1 assay in presence of 20% FBS, IC50=14.3 μM | 22901895 | |
HT-29 cells | Growth inhibition assay | Growth inhibition of human HT-29 cells, IC50=9.5 μM | 23403084 | ||
Ishikawa cells | Function assay | Concentration of compound required to induce 50 % of the maximum stimulation of alkaline phosphatase activity in Ishikawa cells, EC50=0.033 μM | 8201587 | ||
Ishikawa cells | Function assay | 72 h | Antiestrogenic activity in human Ishikawa cells assessed as inhibition of estrogen-induced alkaline phosphatase activity after 72 hrs, IC50=0.17 μM | 18835176 | |
K562 cells | Proliferation assay | 72 h | Antiproliferative activity against human K562 cells after 72 hrs, IC50=5.2 μM | 25420175 | |
KIF5 cells | Cytotoxicity assay | 24 h | Toxicity against human KIF5 cells incubated for 24 hrs by CellTiter Blue cell viability assay, IC50=23.75 μM | 22775474 | |
Lipo cells | Cytotoxicity assay | 96 h | Cytotoxicity against human Lipo cells after 96 hrs by SRB assay, IC50=8.64 μM | 22749392 | |
LNCAP cells | Proliferation assay | 48 h | Antiproliferative activity against human LNCAP cells expressing androgen receptor incubated with 0.6 nM of estradiol and 0.7 nM of testosterone after 48 hrs by sulforhodamine B assay, IC50=10 μM | 21513275 | |
M21 cells | Growth inhibition assay | Growth inhibition of human M21 cells, IC50=11 μM | 23403084 | ||
MCF7 cells | Function assay | Effective concentration against MCF-7 breast tumor cells using MCF-7 assay, EC50=0.01 μM | 12825935 | ||
MCF7 cells | Cytotoxicity assay | 48 h | Cytotoxicity against human MCF7 cells after 48 hrs by SRB assay, IC50=0.027 μM | 22472045 | |
MCF-7-2a cells | Function assay | Antiestrogenic activity in MCF-7-2a cells as concentration required to reduce estradiol effect by 50%, IC50=0.5 μM | 12431063 | ||
MDA-MB-231 cells | Function assay | Inhibition of estrogen receptor negative MDA-MB-231 breast cancer cell proliferation, IC50=0.08 μM | 14971899 | ||
MDA-MB-231 cells | Proliferation assay | Antiproliferative activity against human MDA-MB-231 cells by MTT assay, IC50=0.66 μM | 20451380 | ||
MDA-MB-435 cells | Function assay | Inhibition of MDA-MB-435 breast cancer cell proliferation, IC50=0.05 μM | 14971899 | ||
MDA-MB-435S cells | Cytotoxicity assay | Cytotoxicity against human MDA-MB-435S cells assessed as cell viability by MTT assay, IC50=5.5 μM | 26079090 | ||
MSTO-211H cells | Proliferation assay | 72 h | Antiproliferative activity against human MSTO-211H cells after 72 hrs by trypan blue assay, IC50=23.3 μM | 23735829 | |
NCI-H460 cells | Function assay | 24 h | Anticancer activity against human NCI-H460 cells after 24 hrs by SRB assay, IC50=4.48 μM | 19733085 | |
NIH/3T3 cells | Cytotoxicity assay | 96 h | Cytotoxicity against mouse NIH/3T3 cells after 96 hrs by SRB assay, IC50=7.26 μM | 22749392 | |
PC3 cells | Proliferation assay | 24 h | Antiproliferative activity against human PC3 cells after 24 hrs by MTT assay, IC50=7 μM | 24880230 | |
ScN2a-cl3 cells | Cytotoxicity assay | 5 days | Cytotoxicity against mouse dividing ScN2a-cl3 cells assessed as cell viability after 5 days by calcein-AM staining-based fluorescence assay, IC50=4.89 μM | 24183589 | |
SKOV3 cells | Function assay | 24 h | Anticancer activity against human SKOV3 cells after 24 hrs by SRB assay, IC50=6.4 μM | 19733085 | |
T47D cells | Function assay | Antiestrogenic activity in human T47D cells expressing estrogen receptor assessed as estrogen-dependent transcription by luciferase reporter gene assay, IC50=0.1 μM | 19131248 | ||
T47D cells | Growth inhibition assay | 72 h | Growth inhibition of human estrogen-dependent T47D cells after 72 hrs, IC50=1 μM | 19131248 | |
yeast AH109 cells | Function assay | 24 h | Antagonist activity at ERbeta receptor LBD expressed in yeast AH109 cells assessed as inhibition of interaction with SRC1 after 24 hrs by alpha-galactosidase assay, IC50=1.66 μM | 22647217 |
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
NCT00041080 | Fallopian Tube Cancer ... 展开 >> Primary Peritoneal Cavity Cancer Recurrent Ovarian Epithelial Cancer Stage III Ovarian Epithelial Cancer Stage IV Ovarian Epithelial Cancer 收起 << | Phase 3 | Completed | - | United States, Pennsylvania ... 展开 >> Gynecologic Oncology Group Philadelphia, Pennsylvania, United States, 19103 收起 << |
NCT00041080 | - | Completed | - | - | |
NCT03011684 | Infertility | Phase 3 | Recruiting | December 2019 | United States, California ... 展开 >> University of California at San Francisco Recruiting San Francisco, California, United States, 94143 Contact: Mitchell Rosen, M.D. Mitchell.Rosen@ucsf.edu Contact: Joseph Letourneau joseph.letourneau@ucsf.edu Principal Investigator: Mitchell Rosen, M.D. 收起 << |
NCT00036270 | Breast Neoplasms | Phase 3 | Completed | - | - |
NCT01553903 | Breast Cancer | Phase 4 | Completed | - | France ... 展开 >> Institut Claudius REGAUD Toulouse, France, 31052 收起 << |
NCT00036270 | - | Completed | - | - | |
NCT00118157 | Estrogen Receptor Positive ... 展开 >> Male Breast Carcinoma Progesterone Receptor Positive Recurrent Breast Carcinoma Stage IIIB Breast Cancer Stage IIIC Breast Cancer Stage IV Breast Cancer 收起 << | Phase 2 | Completed | - | United States, Michigan ... 展开 >> Harper University Hospital - DMC Detroit, Michigan, United States, 48201 Wayne State University/Karmanos Cancer Institute Detroit, Michigan, United States, 48201 收起 << |
NCT00118157 | - | Completed | - | - | |
NCT02584465 | Ovarian Carcinoma | Phase 2 | Recruiting | May 2022 | France ... 展开 >> ICO Paul Papin Active, not recruiting Angers, France, 49100 Institut Sainte-Catherine Active, not recruiting Avignon, France, 84918 Hôpital Jean Minjoz Active, not recruiting Besancon, France, 25030 Institut Bergonié Recruiting Bordeaux, France, 33076 Contact: Anne FLOQUET, MD 5 56 33 33 33 ext 0033 a.floquet@bordeaux.unicancer.fr Polyclinique Bordeaux Nord Active, not recruiting Bordeaux, France, 33300 Centre François Baclesse Enrolling by invitation Caen, France, 14000 Centre Hospitalier de Cholet Active, not recruiting Cholet, France, 49300 Centre Jean Perrin Enrolling by invitation Clermont-ferrand, France, 63000 Centre Oscar Lambret Active, not recruiting Lille, France, 59020 Centre Hospitalier Universitaire Dupuytren Enrolling by invitation Limoges, France, 87042 Centre Léon Bérard Recruiting Lyon, France, 69373 Contact: Olivier TREDAN, MD 4 78 78 59 16 ext 0033 olivier.tredan@lyon.unicancer.fr Institut Paoli Calmettes Recruiting Marseille, France, 13009 Contact: Magali PROVANSAL, MD 4 91 22 37 40 ext 0033 provansalm@ipc.unicancer.fr Hôpital de Mont-de-Marsan Active, not recruiting Mont de Marsan, France, 40024 Centre Azuréen de Cancérologie Recruiting Mougins, France, 06250 Contact: Rémy LARGILLIER 4 92 92 37 37 ext 0033 r.largillier@cac-mougins.fr ORACLE - Centre d'Oncologie de Gentilly Active, not recruiting Nancy, France, 54100 Centre Catherine de Sienne Recruiting Nantes, France, 44202 Contact: Alain LORTHOLARY, MD 2 28 27 21 71 ext 0033 lortholary.alain@catherinedesienne.fr Centre Hospitalier Régional d'Orléans Active, not recruiting Orléans, France, 45067 Institut Mutualiste Montsouris Recruiting Paris, France, 75014 Contact: Chrostophe LOUVET, MD 1 56 61 60 35 ext 0033 christophe.louvet@imm.fr Clinique Francheville Active, not recruiting Perigueux, France, 24004 Centre Hospitalier Lyon Sud Active, not recruiting Pierre-Benite, France, 69495 Centre CARIO - HPCA Recruiting Plerin SUR MER, France, 22190 Contact: Anne-Claire HARDY-BESSARD, MD 2 96 75 22 16 ext 0033 ac.hardy@clin-armoricaine.fr Centre Hospitalier Annecy Genevois Active, not recruiting Pringy, France, 74374 Institut Jean Godinot Recruiting Reims, France, 51056 Contact: Aude-Marie SAVOYE, MD 26 50 43 97 ext +33(0)4 aude-marie.savoye@reims.unicancer.fr ICO Centre René Gauducheau Active, not recruiting Saint-herblain, France, 44805 Centre de Radiothérapie - Clinique Sainte-Anne Active, not recruiting Strasbourg, France, 67000 Centre Paul Strauss Active, not recruiting Strasbourg, France, 67065 Centre Hospitalier Universitaire Bretonneau Active, not recruiting Tours, France, 37044 收起 << |
NCT00201851 | Breast Cancer | Phase 3 | Completed | - | Morocco ... 展开 >> National Institute of Oncology Rabat, Morocco Philippines Vicente Soto Memorial Medical Center Cebu, Philippines East Avenue Medical Center Manila, Philippines Philippine General Hospital Manila, Philippines Rizal Manila, Philippines Santo Toma Hospital Manila, Philippines Vietnam Danang General Danang, Vietnam Hospital K, National Cancer Institute Hanoi, Vietnam Hue Central Hue, Vietnam 收起 << |
NCT02747004 | Metastatic Breast Cancer | Phase 2 | Active, not recruiting | May 15, 2019 | - |
NCT00756717 | Breast Cancer | Not Applicable | Unknown | May 2018 | United States, Illinois ... 展开 >> Loyola Univeristy Medical Center, Cardinal Bernardin Cancer Center Maywood, Illinois, United States, 60153 收起 << |
NCT00784888 | - | Completed | - | Turkey ... 展开 >> Pfizer Investigational Site Adana, Turkey, 01330 Pfizer Investigational Site Ankara, Turkey, 06100 Pfizer Investigational Site Ankara, Turkey, 06590 Pfizer Investigational Site Ankara, Turkey Pfizer Investigational Site Bursa, Turkey Pfizer Investigational Site Denizli, Turkey Pfizer Investigational Site Edirne, Turkey Pfizer Investigational Site Erzurum, Turkey Pfizer Investigational Site Gaziantep, Turkey Pfizer Investigational Site Istanbul, Turkey, 34303 Pfizer Investigational Site Istanbul, Turkey Pfizer Investigational Site Izmir, Turkey, 35340 Pfizer Investigational Site Izmir, Turkey Pfizer Investigational Site Kocaeli, Turkey Pfizer Investigational Site Malatya, Turkey Pfizer Investigational Site Trabzon, Turkey 收起 << | |
NCT00210028 | Breast Neoplasms | Phase 2 | Terminated | - | France ... 展开 >> Institut Bergonie Bordeaux, France Institut Val d'Aurelle_ Paul Lamarque Montpellier, France Institut Claudius Regaud Toulouse, France 收起 << |
NCT00201851 | - | Completed | - | - | |
NCT01220076 | Non Metastatic Breast Cancer | Phase 2 | Unknown | November 2016 | France ... 展开 >> Centre Léon Berard Recruiting Lyon, France, 69000 Contact: Thomas Bachelot, Md +33 478 78 28 28. Institut Curie Recruiting Paris, France Contact: Paul ¨Couttu, MD +33 1 56 24 55 00 Centre René Gauducheau Recruiting Saint Herblain, France, 44805 Contact: Mario Campone, MD +33240679900 收起 << |
NCT02913430 | Metastatic Breast Cancer | Phase 2 | Recruiting | March 2020 | United States, Pennsylvania ... 展开 >> Magee-Womens Hospital UPMC Recruiting Pittsburgh, Pennsylvania, United States, 15213 Contact: Shannon L. Cieply 412-641-2357 收起 << |
NCT00072462 | Breast Cancer | Phase 3 | Active, not recruiting | January 2022 | - |
NCT02993159 | Ductal Breast Carcinoma In Sit... 展开 >>u Estrogen Receptor Positive 收起 << | Phase 2 | Recruiting | July 15, 2019 | United States, Illinois ... 展开 >> Northwestern University Recruiting Chicago, Illinois, United States, 60611 Contact: Seema A. Khan, MD 312-503-4236 skhan@nm.org Principal Investigator: Seema A. Khan, MD United States, Kentucky Saint Elizabeth Medical Center South Recruiting Edgewood, Kentucky, United States, 41017 Contact: Joseph M. Guenther, MD 859-344-1600 Joseph.Guenther@stelizabeth.com Principal Investigator: Joseph M. Guenther, MD United States, Minnesota Mayo Clinic Not yet recruiting Rochester, Minnesota, United States, 55905 Contact: Amy C. Degnim, MD 507-284-4499 degnim.amy@mayo.edu Principal Investigator: Amy C. Degnim, MD United States, New York Memorial Sloan-Kettering Cancer Center Recruiting New York, New York, United States, 10065 Contact: Melissa L. Pilewskie, MD 646-888-4590 pilewskm@mskcc.org Principal Investigator: Melissa L. Pilewskie, MD United States, North Carolina Duke University Medical Center Recruiting Durham, North Carolina, United States, 27710 Contact: Eun-Sil (Shelley) Hwang, MD 919-684-6849 shelly.hwang@duke.edu Principal Investigator: Eun-Sil (Shelley) Hwang, MD United States, Ohio Cleveland Clinic Recruiting Cleveland, Ohio, United States, 44106 Contact: Stephen R. Grobmyer, MD 216-636-2843 grobmys@ccf.org Principal Investigator: Stephen R. Grobmyer, MD 收起 << |
NCT00295100 | Breast Cancer | Phase 2 | Completed | - | United States, California ... 展开 >> UCLA Medical Center Los Angeles, California, United States, 90095 United States, Massachusetts Dana Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, Michigan Wayne State University Detroit, Michigan, United States, 48201 United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55905 United States, Pennsylvania University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 Fox Chase Cancer Center Philadelphia, Pennsylvania, United States, 19111 Italy European Institute of Oncology Milan, Italy 收起 << |
NCT02311933 | Estrogen Receptor Positive ... 展开 >> HER2/Neu Negative Recurrent Breast Carcinoma Stage III Breast Cancer AJCC v7 Stage IIIA Breast Cancer AJCC v7 Stage IIIB Breast Cancer AJCC v7 Stage IIIC Breast Cancer AJCC v7 Stage IV Breast Cancer AJCC v6 and v7 收起 << | Phase 2 | Active, not recruiting | - | - |
NCT00999921 | Benign Breast Disease ... 展开 >> Fibrocystic Disease of Breast Fibroadenoma Mastalgia 收起 << | Phase 4 | Completed | - | India ... 展开 >> Department of Surgery, Medical College, Kolkata Kolkata, West Bengal, India, 700073 收起 << |
NCT00999921 | - | Completed | - | - | |
NCT03707340 | - | Recruiting | September 2019 | United States, New Jersey ... 展开 >> Memoral Sloan Kettering Basking Ridge Recruiting Basking Ridge, New Jersey, United States, 07920 Contact: Shari Goldfarb, MD 646-888-5080 Memoral Sloan Kettering Monmouth Recruiting Middletown, New Jersey, United States, 07748 Contact: Shari Goldfarb, MD 646-888-5080 United States, New York Memorial Sloan Kettering Cancer Center @ Commack Recruiting Commack, New York, United States, 11725 Contact: Shari Goldfarb, MD 646-888-5080 Memoral Sloan Kettering Westchester Recruiting Harrison, New York, United States, 10604 Contact: Shari Goldfarb, MD 646-888-5080 Memorial Sloan - Kettering Cancer Center Recruiting New York, New York, United States, 10021 Contact: Shari Goldfarb, MD 646-888-5080 Memorial Sloan Kettering @ Rockville Recruiting Rockville Centre, New York, United States, 11570 Contact: Shari Goldfarb, MD 646-888-5080 收起 << | |
NCT00827307 | Mammography E... 展开 >>strogen Lipemia Endometrium Ultrasonography 收起 << | Not Applicable | Completed | - | China, Zhejiang ... 展开 >> Zhejiang Cancer Hospital Hangzhou, Zhejiang, China, 310022 收起 << |
NCT00287534 | Breast Cancer | Phase 2 | Completed | - | Germany ... 展开 >> Research Site Albstadt, Germany Research Site Berlin, Germany Research Site Cloppenburg, Germany Research Site Eggenfelden, Germany Research Site Frankfurt, Germany Research Site Freiburg, Germany Research Site Goettingen, Germany Research Site Halle, Germany Research Site Hamburg, Germany Research Site Hanau, Germany Research Site Hannover, Germany Research Site Heidelberg, Germany Research Site Hoyerswerda, Germany Research Site Idar-Oberstein, Germany Research Site Jena, Germany Research Site Karlsruhe, Germany Research Site Kassel, Germany Research Site Kiel, Germany Research Site Leonberg, Germany Research Site Lingen, Germany Research Site Luebeck, Germany Research Site Magdeburg, Germany Research Site Mainz, Germany Research Site Mannheim, Germany Research Site Muenchen, Germany Research Site Muenster, Germany Research Site Neustadt, Germany Research Site Osnabrueck, Germany Research Site Paderborn, Germany Research Site Pforzheim, Germany Research Site Recklinghausen, Germany Research Site Rosenheim, Germany Research Site Rostock, Germany Research Site Ruesselsheim, Germany Research Site Schleswig, Germany Research Site Siegen, Germany Research Site Titisee-Neustadt, Germany Research Site Tuebingen, Germany Research Site Ulm, Germany Research Site Waiblingen, Germany Research Site Westerstede, Germany Research Site Worms, Germany Research Site Wuerzburg, Germany 收起 << |
NCT01821066 | Healthy | Phase 1 | Completed | - | United States, Connecticut ... 展开 >> Pfizer Investigational Site New Haven, Connecticut, United States, 06511 收起 << |
NCT01298713 | Breast Neoplasms ... 展开 >> mTor Protein 收起 << | Phase 2 | Completed | - | France ... 展开 >> Hopital Hotel Dieu Paris, France, 75004 收起 << |
NCT00952731 | - | Completed | - | - | |
NCT00952731 | Ductal Breast Carcinoma in Sit... 展开 >>u Estrogen Receptor-positive Breast Cancer 收起 << | Phase 2 | Completed | - | United States, Illinois ... 展开 >> Northwestern University Chicago, Illinois, United States, 60611 收起 << |
NCT00228930 | - | Completed | - | United States, Indiana ... 展开 >> Indiana University Indianapolis, Indiana, United States, 46202 United States, Michigan UMCCC Ann Arbor, Michigan, United States, 48109 收起 << | |
NCT02355600 | - | Recruiting | December 2020 | Spain ... 展开 >> Hospital Universitari i Politècnic La Fe Recruiting Valencia, Spain, 46026 Contact: Ainhoa Romero, MD ainhoa.romero.espinos@gmail.com Sub-Investigator: Ainhoa Romero Espinós, MD Sub-Investigator: Alicia Marzal Escrivá, MD Sub-Investigator: Antonio Pellicer, MD Sub-Investigator: Natalia Fischer, MD Sub-Investigator: Daniella Galliano, MD Sub-Investigator: Ignacio Iniesta, BSc Sub-Investigator: Irene Peinado, BSc 收起 << | |
NCT01638247 | Male Breast Cancer | Phase 3 | Completed | - | Germany ... 展开 >> Kliniken Essen-Mitte Essen, Nordrhein-Westfalen, Germany, 45136 收起 << |
NCT00411203 | Bipolar Disorder | Phase 3 | Completed | - | Turkey ... 展开 >> Dokuz Eylül University, Department of Psychiatry Izmir, Turkey, 35340 收起 << |
NCT00286117 | Breast Cancer | Phase 3 | Completed | - | Italy ... 展开 >> Research Site Arezzo, Italy Research Site Bologna, Italy Research Site Casalpusterlengo, Italy Research Site Catania, Italy Research Site Chieti, Italy Research Site Ferrara, Italy Research Site Firenze, Italy Research Site Forli, Italy Research Site Genova, Italy Research Site Lugo, Italy Research Site Messina, Italy Research Site Milano, Italy Research Site Monserrato, Italy Research Site Palermo, Italy Research Site Pavia, Italy Research Site Pinerolo, Italy Research Site Roma, Italy Research Site Rovigo, Italy Research Site San Remo, Italy Research Site Saronno, Italy Research Site Sassari, Italy Research Site Terni, Italy Research Site Torino, Italy Research Site Trieste, Italy Research Site Vicenza, Italy 收起 << |
NCT01685255 | Ovarian Cancer ... 展开 >> Genitourinary (GU) Tumors 收起 << | Phase 2 | Terminated(Study was terminate... 展开 >>d by the sponsor for lack of evidence of superiority and slow study accrual.) 收起 << | - | - |
NCT00815555 | - | Unknown | - | Israel ... 展开 >> Clinical Pharmacology Unit - Assaf Harofeh Medical Center Recruiting Zerifin, Israel, 70300 Contact: Matitiahu Berkovitch, Prof 972-57-345152 mberkovitch@asaf.health.gov.il 收起 << | |
NCT00365599 | Breast Cancer | Phase 2 | Completed | - | United States, California ... 展开 >> University of California San Francisco, California, United States, 94143 United States, Florida Bethesda Memorial Hospital Research Center Boynton Beach, Florida, United States, 33435 M.D. Anderson of Orlando Orlando, Florida, United States, 32806 Fawcett Memorial Hospital Port Charlotte, Florida, United States, 33949 Martin Memorial Cancer Center Stuart, Florida, United States, 34994 Tallahassee Memorial HealthCare, Inc. Tallahassee, Florida, United States, 32308 H. Lee Moffitt Cancer Center & Research Institute Tampa, Florida, United States, 33612 United States, Georgia St. Joseph's/Candler Savannah, Georgia, United States, 31405 收起 << |
NCT02914158 | Breast Cancer | Phase 3 | Recruiting | December 2025 | China ... 展开 >> Cancer Hospital Chinese Academy of Medical Sciences Active, not recruiting Beijing, China Peking University First Hospital Active, not recruiting Beijing, China Dongguan People's Hospital Recruiting Dongguan, China Contact: Ailing Zhang GuangDong Hospital Of Traditional Chinese Medicine Recruiting Guangzhou, China Contact: Qianjun Chen Guangdong People's Hospital Active, not recruiting Guangzhou, China Guangdong Provincial Women and Children's Hospital Recruiting Guangzhou, China Contact: Zhang A Qin Guangzhou First Municipal People's Hospital Recruiting Guangzhou, China Contact: Li Zhao Guangzhou Women and Childrens Medical Center Recruiting Guangzhou, China Contact: Hongming Ma Sun Yat-sen Memorial Hospital, Sun Yat-sen University Recruiting Guangzhou, China Contact: Yao H Rui Sun Yat-sen University Cancer Center Recruiting Guangzhou, China Contact: Yuan Z Yu The Second Affiliated Hospital of Guangzhou Medical University Recruiting Guangzhou, China Contact: Lehong Zhang Guilin TCMhospital of China Recruiting Guilin, China Contact: Rui Zhuo Zhejiang Provincial People's Hospital Active, not recruiting Hangzhou, China Harbin Medical University Cancer Hospital Recruiting Harbin, China Contact: Li Cai Yunnan Cancer Hospital Active, not recruiting Kunming, China Maoming People's Hospital Recruiting Maoming, China Contact: Weixiong Yang The first Affiliated Hospital of Guangxi Medical University Recruiting Nanning, China Contact: Jingcai Zhong The Affiliated Hospital of Qingdao University Active, not recruiting Qingdao, China The First Affiliated Hospital of Wenzhou Medical University Active, not recruiting Wenzhou, China Affiliated hospital of Guangdong Medicine College Recruiting Zhanjiang, China Contact: Li J Wen Affiliated hospital of Guangdong Medicine College Recruiting Zhanjiang, China Contact: Zhang Y Qi Lian Jiang People' s Hospital Recruiting Zhanjiang, China Contact: Huang Heng Henan Cancer Hospital Active, not recruiting Zhengzhou, China Zhongshan People's Hospital Recruiting Zhongshan, China Contact: Feihai Ling The Fifth Affiliated Hospital Sun Yat-Sen University Recruiting Zhuhai, China Contact: Hongyu Zhang 收起 << |
NCT02093351 | Solid Tumours | Phase 1 | Active, not recruiting | December 31, 2018 | Belgium ... 展开 >> Research Site Brussels, Belgium, 1090 Research Site Edegem, Belgium, 2650 Research Site Gent, Belgium, 9000 Research Site Leuven, Belgium, 3000 Research Site Liège, Belgium, 4000 Research Site Wilrijk, Belgium, 2610 Denmark Research Site Herlev, Denmark, 2730 France Research Site Bordeaux, France, 33076 Netherlands Research Site Amsterdam, Netherlands, 1081 HV Research Site Utrecht, Netherlands, 3584 CX United Kingdom Research Site London, United Kingdom, SE1 9RT Research Site Manchester, United Kingdom, M20 4BX Research Site Newcastle Upon Tyne, United Kingdom, NE7 7DN Research Site Sutton, United Kingdom, SM2 5PT 收起 << |
NCT02062489 | Breast Cancer | Phase 4 | Recruiting | May 2024 | China, Guangdong ... 展开 >> The First Affiliated Hospital of Guangzhou Medical University Recruiting Guangzhou, Guangdong, China, 510000 Contact: Wenbo Zheng The First Affiliated Hospital of Sun Yat-sen University Recruiting Guangzhou, Guangdong, China, 510000 Contact: Zhuanghong Wu, M.D. Guangdong Women and Children Hospital Recruiting Guangzhou, Guangdong, China, 510010 Contact: Anqin Zhang 86-13925115929 Guangzhou Army General Hospital Recruiting Guangzhou, Guangdong, China, 510010 Contact: Chenfang Zhang 86-13889908978 Sun Yat-Sen University Cancer Center Recruiting Guangzhou, Guangdong, China, 510060 Contact: Xiaoming Xie, M.D.,Ph.D. 86-13826109540 xiexm@sysucc.org.cn Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University Recruiting Guangzhou, Guangdong, China, 510120 Contact: Erwei Song, M.D.,Ph.D. songerwei02@yahoo.com.cn Contact: Qiang Liu victorlq@hotmail.com.com Principal Investigator: Erwei Song, M.D.,Ph.D. Guangzhou Women and Children Hospital Recruiting Guangzhou, Guangdong, China, 510180 Contact: Hongmin Ma 86-13922723808 China, Xinjiang Xinjiang Medical School Cancer Center Recruiting Xinjiang, Xinjiang, China Contact: Binlin Ma, M.D. Contact: Gang Sun, M.D. China, Zhejiang Zhejiang Cancer Hospital Recruiting Hangzhou, Zhejiang, China, 310022 Contact: Hongjian Yang, M.D. 收起 << |
NCT00424164 | Breast Cancer | Phase 1 | Unknown | - | France ... 展开 >> Centre Regional Rene Gauducheau Dijon, France, 21079 收起 << |
NCT02093351 | - | Active, not recruiting | - | - | |
NCT01896050 | - | Completed | - | - | |
NCT00830973 | - | Completed | - | United States, New Jersey ... 展开 >> Robert Epstein Franklin Lakes, New Jersey, United States, 07417 收起 << | |
NCT01896050 | - | Completed | - | United States, Michigan ... 展开 >> University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States, 48109 收起 << | |
NCT00080743 | Breast Cancer | Phase 2 | Completed | - | United States, New Hampshire ... 展开 >> Norris Cotton Cancer Center at Dartmouth-Hitchcock Medical Center Lebanon, New Hampshire, United States, 03756 收起 << |
NCT00963209 | Breast Cancer | Phase 3 | Unknown | December 2013 | Switzerland ... 展开 >> Hôpitaux Universitaire de Genève Recruiting Genève, Switzerland, 1211 Contact: Alexandre Bodmer, MD 41 22 382 40 14 Centre Hospitalier Universitaire Vaudois Recruiting Lausanne, Switzerland, 1011 Contact: Khalil Zaman, MD 41-21-314-0168 Khalil.Zaman@chuv.ch 收起 << |
NCT03504631 | - | Recruiting | December 1, 2018 | Indonesia ... 展开 >> Dharmais hospital Recruiting Jakarta, DKI Jakarta, Indonesia, 11420 Contact: Denni Jokopurwanto, MD, PhD +62811153590 dennijoko@gmail.com 收起 << | |
NCT00365599 | - | Completed | - | - | |
NCT00919399 | Breast Neoplasms | Phase 2 | Completed | - | France ... 展开 >> CHU de Toulouse Rangueil Toulouse, France Institut Claudius Regaud Toulouse, France 收起 << |
NCT02094495 | - | Unknown | March 2017 | Korea, Republic of ... 展开 >> Center for Breast Cancer, National Cancer Center Recruiting Goyang-si, Gyeonggi-do, Korea, Republic of, 410-769 Contact: Eun Sook Lee, MD, PhD +82-31-920-2011 eslee@ncc.re.kr Sub-Investigator: Myong Cheol Lim 收起 << | |
NCT00295646 | Breast Cancer | Phase 3 | Unknown | June 2016 | - |
NCT00912548 | Breast Cancer | Phase 3 | Unknown | December 2015 | Korea, Republic of ... 展开 >> Department of Surgery, Korea Cancer Center Hospital Seoul, Korea, Republic of 收起 << |
NCT03423199 | Breast Neoplasms | Phase 3 | Recruiting | February 2022 | Japan ... 展开 >> Aichi Cancer Center Hospital Recruiting Nagoya, Aichi, Japan, 464-8681 Contact: Hiroji Iwata, MD National Cancer Center Hospital East Recruiting Kashiwa, Chiba, Japan, 2778577 Contact: Hirofumi Mukai, MD, PhD National Hospital Organization Shikoku Cancer Center Recruiting Matsuyama, Ehime, Japan, 7910280 Contact: Kenjiro Aogi National Hospital Organization Hokkaido Cancer Center Recruiting Sapporo, Hokkaido, Japan, 0030804 Contact: Masato Takahashi, MD, PhD Hyogo Cancer Center Recruiting Akashi, Hyogo, Japan, 6738558 Contact: Koji Matsumoto, MD Kanagawa Cancer Center Recruiting Yokohama, Kanagawa, Japan, 2418515 Contact: Toshinari Yamashita, MD, PhD Kindai University Hospital Recruiting Ōsaka-sayama, Osaka, Japan, 5898511 Contact: Junji Tsurutani, MD, PhD Toranomon Hospital Recruiting Minato-Ku, Tokyo, Japan, 1058470 Contact: Toshimi Takano, MD Chiba Cancer Center Recruiting Chiba, Japan, 2608717 Contact: Naohito Yamamoto, MD, PhD Kyusyu Cancer Center Recruiting Fukuoka, Japan, 8111395 Contact: Eriko Tokunaga, MD National Hospital Organization Osaka National Hospital Recruiting Osaka, Japan, 5400006 Contact: Norikazu Masuda National Cancer Center Hospital Recruiting Tokyo, Japan, 104-0045 Contact: Kenji Tamura, MD, PhD Korea, Republic of National Cancer Center Recruiting Gyeonggi-do, Korea, Republic of, 10408 Contact: Keun Seok Lee, MD, PhD Ajou University Hospital Recruiting Gyeonggi-do, Korea, Republic of, 16499 Contact: Seok Yun Kang, MD Seoul National University Bundang Hospital Recruiting Gyeonggi-do, Korea, Republic of, 463-707 Contact: Jee Hyun Kim, MD, MS, PhD Seoul National University Hospital Recruiting Seoul, Korea, Republic of, 03080 Contact: Kyung-Hun Lee, MS, PhD Asan Medical Center Recruiting Seoul, Korea, Republic of, 05505 Contact: Kyung Hae Jung, MD, PhD Severance Hospital, Yonsei University Health System Recruiting Soeul, Korea, Republic of, 03722 Contact: Joo Hyuk Sohn, MD Singapore National University Hospital Recruiting Singapore, Singapore, 119882 Contact: Soo Chin Lee, MMed, MRCP National Cancer Centre Singapore Recruiting Singapore, Singapore, 169610 Contact: Yoon Sim Yap, MD Taiwan National Taiwan University Hospital Recruiting Taipei, Taiwan, 10048 Contact: Yen-Shen Lu, PhD Taipei Vetarans General Hospital Recruiting Taipei, Taiwan, 11217 Contact: Ling-Ming Tseng, MD Sun Yat-Sen Cancer Center Recruiting Taipei, Taiwan, 11259 Contact: Mei-Ching Liu, MD 收起 << |
NCT00206492 | Breast Cancer | Phase 2 | Terminated(halted by the PI on... 展开 >>ly 3 of 45 subjects were accrued.) 收起 << | - | United States, Texas ... 展开 >> Baylor Breast Center Houston, Texas, United States, 77030 收起 << |
NCT03060304 | Endometrium | Phase 4 | Not yet recruiting | June 2020 | - |
NCT02479256 | PCOS | Phase 4 | Completed | - | Egypt ... 展开 >> Ain Shams University Maternity Hospital Cairo, Egypt 收起 << |
NCT00896155 | Pulmonary Fibrosis ... 展开 >> Breast Cancer 收起 << | Phase 3 | Unknown | December 2013 | India ... 展开 >> Tata Memorial Center Recruiting Parel, Mumbai, India, 400012 Contact: Anusheel Munshi, MD -91-22-24177000 ext 7144 收起 << |
NCT00537771 | Breast Cancer | Phase 4 | Completed | - | China, Fujian ... 展开 >> Research Site Fuzhou, Fujian, China China, Guangdong Research Site Guangzhou, Guangdong, China China, Guangxi Research Site Nanning, Guangxi, China China, Hubei Research Site Wuchang, Hubei, China Research Site Wuhan, Hubei, China China, Jiangsu Research Site Nanjing, Jiangsu, China China, Jilin Research Site Changchun, Jilin, China China, Liaoning Research Site Dalian, Liaoning, China China, Shandong Research Site Jinan, Shandong, China China, Shanghai Research Site Shanghai, Shanghai, China China, Shanxi Research Site Taiyuan, Shanxi, China Research Site Xian, Shanxi, China China, Sichuan Research Site Chengdu, Sichuan, China China, Yunnan Research Site Kunming, Yunnan, China China, Zhejiang Research Site Hangzhou, Zhejiang, China China Research Site Tianjin, China 收起 << |
NCT00537771 | - | Completed | - | - | |
NCT02404844 | Breast Cancer | Phase 2 | Completed | - | Germany ... 展开 >> iOMEDICO AG Freiburg, Baden-Württemberg, Germany, 79108 收起 << |
NCT00973037 | - | Unknown | April 2016 | Korea, Republic of ... 展开 >> Korea University Anam Hopital Recruiting Seoul, Korea, Republic of, 136-705 Contact: Eun Sook Lee, MD, PhD 82-2-920-6744 eslee@korea.ac.kr Principal Investigator: Eun Sook Lee, MD, PhD 收起 << | |
NCT00309491 | Early-stage Breast Cancer | Phase 3 | Completed | - | - |
NCT00687102 | Cognition Agi... 展开 >>ng 收起 << | Phase 3 | Completed | - | - |
NCT00687102 | - | Completed | - | - | |
NCT02344940 | Breast Cancer | Phase 4 | Active, not recruiting | August 2018 | China, Shanghai ... 展开 >> Ruijin Hospital, Shanghai Jiaotong University School of Medicine Shanghai, Shanghai, China, 200025 收起 << |
NCT01357772 | Intraepithelial Carcinoma | Phase 3 | Active, not recruiting | December 2023 | Italy ... 展开 >> Istituto Scientifico Romagnolo per lo studio e la cura dei tumori Meldola, Forlì-Cesena, Italy, 47521 Ospedale di Carpi "Bernardino Ramazzini" Carpi, Modena, Italy, 41012 IRCCS Ospedale Oncologico di Bari - Istituto tumori "G. Paolo II" Bari, Italy, 70124 Fondazione per la ricerca e la Cura dei Tumori "T. Campanella" Catanzaro, Italy, 88100 E.O. Ospedali Galliera Genoa, Italy, 16128 AOU IRCSS San Martino - IST Genova, Italy, 16100 Istituto Europeo di Oncologia Milano, Italy, 20100 A. O. Universitaria Policlinico di Modena Modena, Italy, 41100 Istituto nazionale per lo studio e la cura dei tumori, IRCCS "Fondazione Pascale" Napoli, Italy, 80131 Fondazione Salvatore Maugeri Pavia, Italy, 27100 Ospedale Santa Maria delle Croci Ravenna, Italy, 48018 A.O. Universitaria S. Giovanni Battista - "Le Molinette" Torino, Italy, 10123 Presidio Ospedaliero "SS. Antonio e Margherita" Tortona, Italy, 15057 Ospedale di Circolo e Fondazione Macchi Varese, Italy, 21100 A.O. Vicenza Vicenza, Italy, 36100 收起 << |
NCT00165308 | Hodgkin's Disease ... 展开 >> Breast Cancer 收起 << | Not Applicable | Completed | - | United States, Massachusetts ... 展开 >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 收起 << |
NCT02801786 | Pain Discomfo... 展开 >>rt 收起 << | Phase 2 Phase 3 | Not yet recruiting | June 2021 | Brazil ... 展开 >> Universidade Federal de Goias Not yet recruiting Goiania, Goias, Brazil, 74605050 Contact: Ruffo Freitas 556281885540 ruffojr@terra.com.br Principal Investigator: Ruffo Freitas Junior 收起 << |
NCT02690870 | Infertility | Phase 4 | Not yet recruiting | March 2019 | - |
NCT02285179 | Breast Cancer | Phase 1 Phase 2 | Recruiting | July 2019 | France ... 展开 >> Gustave Roussy Not yet recruiting Paris, France Principal Investigator: Mahasti Saghatchian, MD Netherlands Antoni van Leeuwenhoek Recruiting Amsterdam, Netherlands, 1066 CX Contact: Sabine C Linn, MD +3120512 ext 2951 s.linn@nki.nl Contact: Annelot van Rossum, PhD +3120512 ext 2004 a.v.rossum@nki.nl Principal Investigator: Sabine C Linn, MD Reinier de Graaf Gasthuis Recruiting Delft, Netherlands Contact: K. Beelen, MD, PhD Principal Investigator: K. Beelen, MD, PhD Haaglanden Medisch Centrum Recruiting Den Haag, Netherlands Contact: R. Oosterkamp, MD, PhD Principal Investigator: R. Oosterkamp, MD, PhD Deventer Ziekenhuis Recruiting Deventer, Netherlands Contact: A. Imholz, MD, PhD Principal Investigator: A. Imholz, MD, PhD Ziekenhuis Groep Twente Recruiting Hengelo, Netherlands Contact: E. Siemerink, MD, PhD Principal Investigator: E. Siemerink, MD, PhD MUMC Recruiting Maastricht, Netherlands Contact: M. de Boer, MD, PhD Principal Investigator: M. de Boer, MD, PhD Spain Hospital Germans Trias i Pujol Recruiting Badalona, Spain Contact: M. Margeli Vila, MD, PhD Principal Investigator: M. Margeli Vila, MD, PhD Vall d'Hebron University Hospital/VHIO Recruiting Barcelona, Spain, 080035 Contact: Mafalda AM Oliviera, MD moliveira@vhio.net Hospital Clínic de Barcelona Recruiting Barcelona, Spain Contact: J. Garcia Corbacho, MD, PhD Principal Investigator: J. Garcia Corbacho, MD, PhD Hospital ICO-Hospitalet (Bellvitge) Recruiting Barcelona, Spain Contact: S. Pernas, MD, PhD Principal Investigator: S. Pernas, MD, PhD Hospital Arnau de Vilanova Recruiting Lleida, Spain Contact: S. Morales Murillo, MD, PhD Principal Investigator: S. Morales Murillo, MD, PhD Hospital Universitari Sant Joan de Reus Recruiting Tarragona, Spain Contact: K. Amillano, MD, PhD Principal Investigator: K. Amillano, MD, PhD United Kingdom University of Cambridge Recruiting Cambridge, United Kingdom, CB20QQ Contact: Richard D Baird, MA MRCP PhD +44122376 ext 8434 rdb39@medschl.cam.ac.uk 收起 << |
NCT02835079 | Duchenne Muscular Dystrophy | Phase 1 | Active, not recruiting | November 2020 | - |
NCT02586675 | Breast Cancer ... 展开 >> Breast Cancer - Female Breast Cancer - Male 收起 << | Phase 1 | Active, not recruiting | December 2018 | United States, Florida ... 展开 >> H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States, 33612 收起 << |
NCT02903121 | Bleeding Impl... 展开 >>ants Breakthrough Bleeding 收起 << | Phase 2 | Recruiting | June 2019 | United States, Oregon ... 展开 >> OHSU Recruiting Portland, Oregon, United States, 97239 Contact: Alison B Edelman, MD, MPH 503-494-5949 edelmana@ohsu.edu Principal Investigator: Alison B Edelman, MD, MPH 收起 << |
NCT01257581 | Amyotrophic Lateral Sclerosis | Phase 2 | Completed | - | United States, Kansas ... 展开 >> University of Kansas Medical Center Kansas City, Kansas, United States, 66160 United States, Massachusetts Massachusetts General Hospital Boston, Massachusetts, United States, 02114 University of Massachusetts Medical Center Worcester, Massachusetts, United States, 01655 United States, Missouri Washington University at St. Louis St. Louis, Missouri, United States, 63110 United States, New York SUNY Upstate Medical University Syracuse, New York, United States, 13210 United States, North Carolina Carolinas Medical Center Charlotte, North Carolina, United States, 28203 United States, Pennsylvania Pennsylvania State University, Hershey Medical Center Hershey, Pennsylvania, United States, 17033 United States, Washington University of Washington Medical Center Seattle, Washington, United States, 98195 United States, Wisconsin Medical College of Wisconsin Milwaukee, Wisconsin, United States, 53226 收起 << |
NCT03528902 | Hypertension ... 展开 >>Pulmonary Arterial Hypertension Familial Primary Pulmonary Hypertension Primary Pulmonary Hypertension Lung Diseases Tamoxifen Estrogen Receptor Antagonist Hormone Antagonists Estrogens 收起 << | Phase 2 | Recruiting | June 30, 2023 | United States, Tennessee ... 展开 >> Vanderbilt University Medical Center Recruiting Nashville, Tennessee, United States, 37232 Contact: Shannon Cordell, RN 615-343-8277 shannon.eason@vanderbilt.edu Contact: Errine Garnett, MS 615-343-4252 errine.t.garnett@vanderbilt.edu Principal Investigator: Eric D Austin, MD, MSc Principal Investigator: James E Loyd, MD Sub-Investigator: Anna R Hemnes, MD Sub-Investigator: Evan Brittain, MD, MSc 收起 << |
NCT01257581 | - | Completed | - | - | |
NCT03045653 | Breast Cancer Metastatic | Phase 2 | Completed | - | China, Guangdong ... 展开 >> Sun Yat-sen University, Cancer Center Guangzhou, Guangdong, China, 510060 收起 << |
NCT00710970 | Urinary Bladder Neoplasms | Phase 2 | Completed | - | United States, Texas ... 展开 >> Baylor College Of Medicine Houston, Texas, United States, 77030 Italy San Camillo and Forlanini Hospitals Rome, Italy 收起 << |
NCT00710970 | - | Completed | - | - | |
NCT03354039 | Duchenne Muscular Dystrophy | Phase 3 | Recruiting | June 2020 | Switzerland ... 展开 >> University Children's Hospital Basel Recruiting Basel, Switzerland, 4031 Contact: Patricia Hafner, MD +41 61 704 12 12 patricia.hafner@ukbb.ch Contact: Daniela Rubino +41 61 704 12 12 daniela.rubino-nacht@ukbb.ch Principal Investigator: Dirk Fischer, MD Sub-Investigator: Patricia Hafner, MD 收起 << |
NCT00532454 | Breast Cancer ... 展开 >> Metastatic Disease 收起 << | Phase 2 | Terminated(planned to design a... 展开 >> prospective study) 收起 << | - | Korea, Republic of ... 展开 >> National Cancer Center 809 Madu1-dong, Ilsandong-gu, Goyang-si, Gyeonggi-do, Korea, Republic of, 410-769 National cancer center Goyang-si, Gyeonggi-do, Korea, Republic of, 410-769 收起 << |
NCT03573648 | Breast Cancer | Phase 2 | Recruiting | August 2020 | United States, Maryland ... 展开 >> Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Recruiting Baltimore, Maryland, United States, 21287 Contact: Hopkins Breast Trials HopkinsBreastTrials@jhmi.edu Contact: Kimmel Cancer Center Clinical Research Office 410-955-8866 jhcccro@jhmi.edu Principal Investigator: Cesar A Santa-Maria, MD, MSCI 收起 << |
NCT00900744 | - | Completed | - | United States, New York ... 展开 >> Icahn School of Medicine at Mount Sinai New York, New York, United States, 10029 收起 << | |
NCT01194427 | - | Terminated(Difficulty meeting ... 展开 >>patient accrual goals) 收起 << | - | - | |
NCT01196936 | Breast Cancer | Phase 2 | Active, not recruiting | December 2018 | United States, Alabama ... 展开 >> University of Alabama at Birmingham Birmingham, Alabama, United States, 35233 United States, California City of Hope Medical Center Duarte, California, United States, 91010 United States, Colorado University of Colorado, Anschutz Medical Campus Aurora, Colorado, United States, 80045 United States, Illinois University of Chicago Chicago, Illinois, United States, 60637 United States, Massachusetts Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, Michigan University of Michigan Ann Arbor, Michigan, United States, 48109-5718 United States, Minnesota University of Minnesota Minneapolis, Minnesota, United States, 55455 Mayo Clinic Rochester, Minnesota, United States, 55905 United States, North Carolina Wake Forest University Winston-Salem, North Carolina, United States, 27157 United States, Tennessee St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 United States, Texas MD Anderson Houston, Texas, United States, 77030 United States, Washington Seattle Cancer Care Alliance Seattle, Washington, United States, 98109 Canada, Ontario University Health Network, Toronto Toronto, Ontario, Canada, M5G 2M9 收起 << |
NCT02482740 | Uterine Cervical Neoplasms | Phase 2 | Unknown | June 2017 | Taiwan ... 展开 >> Dept. of Obstetrics and Gynecology, Kaohsiung Chang Gung Memorial Hospital Not yet recruiting Kaohsiung, No 123, Dapi Rd, Niaosong Dist, Taiwan, 83301 Contact: Chan-Chao Chang, Bachelor +886975056401 chanchao@adm.cgmh.org.tw Contact: Hung-Chung Fu +886975056423 allen133@adm.cgmh.org.tw Sub-Investigator: Hao Lin, Bachelor Sub-Investigator: Yu-Che Ou, Bachelor Sub-Investigator: Ching-Chou Tsai, Master Sub-Investigator: Chen-Hsuan Wu, Bachelor Kaohsiung Medical University Chung-Ho Memorial Hospital Not yet recruiting Kaohsiung, No.100, Ziyou 1st Rd., Sanmin Dist., Taiwan, 807-56 Contact: Yu-Chieh Chen, Master +886975356642 benjamin2727@yahoo.com.tw Contact: Yu-Chieh Chen, Master +886975-356-642 benjamin2727@yahoo.com.tw Chung Shan Medical University Hospital Not yet recruiting Taichung, No.110,sec. 1,Jianguo NRd.,South Dist., Taiwan, 40201 Contact: Chih-Jen Tseng, Master +8864-24739595 ext 34501 tsengcj@gmail.com National Cheng Kung University Hospital Not yet recruiting Tainan, No.138, Shengli Rd., North Dist., Taiwan, 70403 Contact: Ching-I Wu, Bachelor Contact: Ya-Min Cheng +886921566219 chengym@mail.ncku.edu.tw China Medical University Hospital Not yet recruiting Taichung, No.2, Yude Rd., North Dist.,, Taiwan, 40447 Contact: Wu-Chou Lin, PhD +886-4-22052121 ext 2063 sun.bau@msa.hinet.net Contact: Lian-Shung Yeh, Master +886-4-22052121 ext 2063 lsyeh@mail.cmuh.org.tw Sub-Investigator: Yao-Ching Hung, PhD Kaohsiung Veterans General Hospital Not yet recruiting Kaohsiung, No.386, Dazhong 1st Rd., Zuoying Dist., Taiwan, 81362 Contact: Wen-Shiung Liou, MD +88673422121 ext 8191 wsliou@vghks.gov.tw Contact: Wen-Shiung Liou, MD +886975581667 wsliou@vghks.gov.tw Department of OB/GYN, Linkou Chang Geng Memorial Hospital Recruiting Taoyuan, Taiwan, 333 Contact: Chyong-Huey Lai, .MD +886975365883 jean0311@hotmail.com Contact: Huei-Jean Huang, MD +886975366298 hjhuang@cgmh.org.tw Sub-Investigator: Ting-Chang Chang, MD Sub-Investigator: Kuan-Gen Huang, MD Sub-Investigator: Angel Chao, PhD Sub-Investigator: Cheng-Tao Lin, MD Sub-Investigator: Jian-Tai Qiu, MD Sub-Investigator: Min-Yu Chen, MD Sub-Investigator: Yunhsin Tang, MD Sub-Investigator: Hung-Hsueh Chou, MD 收起 << |
NCT00764322 | Breast Cancer ... 展开 >> Menopausal Symptoms 收起 << | Phase 2 | Completed | - | United States, North Carolina ... 展开 >> Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill Chapel Hill, North Carolina, United States, 27599-7295 Blumenthal Cancer Center at Carolinas Medical Center Charlotte, North Carolina, United States, 28232-2861 Duke Comprehensive Cancer Center Durham, North Carolina, United States, 27710 Moses Cone Regional Cancer Center at Wesley Long Community Hospital Greensboro, North Carolina, United States, 27403-1198 Leo W. Jenkins Cancer Center at ECU Medical School Greenville, North Carolina, United States, 27834 Rex Cancer Center at Rex Hospital Raleigh, North Carolina, United States, 27607 United States, South Carolina Gibbs Regional Cancer Center at Spartanburg Regional Medical Center Spartanburg, South Carolina, United States, 29303 收起 << |
NCT01189500 | Pharmacokinetics | Phase 4 | Completed | - | United States, Florida ... 展开 >> Pfizer Investigational Site Miami, Florida, United States, 33126 Pfizer Investigational Site Miami, Florida, United States, 33134 收起 << |
NCT01579734 | Breast Cancer | Phase 3 | Active, not recruiting | December 2019 | Italy ... 展开 >> European Institute of Oncology Milan, Italy, 20141 收起 << |
NCT01189500 | - | Completed | - | - | |
NCT02890082 | Breast Cancer | Phase 2 | Recruiting | July 2022 | France ... 展开 >> ICO René Gauducheau Recruiting Nantes, France, 44805 Contact: BORDES Virginie, MD +33 2 40 67 99 00 virginie.bordes@ico.unicancer.fr 收起 << |
NCT01194427 | Stage I Breast Cancer ... 展开 >> Stage II Breast Cancer Stage III Breast Cancer Invasive Breast Cancer 收起 << | Phase 2 | Terminated(Difficulty meeting ... 展开 >>patient accrual goals) 收起 << | - | United States, Maryland ... 展开 >> Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States, 21287 收起 << |
NCT03112031 | Meningitis Streptococcal ... 展开 >> Hiv Meningitis Meningoencephalitis 收起 << | Phase 2 | Recruiting | December 2020 | Vietnam ... 展开 >> Cho Ray Hospital Recruiting Ho Chi Minh City, Vietnam Principal Investigator: Hung Le Quoc, MD Sub-Investigator: Ngan Nguyen Thi Thuy, MD Sub-Investigator: Binh Tran Quang, MD Hospital for Tropical Diseases Recruiting Ho Chi Minh City, Vietnam Principal Investigator: Tung Nguyen Le Nhu, MD Sub-Investigator: Mai Nguyen Thi Hoang, MD Sub-Investigator: Lan Nguyen Phu Huong, MD Sub-Investigator: Tai Luong Thi Hue, MD Sub-Investigator: Phu Nguyen Hoan, MD Sub-Investigator: Chau Nguyen Van Vinh, MD Oxford University Clinical Research Unit Active, not recruiting Ho Chi Minh City, Vietnam 收起 << |
NCT01192308 | Breast Cancer | Phase 1 | Completed | - | Netherlands ... 展开 >> Radboud University Nijmegen Medical Centre Nijmegen, Netherlands 收起 << |
NCT00764322 | - | Completed | - | - | |
NCT01075802 | Breast Cancer ... 展开 >> CYP2D6 Polymorphism 收起 << | Not Applicable | Completed | - | Australia, New South Wales ... 展开 >> St George Hospital Sydney, New South Wales, Australia Westmead Cancer Care Centre Westmead, New South Wales, Australia, 2145 收起 << |
NCT02936206 | Breast Cancer | Phase 1 | Recruiting | October 2019 | United States, New York ... 展开 >> Mount Sinai West Recruiting New York, New York, United States, 10019 Contact: Takhir Mirzoyev 212-523-7289 Takhir.mirzoyev@mountsinai.org Principal Investigator: Anupama Goel, MD Mount Sinai St. Luke's Recruiting New York, New York, United States, 10025 Contact: Audra Caine 212-523-6828 Audra.caine@mountsinai.org Principal Investigator: Aye Moe Thu Ma, MD Icahn School of Medicine at Mount Sinai Recruiting New York, New York, United States, 10029 Principal Investigator: Amy Tiersten, MD Sub-Investigator: Krystal Cascetta, MD Sub-Investigator: Paul H Schmidt, MD 收起 << |
NCT01027416 | Breast Cancer | Not Applicable | Completed | - | United States, Illinois ... 展开 >> University of Chicago Chicago, Illinois, United States, 60601 United States, New York Roswell Park Cancer Institute Buffalo, New York, United States, 14263 收起 << |
NCT00749138 | Chronic Hepatitis C | Phase 1 | Completed | - | United States, Oklahoma ... 展开 >> VA Hospital Oklahoma City, Oklahoma, United States, 73104 收起 << |
NCT01027416 | - | Completed | - | - | |
NCT02322853 | Postmenopausal ... 展开 >> Metastatic Breast Cancer 收起 << | Phase 2 | Terminated(lack of recruitment... 展开 >>) 收起 << | - | France ... 展开 >> Institut Bergonié Bordeaux, France Centre François Baclesse Caen, France Centre Jean Perrin Clermont -Ferrand, France Centre Georges-François Leclerc Dijon, France Centre Léon Bérard Lyon, France Institut Paoli Calmettes Marseille, France Institut de Cancérologie de l'Ouest Nantes, France Hegp, Ap-Hp Paris, France Hôpital St Louis, AP-HP Paris, France Centre Eugène Marquis Rennes, France Centre Henri Becquerel Rouen, France Institut Curie St Cloud, France Institut Claudius Regaud Toulouse, France Institut Gustave Roussy Villejuif, France 收起 << |
NCT02806544 | - | Completed | - | - | |
NCT02806544 | Breast Cancer ... 展开 >> Breast Neoplasms 收起 << | Phase 2 | Completed | - | - |
NCT02166944 | Amyotrophic Lateral Sclerosis ... 展开 >> ALS Functional Ration Scale TAR-DNA-binding Protein-43 Tamoxifen mTOR 收起 << | Phase 1 Phase 2 | Unknown | July 2016 | Taiwan ... 展开 >> Po-Chih Chen Recruiting New Taipei City, Taiwan Contact: Po-Chih Chen, M.D. 886-2-22490088 ext 8112 euphemus2003@msn.com Contact: Chaur-Jong Hu, M.D. 886-2-22490088 ext 8112 chaurjongh@tmu.edu.tw Principal Investigator: Chaur-Jong Hu, M.D. 收起 << |
NCT02488603 | Breast Cancer | Not Applicable | Unknown | - | - |
NCT03351062 | Breast Cancer Female | Phase 3 | Recruiting | December 2025 | - |
NCT02311647 | - | Unknown | February 2017 | Israel ... 展开 >> The Chaim Sheba Medical Center Tel Hashomer, Israel, 52621 收起 << | |
NCT01181518 | - | Unknown | December 2015 | Korea, Republic of ... 展开 >> Inje University Recruiting Busan, Korea, Republic of, 614-735 Contact: Ji-Yeob Choi, Ph.D. 82-51-890-8663 jychoi@inje.ac.kr Principal Investigator: Jae-Gook Shin, MD,PhD 收起 << | |
NCT02668666 | Hormone Receptor Positive Mali... 展开 >>gnant Neoplasm of Breast Human Epidermal Growth Factor 2 Negative Carcinoma of Breast Estrogen Receptor Positive Breast Cancer Progesterone Receptor Positive Tumor Metastatic Breast Cancer 收起 << | Phase 2 | Recruiting | June 2019 | United States, Illinois ... 展开 >> University of Illinois Cancer Center Recruiting Chicago, Illinois, United States, 60612 Contact: Oana Danciu, M.D. Contact: Joanna Hill 312-996-9272 joanhill@uic.edu United States, Michigan Michigan State University Recruiting Lansing, Michigan, United States, 48910 Contact: Karen Luellen 517-975-9534 Karen.Luellen@hc.msu.eduu.edu Principal Investigator: Deimante Tamkus, M.D. United States, Minnesota University of Minnesota Recruiting Minneapolis, Minnesota, United States, 55455 Contact: Erin Zielinski 612-624-0937 eezielin@umn.edu Principal Investigator: Anne Blaes, MD United States, Nebraska University of Nebraska Medical Center Recruiting Omaha, Nebraska, United States, 68198 Contact: Jennifer Messick 402-321-1911 jennifer.messick@unmc.edu Principal Investigator: Pavan Kumar Tandra, MD United States, Pennsylvania Penn State Cancer Institute Recruiting Hershey, Pennsylvania, United States, 17033 Contact: Christina Rodriquez 717-531-5364 crodriguez1@hmc.psu.edu Principal Investigator: Cristina Truica, MD Penn State Cancer Institute Recruiting Hershey, Pennsylvania, United States, 17033 Contact: Sean Fleming 717-531-5364 sfleming1@pennstatehealth.psu.edu Principal Investigator: Cristina Truica, MD United States, Wisconsin University of Wisconsin Recruiting Madison, Wisconsin, United States, 53705 Contact: Cancer Connect 608-262-5223 cancerconnect@uwcarbone.wisc.edu Principal Investigator: Kari Wisinski, MD 收起 << |
NCT02089386 | Barrett Metaplasia | Early Phase 1 | Terminated(Insufficient fundin... 展开 >>g) 收起 << | - | United States, Missouri ... 展开 >> Washington University School of Medicine St. Louis, Missouri, United States, 63110 收起 << |
NCT02070692 | - | Completed | - | - | |
NCT02988986 | Estrogen Receptor Positive Bre... 展开 >>ast Cancer 收起 << | Phase 2 | Active, not recruiting | August 2019 | United States, Texas ... 展开 >> Houston Methodist Hospital Houston, Texas, United States, 77030 Houston Methodist Hospital Willowbrook Houston, Texas, United States, 77070 Houston Methodist Hospital Sugar Land Sugar Land, Texas, United States, 77479 收起 << |
NCT02513849 | Cancer Gastro... 展开 >>intestinal Neoplasms 收起 << | Phase 1 | Recruiting | November 2018 | United Kingdom ... 展开 >> Graduate Entry Medical School, University of Nottingham Recruiting Derby, Derbyshire, United Kingdom, DE33 2NE Royal Derby Hospital Recruiting Derby, United Kingdom Contact: Royal Derby Hospital 1332340131 收起 << |
NCT02824224 | Menorrhagia M... 展开 >>etrorrhagia Medicated Intrauterine Devices 收起 << | Phase 4 | Completed | - | United States, Oregon ... 展开 >> OHSU Center For Women's Health Portland, Oregon, United States, 97239 收起 << |
NCT02070692 | Menstruation Disturbances | Phase 4 | Completed | - | United States, Oregon ... 展开 >> Oregon Health & Science University (OHSU) Portland, Oregon, United States, 97239 收起 << |
NCT03582865 | - | Not yet recruiting | December 2019 | - | |
NCT02197897 | Bladder Cancer | Phase 2 | Recruiting | July 2018 | United States, Texas ... 展开 >> Baylor College of Medicine Recruiting Houston, Texas, United States, 77030 Contact: Guilherme Godoy, MD 713-798-4001 godoy@bcm.edu Contact: Monica Francois 713-798-7296 Monica.Francois@bcm.edu Principal Investigator: Guilherme Godoy, MD Harris Health System Recruiting Houston, Texas, United States, 77030 Contact: Monica Francois 713-798-7296 Monica.Francois@bcm.edu Contact: Sharon Harrison 713-798-2240 Sharonss@bcm.edu 收起 << |
NCT02097459 | Breast Cancer | Phase 3 | Recruiting | - | China ... 展开 >> Peking Union Medical College Hospital Recruiting Beijing, China, 100730 Contact: Qiang Sun, Doctor 8610-69152700 birds90@163.com 收起 << |
NCT00183963 | Breast Carcinoma | Phase 2 | Terminated(Insufficient accrua... 展开 >>l) 收起 << | - | United States, California ... 展开 >> Norris Comprehensive Cancer Center Los Angeles, California, United States, 90033 收起 << |
NCT00684216 | Breast Cancer | Phase 2 Phase 3 | Terminated(acrual too slow) | - | Netherlands ... 展开 >> NKI-AVL Amsterdam, Netherlands, 1066 CX 收起 << |
NCT01973660 | Breast Cancer | Phase 2 | Completed | - | Spain ... 展开 >> Hospital de Torrevieja Torrevieja, Alicante, Spain Institut Català d'Oncologia Hospitalet Hospitalet de Llobregat, Barcelona, Spain Hospital Mutua de Terrassa Terrassa, Barcelona, Spain Consorcio Hospitalario Provincial de Castellón Castelló de la Plana, Castellón, Spain Hospital Clínico Universitario de Santiago de Compostela Santiago de Compostela, Galicia, Spain Hospital Son Llàtzer Palma de Mallorca, Islas Baleares, Spain Hospital Universitario Son Espases Palma de Mallorca, Islas Baleares, Spain Hospital Universitario de Fuenlabrada Fuenlabrada, Madrid, Spain Hospital Universitario Virgen de la Arrixaca El Palmar, Murcia, Spain Hospital Universitario Sant Joan de Reus Reus, Tarragona, Spain Hospital Luis Alcanyís de Xàtiva Xàtiva, Valencia, Spain, 46800 Hospital Universitario Infanta Cristina Badajoz, Spain, 06071 Vall d'Hebron University Hospital Barcelona, Spain, 08035 Hospital Clínic de Barcelona Barcelona, Spain Instituto Dexeus Barcelona, Spain Hospital San Pedro de Alcántara Cáceres, Spain, 10003 Hospital Universitario Arnau de Vilanova de Lleida Lleida, Spain Hospital Universitario 12 de Octubre Madrid, Spain, 28041 Hospital Clínico San Carlos Madrid, Spain Hospital Universitario Ramón y Cajal Madrid, Spain Hospital Clínico Universitario de Valencia Valencia, Spain Hospital Universitario Arnau de Vilanova de Valencia Valencia, Spain 收起 << |
NCT03494400 | Cancer of Breast ... 展开 >> Healthy 收起 << | Not Applicable | Active, not recruiting | April 30, 2019 | Brazil ... 展开 >> Faculdade de Ciências e Tecnologia, Universidade Estadual Paulista Júlio de Mesquita Filho Presidente Prudente, São Paulo, Brazil, 19060-560 收起 << |
NCT00237224 | Breast Cancer | Phase 4 | Completed | - | Mexico ... 展开 >> Novartis Investigative Site Guadalajara, Zacatecas, México DF, Mexico 收起 << |
NCT01950182 | Breast Cancer | Phase 3 | Recruiting | December 2018 | China, Guangdong ... 展开 >> Sun Yat-sen University Cancer Center Recruiting Guangzhou, Guangdong, China, 510060 Contact: Zhong-yu Yuan, MD 86-20-87343794 yuanzhygz@163.com 收起 << |
NCT01674140 | Breast Cancer | Phase 3 | Recruiting | January 2030 | - |
NCT00847366 | Non Small Cell Lung Cancer ... 展开 >> Solid Tumors Metastatic Breast Cancer Sarcomas 收起 << | Not Applicable | Completed | - | - |
NCT02040857 | Breast Cancer | Phase 2 | Active, not recruiting | June 2019 | United States, California ... 展开 >> University of California, San Francisco San Francisco, California, United States, 94115 United States, Indiana Indiana University Health Hospital Indianapolis, Indiana, United States, 46202 United States, Massachusetts Massachusetts General Hospital Boston, Massachusetts, United States, 02214 Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02215 MGH/North Shore Cancer Center Danvers, Massachusetts, United States, 01923 DF/DWCC at Milford Regional Cancer Center Milford, Massachusetts, United States, 01757 South Shore Hospital Weymouth, Massachusetts, United States, 02190 United States, New Hampshire Dana-Farber/New Hampshire Oncology-Hematology Londonderry, New Hampshire, United States, 03053 United States, Pennsylvania University of Pennsylvania-Abramson Cancer Center Philadelphia, Pennsylvania, United States, 19104 收起 << |
NCT00183963 | - | Terminated(Insufficient accrua... 展开 >>l) 收起 << | - | - | |
NCT03691493 | Anatomic Stage IV Breast Cance... 展开 >>r AJCC v8 Estrogen Receptor Positive HER2/Neu Negative Metastatic Breast Carcinoma Metastatic Malignant Neoplasm in the Bone Progesterone Receptor Positive Prognostic Stage IV Breast Cancer AJCC v8 收起 << | Phase 2 | Not yet recruiting | December 31, 2019 | United States, Georgia ... 展开 >> Grady Health System Not yet recruiting Atlanta, Georgia, United States, 30303 Contact: Michelle Knight 404-616-6353 michelle.knight-johnson@emory.edu Emory University Hospital Midtown Not yet recruiting Atlanta, Georgia, United States, 30308 Contact: Swathi Chinaranagari 404-686-0239 swathi.chinaranagari@emory.edu Piedmont Hospital Not yet recruiting Atlanta, Georgia, United States, 30309 Contact: Adam Nowlan, MD, MPH adam.nowlan@piedmont.org Emory University Hospital/Winship Cancer Institute Not yet recruiting Atlanta, Georgia, United States, 30322 Contact: Gabrielle Brown 404-778-2179 gabrielle.michelle.brown@emory.edu Emory Saint Joseph's Hospital Not yet recruiting Atlanta, Georgia, United States, 30342 Contact: Alicia Escobar 678-843-7029 alicia.m.escobar@emory.edu Northside Hospital Not yet recruiting Atlanta, Georgia, United States, 30342 Contact: Nancy Wiggers, MD nancy.wiggers@northside.com John B. Amos Cancer Center Not yet recruiting Columbus, Georgia, United States, 31904 Contact: Andrew Pippas, MD andrew.pippas@columbusregional.com Central Georgia Cancer Care PC Not yet recruiting Macon, Georgia, United States, 31201 Contact: Bradley Sumrall, MD bsumrall@centralgacancercare.com Lewis Cancer and Research Pavilion at Saint Joseph's/Candler Not yet recruiting Savannah, Georgia, United States, 31405 Contact: Howard Zaren, MD drzaren@sjchs.org United States, Maine Maine Medical Center-Bramhall Campus Portland, Maine, United States, 04102 收起 << |
NCT01579227 | - | Active, not recruiting | December 2018 | United States, Ohio ... 展开 >> The Ohio State University Medical Center Columbus, Ohio, United States, 43210 收起 << | |
NCT03373708 | Breast Cancer ... 展开 >> Chemotherapy Endocrine Breast Diseases 收起 << | Phase 2 Phase 3 | Not yet recruiting | December 20, 2019 | - |
NCT01300871 | - | Terminated(Poor patient accrua... 展开 >>l) 收起 << | - | Canada, Ontario ... 展开 >> Princess Margaret Hospital Toronto, Ontario, Canada, M5G 3M9 收起 << | |
NCT00002720 | Breast Cancer | Phase 3 | Completed | - | Italy ... 展开 >> Istituto Nazionale per lo Studio e la Cura dei Tumori Milano (Milan), Italy, 20133 收起 << |
NCT00632723 | Breast Cancer | Phase 2 | Completed | - | - |
NCT02313051 | Metastatic Breast Cancer | Phase 2 | Unknown | December 2017 | China ... 展开 >> Cancer Institute and Hospital, Chinese Academy of Medical Sciences Not yet recruiting Beijing, China, 100021 Contact: Binghe Xu, MD, Ph.D +86-10-87788826 xubinghe@medmail.com.cn Contact: Ying Fan, MD 861087788114 fanyingfy@medmail.com.cn Principal Investigator: Binghe Xu, MD, Ph.D Sub-Investigator: Ying Fan, MD 收起 << |
NCT01273168 | Hormone Receptor-Positive Brea... 展开 >>st Gynecologic Desmoid Hormone Receptor-Positive Neoplasms 收起 << | Phase 1 | Active, not recruiting | June 1, 2020 | United States, Maryland ... 展开 >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 收起 << |
NCT02057133 | Breast Neoplasms | Phase 1 | Recruiting | December 16, 2020 | United States, Arkansas ... 展开 >> Highlands Oncology Group Recruiting Fayetteville, Arkansas, United States, 72703 Contact 479-587-1700 Principal Investigator: Joseph T Beck United States, California University of California - San Diego Recruiting La Jolla, California, United States, 92037-0845 Contact 858-246-4777 Principal Investigator: Teresa Helsten United States, Massachusetts Dana Farber Cancer Institute Recruiting Boston, Massachusetts, United States, 02215 Contact 617-632-5869 Principal Investigator: Sara M Tolaney United States, Minnesota Mayo Clinic Recruiting Rochester, Minnesota, United States, 55905-0002 Contact 507-266-6264 Principal Investigator: Matthew P Goetz United States, New York Columbia University College of Phys & Surgeons Completed New York, New York, United States, 10032 Memorial Sloan Kettering Cancer Center Recruiting New York, New York, United States, 10065 Contact 646-888-5145 Principal Investigator: Komal Jhaveri United States, North Carolina University of North Carolina at Chapel Hill Recruiting Chapel Hill, North Carolina, United States, 27514 Contact 919-843-7714 Principal Investigator: E. Claire Dees United States, Ohio Peggy and Charles Stephenson Oklahoma Cancer Center Recruiting Oklahoma City, Ohio, United States, 73104 Contact 4052717770 Principal Investigator: Kathleen Moore United States, Oregon Providence Cancer Center Oncology Hematology Care Recruiting Portland, Oregon, United States, 97213 Contact 506-216-8636 Principal Investigator: Alison Conlin United States, Pennsylvania Univ of Pittsburgh Cancer Inst. (UPCI) Completed Pittsburgh, Pennsylvania, United States, 15213 United States, Tennessee Sarah Cannon Cancer Center Recruiting Nashville, Tennessee, United States, 37203 Contact 615-327-7212 Principal Investigator: SMO Sarah Cannon Research Inst. Tennessee Oncology PLLC Recruiting Nashville, Tennessee, United States, 37203 Contact 615-329-7274 Principal Investigator: Howard A. Burris III Vanderbilt University Medical Center Recruiting Nashville, Tennessee, United States, 37232-6307 Contact 615-936-3524 Principal Investigator: Brent N Rexer United States, Texas Texas Oncology-Baylor Charles A. Sammons Cancer Center Recruiting Dallas, Texas, United States, 75246 Contact 214-370-1949 Principal Investigator: Carlos H Becerra South Texas Accelerated Research Therapeutics, LLC Recruiting San Antonio, Texas, United States, 78229-3307 Contact 210-593-5250 Principal Investigator: Muralidhar Beeram US Oncology Active, not recruiting The Woodlands, Texas, United States, 77380 收起 << |
NCT00014638 | Breast Cancer | Phase 4 | Completed | - | United States, California ... 展开 >> Alta Bates Comprehensive Cancer Center Berkeley, California, United States, 94704 Long Beach Memorial Breast Center Long Beach, California, United States, 90806 United States, Florida Cancer Research Network, Inc. Hollywood, Florida, United States, 33020 Oncology-Hematology Group of South Florida Miami, Florida, United States, 33176 Pharm Research Pinecrest, Florida, United States, 33156 Cancer Research Network Inc. Plantation, Florida, United States, 33324 Good Samaritan Medical Center West Palm Beach, Florida, United States, 33401 United States, Illinois Illinois Oncology, Ltd. Belleville, Illinois, United States, 62221 Joliet Oncology/Hematology Associates, Ltd. Joliet, Illinois, United States, 60435 Memorial Medical Center Springfield, Illinois, United States, 62781 Carle Cancer Center Urbana, Illinois, United States, 61801 United States, Louisiana Southwest Oncology Association Lafayette, Louisiana, United States, 70503 United States, New Mexico New Mexico Oncology-Hematology Albuquerque, New Mexico, United States, 87109 United States, New York Albert Einstein Comprehensive Cancer Center Bronx, New York, United States, 10461 United States, Ohio Oncology Partnership Network Cincinnati, Ohio, United States, 45238 United States, Tennessee Memphis Cancer Center Memphis, Tennessee, United States, 38119 Dial Research Associates, Inc. Nashville, Tennessee, United States, 37205 United States, Texas Center for Oncology Research and Treatment, Medical City Hospital Dallas, Texas, United States, 75230 United States, Utah Intermountain Hematology/Oncology Associates, Inc. Salt Lake City, Utah, United States, 84124 United States, Washington Cascade Cancer Center Kirkland, Washington, United States, 98034-3013 收起 << |
NCT00006030 | Breast Cancer | Phase 3 | Unknown | - | United Kingdom ... 展开 >> Nottingham City Hospital NHS Trust Nottingham, England, United Kingdom, NG5 1PB 收起 << |
NCT00006369 | Breast Cancer | Phase 2 | Unknown | - | United States, Florida ... 展开 >> H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States, 33612-9497 收起 << |
NCT01249456 | - | Completed | - | Korea, Republic of ... 展开 >> Samsung Medical Center Seoul, Korea, Republic of 收起 << | |
NCT02592083 | Early-Stage Breast Carcinoma ... 展开 >> Hormone Receptor Positive Tumor 收起 << | Phase 2 | Recruiting | December 2024 | Sweden ... 展开 >> Department of Oncology, Karolinska University Hospital Recruiting Stockholm, Sweden, 17176 Contact: Maria Axelsson, RN +46 8 616 ext 4559 maria.axelsson@karolinska.se Contact: Ingrid Lundin, RN +46 8 517 ext 72310 ingrid.lundin@karolinska.se Principal Investigator: Sara Margolin, MD PhD Sub-Investigator: Theodoros Foukakis, MD Assoc. Prof. 收起 << |
NCT00272714 | Cyclic Breast Pain, Cyclic Mas... 展开 >>talgia 收起 << | Phase 2 | Completed | - | - |
NCT02101788 | Low Grade Ovarian Serous Adeno... 展开 >>carcinoma Micropapillary Serous Carcinoma Ovarian Serous Adenocarcinoma Primary Peritoneal Serous Adenocarcinoma Recurrent Ovarian Carcinoma Recurrent Primary Peritoneal Carcinoma 收起 << | Phase 2 Phase 3 | Active, not recruiting | - | - |
NCT03199963 | Mammographic Breast Density | Phase 3 | Recruiting | October 30, 2020 | United States, Arizona ... 展开 >> Mesa Obstetricians and Gynecologists/Cactus Clinical Research Recruiting Mesa, Arizona, United States, 85209 Contact: Study Coordinator Visions Clinical Research Recruiting Tucson, Arizona, United States, 85712 Contact: Study Coordinator United States, California United Clinical Research Recruiting Beverly Hills, California, United States, 90211 Contact: Study Coordinator City of Hope Recruiting Duarte, California, United States, 91010 Contact: Study Coordinator USC-Keck Medical Center Recruiting Los Angeles, California, United States, 90033 United States, Florida South Florida Medical Research Recruiting Aventura, Florida, United States, 33180 Contact: Study Coordinator Lake OB-GYN Associates of Mid-Florida Recruiting Leesburg, Florida, United States, 34748 Contact: Study Coordinator Physician Care Clinical Research, LLC Recruiting Sarasota, Florida, United States, 34239 Contact: Study Coordinator United States, Nevada Affiliated Clinical Research, Inc. Recruiting Las Vegas, Nevada, United States, 89113 Contact: Study Coordinator United States, New Jersey Center for Women's Health and Wellness Recruiting Plainsboro, New Jersey, United States, 08536 Contact: Study Coordinator United States, New Mexico Bosque Women Care/Cactus Clinical Research Recruiting Albuquerque, New Mexico, United States, 87109 Contact: Study Coordinator United States, North Carolina Carolina Women's Research and Wellness Center Recruiting Durham, North Carolina, United States, 27713 Contact: Study Coordinator United States, Ohio Aventiv Research, Inc. Recruiting Columbus, Ohio, United States, 43213 Contact: Study Coordinator United States, South Carolina Coastal Carolina Research Center, Inc. Recruiting Mount Pleasant, South Carolina, United States, 29464 Contact: Study Coordinator United States, Virginia University of Virginia Medical Park Northridge Recruiting Charlottesville, Virginia, United States, 22903 Contact: Study Coordinator United States, Washington Overlake Internal Medicine Associates, PS Recruiting Bellevue, Washington, United States, 98004 Contact: Study Coordinator Dedicated Women's Health Specialists Terminated Puyallup, Washington, United States, 98372 Germany Private Practice - Gynecology Not yet recruiting Frankfurt, Hessen, Germany, 60322 Contact: Study Coordinator Spain Instituto Palacios Salud de La Mujer Recruiting Madrid, Spain, 28009 Contact: Study Coordinator 收起 << |
NCT01231659 | Postmenopausal Women ... 展开 >> Locally Advanced Metastatic Breast Cancer Metastatic Breast Cancer 收起 << | Phase 4 | Completed | - | Israel ... 展开 >> Novartis Investigative Site Jerusalem, Israel, 91120 Novartis Investigative Site Kfar Saba, Israel, 4428164 Novartis Investigative Site Petach Tikva, Israel, 49100 Novartis Investigative Site Ramat Gan, Israel, 5265601 Novartis Investigative Site Rehovot, Israel, 76100 Novartis Investigative Site Tel Aviv, Israel, 62439 Novartis Investigative Site Tel Aviv, Israel, 64239 收起 << |
NCT00290654 | Breast Cancer | Phase 2 | Terminated(Unable to recruit f... 展开 >>urther patients.) 收起 << | - | United States, Minnesota ... 展开 >> Masonic Cancer Center, University of Minnesota Minneapolis, Minnesota, United States, 55455 收起 << |
NCT01064635 | Breast Cancer | Phase 3 | Active, not recruiting | August 2018 | Italy ... 展开 >> Istituto Nazionale per la Ricerca sul Cancro Genoa, Italy, 16132 收起 << |
NCT02603679 | Early-Stage Breast Carcinoma ... 展开 >> Estrogen Receptor Positive Tumor 收起 << | Phase 2 | Recruiting | June 2024 | Sweden ... 展开 >> Theodoros Foukakis Recruiting Stockholm, Sweden, 17176 Contact: Ingrid Lundin, RN +46 8 517 ext 72310 ingrid.lundin@karolinska.se 收起 << |
NCT02344550 | Metastatic Breast Cancer | Phase 2 | Recruiting | August 2018 | Korea, Republic of ... 展开 >> Asan Medical Center Recruiting Seoul, Korea, Republic of, 138-736 Contact: Sung Bae Kim, M.D., Ph D. 82-2-3010-3217 sbkim3@amc.seoul.kr 收起 << |
NCT00290654 | - | Terminated(Unable to recruit f... 展开 >>urther patients.) 收起 << | - | - | |
NCT00569543 | - | Completed | - | United States, Minnesota ... 展开 >> Mayo Clinic Cancer Center Rochester, Minnesota, United States, 55905 United States, Nebraska UNMC Eppley Cancer Center at the University of Nebraska Medical Center Omaha, Nebraska, United States, 68198-6805 收起 << | |
NCT00066807 | Breast Cancer | Phase 3 | Terminated(Poor accrual, patie... 展开 >>nts were followed until completion of 5 yrs treatment) 收起 << | - | Hungary ... 展开 >> National Institute of Oncology Budapest, Hungary, 1122 Italy Centro di Riferimento Oncologico - Aviano Aviano, Italy, 33081 European Institute of Oncology Milan, Italy, 20141 Switzerland Kantonsspital Graubuenden Chur, Switzerland, CH-7000 Centre Hospitalier Universitaire Vaudois Lausanne, Switzerland, 1011 Kantonsspital - St. Gallen St. Gallen, Switzerland, CH-9007 收起 << |
NCT00016341 | Endometrial Cancer | Phase 3 | Terminated | - | - |
NCT00066807 | - | Terminated(Poor accrual, patie... 展开 >>nts were followed until completion of 5 yrs treatment) 收起 << | - | - | |
NCT00884143 | - | Completed | - | Italy ... 展开 >> Research Site Aviano, PN, Italy Research Site Trento, Italy Research Site Verona, Italy 收起 << | |
NCT01016665 | Breast Cancer | Not Applicable | Completed | - | Brazil ... 展开 >> Sao Paulo Federal University Sao Paulo, Brazil, 01530020 收起 << |
NCT01266213 | Metastatic Breast Cancer ... 展开 >> Estrogen Receptor Positive Tumor Breast Cancer Nos Premenopausal 收起 << | Phase 2 | Active, not recruiting | December 2019 | Korea, Republic of ... 展开 >> Samsung Medical Center Seoul, Korea, Republic of, 135-710 收起 << |
NCT01121549 | - | Terminated(See termination rea... 展开 >>son in detailed description.) 收起 << | - | Romania ... 展开 >> Policlinica Judeteana 1 Pitesti - Cabinet oncologie Pitesti, Arges, Romania, 110084 Spitalul Judetean de Urgenta Resita Sectia oncologie medicala Resita, Caras Severin, Romania, 320076 Spitalul Clinic Judetean de Urgenta Cluj, Clinica de Oncologie Medicala si Radioterapie Cluj Napoca, Cluj, Romania, 40006 Institutul Oncologic "Prof. Dr. Ion Chiricuta" Cluj Napoca Cluj-Napoca, Cluj, Romania, 400015 Spitalul Judetean Covasna, Sectia Oncologie medicala Sfantu Gheorghe, Covasna, Romania, 520064 Spitalul Judetean de Urgenta Targoviste Targoviste, Dambovita, Romania, 130095 Spital Clinic Judetean de Urgenta Oradea Oradea, Jud. Bihor, Romania, 410167 Spitalul Judeţean Brasov Brasov, Jud. Brasov, Romania, 505200 Spitalulul Judetean Clinic de Urgenta, Sf. Apostol Andrei Galati, Jud. Galati, Romania, 800367 Spitalul Judetean Bistrita Nasaud - Sectia Oncologie Medicala Bistrita, Jud. Nasaud, Romania, 420178 Spitalul Clinic Judetean de Urgenta Sibiu - Sectia Oncologie Medicala Sibiu, Jud. Sibiu, Romania, 550245 Spitalul Judetean Drobeta Turnu Severin - Sectie oncologie Drobeta Turnu Severin, Mehedinti, Romania, 220064 Spitalul Judetean Targu Mures Targu Mures, Mures, Romania, 540140 Spitalulul Municipal de Urgenta Roman Roman, Neamt, Romania, 617385 Spitalul Judetean de Urgenta Slatina, Sectie oncologie Slatina, Olt, Romania, 230008 Spitalul Municipal Campina Sectia oncologie Campina, Prahova, Romania, 107425 Spitalul Municipal Ploiesti Sectia oncologie Ploiesti, Prahova, Romania, 100337 Spitalul Municipal Medias Compartimentul Oncologie medicala Medias, Sibiu, Romania, 551026 Spitalul Clinic Municipal de Urgenta Timisoara Clinica Oncologie Medicala Timisoara, Timis, Romania, 300223 Spitalul Clinic Municipal Timisoara Sectia oncologie medicala Timisoara, Timis, Romania, 300223 Oncomed Srl Timisoara, Timis, Romania, 300239 Spitalul Judetean de Urgenta Bacau Bacau, Romania, 600114 Policlinica Theodor Burghele, cabinet oncologie Bucharest, Romania, 50659 Str. Povernei 42, Sector 1 Bucharest, Romania, 7000 CMDT MAPN Washington Ambulator oncologie Bucuresti, Romania, 011794 Ambulator Spital Colentina, cabinet oncologie Bucuresti, Romania, 020142 Cabinet Oncologie Medicala Bucuresti, Romania, 020947 Ambulator Spital Sf. Pantelimon, cabinet oncolgie Bucuresti, Romania, 021659 Institutul Oncologic "Prof. Dr. Al. Trestioreanu" Bucuresti, Romania, 022328 Ambulator Spital Clinic Colţea, cabinet oncologie Bucuresti, Romania, 030171 Centru D.T. Titan Cabinet oncologie Bucuresti, Romania, 030442 Policlinica Sf. Ioan Bucuresti, cabinet oncologie Bucuresti, Romania, 042121 Ambulator Specialitate Cotroceni, cabinet oncolgie Bucuresti, Romania, 7000 Spitalulul Judetean de Urgenta Deva, Ambulator oncologie medicala Hunedoara, Romania, 331021 Spitalulul Clinic Judetean de Urgenta Sf. Spiridon, Ambulatoriu de specialitate adulti - Stationar o Iasi, Romania, 700106 Spitalul Clinic Judetean de Urgenta "Sf. Spiridon" Iasi Clinica Oncologie Medicala Iasi, Romania, 700111 Spitalul Clinic de Urgenta Oradea, Romania, 410032 Spitalulul Clinic Judetean de Urgenta Sibiu- Sectia Oncologie medicala Sibiu, Romania, 550245 Spitalulul Judetean de Urgenta, Sf. Ioan cel Nou Suceava, Romania, 720131 Spitalul Judetean de Urgenta Targu Jiu, Ambulator Spital - Oncologie medicala Targu Jiu, Romania, 210140 收起 << | |
NCT01121549 | - | Terminated(See termination rea... 展开 >>son in detailed description.) 收起 << | - | - | |
NCT00206544 | Bipolar Disorder ... 展开 >> Mania Schizoaffective Disorder 收起 << | Phase 2 | Completed | - | Australia, Victoria ... 展开 >> Bayside Health - The Alfred Hospital Melbourne, Victoria, Australia, 3004 收起 << |
NCT00002582 | Breast Cancer | Phase 3 | Completed | - | United Kingdom ... 展开 >> Cancer Research Campaign Trials Unit-Birmingham (CRCTU) Birmingham, England, United Kingdom, B15 2TT Beatson Oncology Centre Glasgow, Scotland, United Kingdom, G11 6NT 收起 << |
NCT00738777 | Breast Cancer | Phase 2 | Recruiting | June 2020 | Netherlands ... 展开 >> Medisch Centrum Haaglanden Recruiting den Haag, ZH, Netherlands Contact: H M Oosterkamp, MD Principal Investigator: H M Oosterkamp, MD NKI-AVL Recruiting Amsterdam, Netherlands, 1066 CX Contact: Sabine C Linn, MD +31-20-5129111 ext 2591 s.linn@nki.nl Contact: Annelot van Rossum, MD +31-20-5129111 ext 2004 a.v.rossum@nki.nl Principal Investigator: Sabine C Linn, MD St. Antonius ziekenhuis Not yet recruiting Nieuwegein, Netherlands Contact: Paul C de Jong, MD Principal Investigator: Paul C de Jong, MD UMC St. Radboud Recruiting Nijmegen, Netherlands Contact: Hanneke WM Laarhoven, MD Principal Investigator: Hanneke WM Laarhoven, MD 收起 << |
NCT00152178 | Breast Cancer | Phase 3 | Completed | - | Japan ... 展开 >> Osaka Medical Center for Cancer and Cardiovascular Diseases 1-1-3, Nakamichi, Higashinari-ku, Osaka, Osaka, Japan 收起 << |
NCT03137368 | CYP2D6 Polymorphism | Phase 3 | Enrolling by invitation | October 30, 2023 | China, Beijing ... 展开 >> CancerIHCAMS Beijing, Beijing, China, 100010 收起 << |
NCT00002581 | Breast Cancer | Phase 3 | Completed | - | United Kingdom ... 展开 >> Aberdeen Royal Infirmary Aberdeen, Scotland, United Kingdom, AB25 2ZN Ninewells Hospital and Medical School Dundee, Scotland, United Kingdom, DD1 9SY Western General Hospital Edinburgh, Scotland, United Kingdom, EH4 9NQ Beatson Oncology Centre Glasgow, Scotland, United Kingdom, G11 6NT University of Glasgow Glasgow, Scotland, United Kingdom, G61 1BD Raigmore Hospital Inverness, Scotland, United Kingdom, 1V2 3UJ Royal Alexandra Hospital Paisley, Scotland, United Kingdom Ayr Hospital Ayr, United Kingdom, KA6 6DX Falkirk Royal Infirmary Falkirk, United Kingdom, FK1 5RE 收起 << |
NCT00002579 | Breast Cancer | Phase 3 | Completed | - | United Kingdom ... 展开 >> Leicester Royal Infirmary NHS Trust Leicester, England, United Kingdom, LE1 5WW Aberdeen Royal Infirmary Aberdeen, Scotland, United Kingdom, AB25 2ZN Ninewells Hospital and Medical School Dundee, Scotland, United Kingdom, DD1 9SY Western General Hospital Edinburgh, Scotland, United Kingdom, EH4 9NQ Beatson Oncology Centre Glasgow, Scotland, United Kingdom, G11 6NT University of Glasgow Glasgow, Scotland, United Kingdom, G61 1BD Raigmore Hospital Inverness, Scotland, United Kingdom, 1V2 3UJ Royal Alexandra Hospital Paisley, Scotland, United Kingdom Ayr Hospital Ayr, United Kingdom, KA6 6DX Falkirk Royal Infirmary Falkirk, United Kingdom, FK1 5RE 收起 << |
NCT00002580 | Breast Cancer | Phase 3 | Completed | - | United Kingdom ... 展开 >> University Hospitals of Leicester Leicester, England, United Kingdom, LE1 5WW Aberdeen Royal Infirmary Aberdeen, Scotland, United Kingdom, AB25 2ZN Ninewells Hospital and Medical School Dundee, Scotland, United Kingdom, DD1 9SY Western General Hospital Edinburgh, Scotland, United Kingdom, EH4 9NQ Beatson Oncology Centre Glasgow, Scotland, United Kingdom, G11 6NT University of Glasgow Glasgow, Scotland, United Kingdom, G61 1BD Raigmore Hospital Inverness, Scotland, United Kingdom, 1V2 3UJ Royal Alexandra Hospital Paisley, Scotland, United Kingdom Ayr Hospital Ayr, United Kingdom, KA6 6DX Falkirk Royal Infirmary Falkirk, United Kingdom, FK1 5RE 收起 << |
NCT02333370 | Hormone Receptor Positive, HER... 展开 >>2-negative, Advanced Breast Cancer 收起 << | Phase 1 | Active, not recruiting | October 26, 2020 | Hong Kong ... 展开 >> Novartis Investigative Site Hong Kong, Hong Kong Japan Novartis Investigative Site Nagoya-city, Aichi, Japan, 467-8602 Novartis Investigative Site Sapporo-city, Hokkaido, Japan, 003-0804 Novartis Investigative Site Yokohama-city, Kanagawa, Japan, 241-8515 Novartis Investigative Site Osaka-city, Osaka, Japan, 540-0006 Novartis Investigative Site Suita-city, Osaka, Japan, 565 0871 Novartis Investigative Site Hidaka-city, Saitama, Japan, 350-1298 Novartis Investigative Site Kitaadachi-gun, Saitama, Japan, 362-0806 Novartis Investigative Site Sunto Gun, Shizuoka, Japan, 411-8777 Novartis Investigative Site Bunkyo-ku, Tokyo, Japan, 113-8431 Novartis Investigative Site Bunkyo-ku, Tokyo, Japan, 113-8677 Novartis Investigative Site Koto-ku, Tokyo, Japan, 135 8550 Novartis Investigative Site Shinagawa-ku, Tokyo, Japan, 142-8666 Novartis Investigative Site Shinjuku-ku, Tokyo, Japan, 160-0023 Singapore Novartis Investigative Site Singapore, Singapore, 169610 收起 << |
NCT02764541 | Breast Cancer | Phase 2 | Recruiting | November 2019 | United States, Connecticut ... 展开 >> Stamford Hospital Recruiting Stamford, Connecticut, United States, 06904 Contact: K.M. Steve Lo, MD slo@stamhealth.org United States, Maine Eastern Maine Medical Center Recruiting Brewer, Maine, United States, 04412 Contact: Thomas H. Openshaw, MD topenshaw@emhs.org United States, Massachusetts Dana-Farber at St. Elizabeth's Medical Center Recruiting Boston, Massachusetts, United States, 02135 Contact: Caroline Block, MD caroline_block@dfci.harvard.edu Beth Israel Deaconess Medical Center Recruiting Boston, Massachusetts, United States, 02215 Contact: Steven Come, MD 617-667-4599 scome@bidmc.harvard.edu Dana-Farber Cancer Institute Recruiting Boston, Massachusetts, United States, 02215 Contact: Otto F Metzger, MD 617-632-3800 ometzger@partners.org Principal Investigator: Otto F Metzger, MD DF/BWCC at Milford Regional Medical Center Recruiting Milford, Massachusetts, United States, 01757 Contact: Michael Constantine, MD michael_constantine@dfci.harvard.edu DF/BWCC in clinical affiliation with South Shore Hospital Recruiting South Weymouth, Massachusetts, United States, 02190 Contact: Meredith Faggen, MD meredith_faggen@dfci.harvard.edu United States, Rhode Island Lifespan Recruiting Providence, Rhode Island, United States, 02903 Contact: Mary Anne Fenton, MD mfenton@lifespan.org United States, Tennessee Sarah Cannon Research Institute Recruiting Nashville, Tennessee, United States, 37203 Contact: Denise A. Yardley, MD dyardley@tnonc.com Vanderbilt University Medical Center Recruiting Nashville, Tennessee, United States, 37232 Contact: Ingrid Mayer, MD ingrid.mayer@vanderbilt.edu 收起 << |
NCT00943527 | - | Completed | - | United States, Minnesota ... 展开 >> Mayo Clinic Rochester, Minnesota, United States, 55905 收起 << | |
NCT01971515 | Solid Tumor | Phase 1 | Completed | - | United States, Alabama ... 展开 >> University of Alabama at Birmingham Birmingham, Alabama, United States, 35294 United States, California Cedars Sinai Medical Center Los Angeles, California, United States, 90048 University of California at San Diego, Moores Cancer Center San Diego, California, United States, 92093 United States, Florida Sylvester Comprehensive Cancer Center Miami, Florida, United States, 33136 United States, Louisiana Metairie Oncology Metairie, Louisiana, United States, 70006 United States, Massachusetts Massachusetts General Hospital Boston, Massachusetts, United States, 02114 United States, Michigan Karmanos Cancer Institute Detroit, Michigan, United States, 48201 Henry Ford Hospital Detroit, Michigan, United States, 48202 United States, Missouri Washington University School of Medicine Saint Louis, Missouri, United States, 63110 United States, New York Mount Sinai New York, New York, United States, 10029 United States, South Carolina Medical University of South Carolina Charleston, South Carolina, United States, 29425 United States, Texas Mary Crowley Cancer Research Center Dallas, Texas, United States, 75251 MD Anderson Cancer Center Houston, Texas, United States, 77030 University of Texas Health Science Center at San Antonio San Antonio, Texas, United States, 78229 United States, Vermont Fletcher Allen Health Care, Inc. Burlington, Vermont, United States, 05401 收起 << |
NCT00002528 | Breast Cancer | Phase 3 | Completed | - | Australia, New South Wales ... 展开 >> Royal Prince Alfred Hospital, Sydney Sydney, New South Wales, Australia, 2050 Newcastle Mater Misericordiae Hospital Waratah, New South Wales, Australia, 2298 Australia, South Australia Royal Adelaide Hospital Adelaide, South Australia, Australia, 5000 Australia, Victoria Anti-Cancer Council of Victoria, Melbourne Parkville, Victoria, Australia, 3050 Australia, Western Australia Sir Charles Gairdner Hospital, Perth Perth, Western Australia, Australia, 6009 Hungary National Institute of Oncology Budapest, Hungary, 1125 Israel Hadassah University Hospital Jerusalem, Israel, 91120 Italy Centro di Riferimento Oncologico - Aviano Aviano, Italy, 33081 Spedali Civili Brescia, Italy, 25124 Presidio Ospedaliero-Gorizia Gorizia, Italy, 34170 Ospedale Civile Rimini Rimini, Italy, 47900 Ospedale San Eugenio Rome, Italy, 00144 New Zealand Auckland Adventist Hospital Auckland, New Zealand, 5 Slovenia Institute of Oncology, Ljubljana Ljubljana, Slovenia, Sl-1000 South Africa Groote Schuur Hospital, Cape Town Cape Town, South Africa, 7925 Sweden Sahlgrenska University Hospital Gothenburg (Goteborg), Sweden, S-413 45 Switzerland University Hospital Basel, Switzerland, CH-4031 Inselspital, Bern Bern, Switzerland, CH-3010 Centre Hospitalier Universitaire Vaudois Lausanne, Switzerland, CH-1011 Kantonsspital - St. Gallen St. Gallen, Switzerland, CH-9006 UniversitaetsSpital Zurich, Switzerland, CH-8091 收起 << |
NCT00767585 | - | Completed | - | Slovenia ... 展开 >> Research Site Ljubljana, Slovenia 收起 << | |
NCT00083044 | - | Withdrawn(Funding ended and wi... 展开 >>ll not be renewed) 收起 << | - | United States, Alabama ... 展开 >> Comprehensive Cancer Center at University of Alabama at Birmingham Birmingham, Alabama, United States, 35294 United States, Illinois Robert H. Lurie Comprehensive Cancer Center at Northwestern University Chicago, Illinois, United States, 60611-3013 收起 << | |
NCT02480218 | - | Completed | - | Canada, Ontario ... 展开 >> Sunnybrook Health Sciences Centre Toronto, Ontario, Canada, M4N 3M5 收起 << | |
NCT01622361 | Breast Cancer | Phase 3 | Unknown | February 2016 | Korea, Republic of ... 展开 >> Asan Medical Center Recruiting Seoul, Songpa-gu, Korea, Republic of, 138-736 Contact: Ahn Sei Hyun, M.D. 82-2-3010-3490 ahnsh@amc.seoul.kr Principal Investigator: A. S. Hyun, MD.PhD 收起 << |
NCT03211572 | Breast Cancer | Phase 2 | Not yet recruiting | August 2018 | - |
NCT02728622 | Ovarian Cancer ... 展开 >> Peritoneal Cancer Cancer of the Fallopian Tube 收起 << | Phase 3 | Completed | - | - |
NCT00002460 | Breast Cancer | Phase 3 | Unknown | - | Belgium ... 展开 >> Hopital De Braine-L'Alleud-Waterloo Braine-L'Alleud, Belgium, 1420 Institut Jules Bordet Brussels, Belgium, 1000 U.Z. Sint-Rafael Leuven, Belgium, B-3000 United Kingdom Royal Sussex County Hospital Brighton, England, United Kingdom, BN2 5BE Castle Hill Hospital Cottingham, England, United Kingdom, HU16 5JQ Walsgrave Hospital Coventry, England, United Kingdom, CV2 2DX Mayday University Hospital Croydon, England, United Kingdom Huddersfield Royal Infirmary Huddersfield, West Yorks, England, United Kingdom, HD3 3EA Cookridge Hospital Leeds, England, United Kingdom, LS16 6QB Whittington Hospital London, England, United Kingdom, N19 5NF Guy's, King's and St. Thomas' Hospitals Trust London, England, United Kingdom, SE1 7EH Cancer Research Campaign Clinical Trials Unit-London London, England, United Kingdom, SE5 9NU Royal Marsden NHS Trust London, England, United Kingdom, SW3 6JJ Middlesex Hospital- Meyerstein Institute London, England, United Kingdom, W1N 8AA Clatterbridge Centre for Oncology NHS Trust Merseyside, England, United Kingdom, L63 4JY South Tees Acute Hospitals NHS Trust Middlesbrough, Cleveland, England, United Kingdom, TS4 3BW Newcastle General Hospital Newcastle Upon Tyne, England, United Kingdom, NE4 6BE Derriford Hospital Plymouth, England, United Kingdom, PL6 8DH Portsmouth Hospitals NHS Trust Portsmouth, England, United Kingdom, P03 6AD Salisbury General Infirmary Salisbury, England, United Kingdom, SP2 7SX Royal South Hants Hospital Southampton, England, United Kingdom, SO14 0YG Southampton General Hospital Southampton, England, United Kingdom, SO16 6YD North Tees General Hospital Stockton-On-Tees, England, United Kingdom, TS19 8PE North Staffs Royal Infirmary Stoke-On-Trent, England, United Kingdom, ST4 7LN Radiotherapy Department Stratford-on-Avon, Warwickshire, England, United Kingdom, CV37 6NX Sunderland Royal Infirmary Sunderland, England, United Kingdom, SR2 7JE Royal Marsden Hospital Sutton, England, United Kingdom, SM2 5PT Royal Hampshire County Hospital Winchester, England, United Kingdom, SO22 5DG Belfast City Hospital Trust Belfast, Northern Ireland, United Kingdom, BT8 8JR Belfast City Hospital Trust Belfast, Northern Ireland, United Kingdom, BT9 7AB Mid-Ulster Hospital Londonderry, Northern Ireland, United Kingdom, BT45 5EX Ards General Hospital Newtownards, Northern Ireland, United Kingdom Ninewells Hospital and Medical School Dundee, Scotland, United Kingdom, DD1 9SY Velindre Hospital Cardiff, Wales, United Kingdom, CF4 7XL 收起 << |
NCT02866955 | Breast Cancer | Phase 2 | Recruiting | July 2017 | France ... 展开 >> Institut Sainte Catherine Recruiting Avignon, France, 84082 Contact: Serin Daniel, MD CHU Besançon-Jean Minjoz Recruiting Besançon, France, 25030 Contact: Villanueva Christian, MD Polyclinique de Blois Recruiting Blois, France, 41260 Contact: Laplaige Philippe, MD CHU Avicenne Recruiting Bobigny, France, 93009 Contact: Zelek Laurent, MD Polyclinique Bordeaux Nord Aquitaine Recruiting Bordeaux, France, 33077 Contact: Dohollou Nadine, MD CHRU Brest Recruiting Brest, France, 29200 Contact: Simon Hélène, MD Centre O. Lambret Recruiting Lille, France, 59020 Contact: Bonneterre Jacques, MD CLCC Léon Bérard Recruiting Lyon, France, 69373 Contact: Guastalla Jean Paul, MD Hôpital Privé Clairval Recruiting Marseille, France, 13009 Contact: Robert Hervé, MD CHBM Site du Mittan Recruiting Montbeliard, France, 25200 Contact: Villanueva Christian, MD CLCC Val d'Aurel Recruiting Montpellier, France, 34298 Contact: Lemanski Claire, MD Centre Catherine de Sienne Recruiting Nantes, France, 44202 Contact: Lortholary Alain, MD Centre Antoine Lacassagne Recruiting Nice, France, 06189 Contact: Ferrero Jean Marc, MD CHU Tenon Recruiting Paris, France, 75020 Contact: Gligorov Joseph, MD Hôpital Européen Georges Pompidou Recruiting Paris, France, 75908 Contact: Médioni Jacques, MD Institut Jean Godinot Recruiting Reims, France, 51056 Contact: Eymard Jean-Christophe, MD Polyclinique Courlancy Reims Recruiting Reims, France, 51100 Contact: Facchini Thomas, MD Clinique armoricaine Recruiting Saint Brieuc, France, 22015 Contact: Besson Dominique, MD Centre Paul Strauss Recruiting Strasbourg, France, 67000 Contact: Petit Thierry, md Clinique Sainte Anne Recruiting Strasbourg, France, 67085 Contact: Dourthe Louis-Marie, MD Institut de Cancérologie de Lorraine Recruiting Vandoeuvre-lès-Nancy, France, 54519 Contact: Luporsi Elisabeth, MD 收起 << |
NCT00077168 | Breast Cancer | Phase 2 | Unknown | - | United Kingdom ... 展开 >> Frenchay Hospital at North Bristol NHS Trust Bristol, England, United Kingdom, BS16 1LE Bristol Haematology and Oncology Centre Bristol, England, United Kingdom, BS2 8ED Broomfield Hospital Broomefield, England, United Kingdom, CM1 7ET Chelmsford and Essex Centre Chelmsford, England, United Kingdom, CM2 0QH Essex County Hospital Colchester, England, United Kingdom, C03 3NB Derbyshire Royal Infirmary Derby, England, United Kingdom, DE1 2QY Queen's Hospital Derby, England, United Kingdom, DE1 2QY Dorset County Hospital Dorchester, England, United Kingdom, DT1 2JY St. Luke's Cancer Centre at Royal Surrey County Hospital Guildford, England, United Kingdom, GU2 7XX Leeds Cancer Centre at St. James's University Hospital Leeds, England, United Kingdom, LS9 7TF Lincoln County Hospital Lincoln, England, United Kingdom, LN2 5QY Charing Cross Hospital London, England, United Kingdom, W6 8RF South Manchester University Hospital Manchester, England, United Kingdom, M23 9LT Clatterbridge Centre for Oncology NHS Trust Merseyside, England, United Kingdom, CH63 4JY Milton Keynes General Hospital Milton Keynes, England, United Kingdom, MK6 5LD Derriford Hospital Plymouth, England, United Kingdom, PL6 8DH Poole Hospital NHS Trust Poole Dorset, England, United Kingdom, BH15 2JB Berkshire Cancer Centre at Royal Berkshire Hospital Reading, England, United Kingdom, RG1 5AN Scarborough General Hospital Scarborough, England, United Kingdom, YO12 6QL University Hospital of North Tees Stockton-On-Tees, England, United Kingdom, TS19 8PE Royal Marsden NHS Foundation Trust - Surrey Sutton, England, United Kingdom, SM2 5PT Torbay Hospital Torquay Devon, England, United Kingdom, TQ2 7AA Hillingdon Hospital Uxbridge, England, United Kingdom, UB8 3NN Worcester Royal Hospital Worcester, England, United Kingdom, WR5 1DD Aberdeen Royal Infirmary at NHS Grampian Aberdeen, Scotland, United Kingdom, AB25 2ZN Ninewells Hospital Dundee, Scotland, United Kingdom, DD1 9SY University of Glasgow Glasgow, Scotland, United Kingdom, G11 6NT Ysbyty Gwynedd Bangor, Wales, United Kingdom, LL57 2PW University Hospital of Wales Cardiff, Wales, United Kingdom, CF14 4XW 收起 << |
NCT00010140 | Breast Cancer | Phase 3 | Unknown | - | United Kingdom ... 展开 >> Charing Cross Hospital London, England, United Kingdom, W12 0NN 收起 << |
NCT00727948 | Breast Cancer ... 展开 >> Angiogenesis 收起 << | Early Phase 1 | Unknown | December 2011 | United States, Vermont ... 展开 >> University of Vermont Burlington, Vermont, United States, 05401 收起 << |
NCT03382834 | HIV Infections | Early Phase 1 | Active, not recruiting | June 30, 2023 | United States, Alabama ... 展开 >> Alabama CRS Birmingham, Alabama, United States, 35294 United States, California UCLA CARE Center CRS Los Angeles, California, United States, 90035 Ucsf Hiv/Aids Crs San Francisco, California, United States, 94110 Harbor-UCLA CRS Torrance, California, United States, 90502 United States, Colorado University of Colorado Hospital CRS Aurora, Colorado, United States, 80045 United States, District of Columbia Whitman-Walker Health CRS Washington, District of Columbia, United States, 20005 United States, Georgia The Ponce de Leon Center CRS Atlanta, Georgia, United States, 30308-2012 United States, Illinois Northwestern University CRS Chicago, Illinois, United States, 60611 United States, Massachusetts Massachusetts General Hospital CRS (MGH CRS) Boston, Massachusetts, United States, 02114 United States, New Jersey New Jersey Medical School Clinical Research Center CRS Newark, New Jersey, United States, 07103 United States, North Carolina Chapel Hill CRS Chapel Hill, North Carolina, United States, 27599 Greensboro CRS Greensboro, North Carolina, United States, 27401 United States, Ohio Cincinnati Clinical Research Site Cincinnati, Ohio, United States, 45219 United States, Pennsylvania Penn Therapeutics, CRS Philadelphia, Pennsylvania, United States, 19104 Puerto Rico Puerto Rico AIDS Clinical Trials Unit CRS San Juan, Puerto Rico, 00935 收起 << |
NCT00126464 | Breast Cancer | Not Applicable | Unknown | - | United States, California ... 展开 >> Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai Medical Center Los Angeles, California, United States, 90048 收起 << |
NCT02206984 | Breast Cancer | Not Applicable | Recruiting | October 2020 | United States, Alabama ... 展开 >> UAB Comprehensive Cancer Center Recruiting Birmingham, Alabama, United States, 35294 Contact: Erica M Reasor-Stringer, MD 205-934-3411 strinem@uab.edu Contact: Liz Busby, RN, BSN 205-934-0337 lizbusby@uab.edu United States, California UCSF Helen Diller Family Comprehensive Cancer Center Recruiting San Francisco, California, United States, 94143 Contact: Rita Muktar, MD 415-353-7070 rita.mukhtar@ucsf.edu United States, Indiana IU Simon Cancer Center Withdrawn Indianapolis, Indiana, United States, 46202 United States, Minnesota Mayo Clinic Recruiting Rochester, Minnesota, United States, 55905 Contact: Tina Hieken, MD 855-776-0015 Hieken.Tina@mayo.edu Contact: Kim Hitchcock 507-266-3867 hitchcock.kim@mayo.edu United States, New York ALBERT EINSTEIN COLLEGE OF MEDICINE Montefiore Medical Center Recruiting Bronx, New York, United States, 10467 Contact: Joseph Sparano, MD 718-405-8404 JSPARANO@montefiore.org Contact: Vilma Calderon, RN VCALDERO@montefiore.org United States, North Carolina University of North Carolina at Chapel Hill Recruiting Chapel Hill, North Carolina, United States, 27514 Contact: Kristalyn Gallagher, DO 919-966-5221 kristalyn_gallagher@med.unc.edu Contact: Rachel Phipps, RN United States, Pennsylvania Magee Womens Hospital of UPMC Recruiting Pittsburgh, Pennsylvania, United States, 15213 Contact: Brenda L Steele, BSN, RN 412-641-3418 Steebx@upmc.edu United States, Texas University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77064 Contact: Alastair Thompson, MD 713-745-2792 athompson1@mdanderson.org Contact: Jaime Crow, MS 717-792-6443 jrcrow@mdanderson.org United States, Washington Univ. of Washington, Seattle Cancer Care Alliance, Fred Hutchinson Cancer Research Center Recruiting Seattle, Washington, United States, 98109 Contact: Hannah Linden, MD 206-288-1234 hmlinden@seattlecca.org Contact: Obsy Tadesse 206-288-6831 otadesse@seattlecca.org 收起 << |
NCT00793377 | Primary Breast Cancer | Phase 3 | Completed | - | Germany ... 展开 >> German Breast Group Neu-Isenburg, Hessen, Germany, 06102 收起 << |
NCT01239745 | - | Terminated(See termination rea... 展开 >>son in detailed description.) 收起 << | - | Croatia ... 展开 >> General Hospital Karlovac Karlovac, Croatia, 47000 University Hospital Center Osijek Osijek, Croatia, 31000 General Hospital Pula Pula, Croatia, 52000 University Hospital Center Rijeka Rijeka, Croatia, 51000 University Hospital Center Split Split, Croatia, 21000 General Hospital Varazdin Varazdin, Croatia, 42000 Clinic for Tumors Zagreb, Croatia, 10000 University Hospital Center "Sestre milosrdnice" Zagreb, Croatia, 10000 Estonia North Estonia Medical Centre Foundation Tallinn, Estonia, 13419 Serbia Institute for Oncology and Radiology of Serbia Belgrade, Serbia, 11000 Oncology Clinic, Medical center, Bezanijska Kosa Beograd, Serbia, 11080 收起 << | |
NCT00375622 | Hereditary Hemorrhagic Telangi... 展开 >>ectasia 收起 << | Phase 2 | Completed | - | Israel ... 展开 >> Rabin Medical Center Petah Tikva, Israel, 49100 收起 << |
NCT01352091 | Breast Cancer | Phase 3 | Unknown | April 2018 | China, Shanghai ... 展开 >> FUSCC Recruiting Shanghai, Shanghai, China, 200032 Contact: Zhi-min Shao, MD 86-021-64175590 ext 8808 zhimingshao@yahoo.com 收起 << |
NCT03458221 | Ovarian Carcinoma ... 展开 >> Signal Transduction Pathway Deregulation Therapy-Associated Cancer 收起 << | Phase 3 | Not yet recruiting | December 1, 2022 | Netherlands ... 展开 >> Catharina Ziekenhuis Not yet recruiting Eindhoven, Brabant, Netherlands, 5623EJ Contact: Jurgen M Piek, MD. PhD. +31(0)40 239 9111 jurgen.piek@catharinaziekenhuis.nl Radboudumc Not yet recruiting Nijmegen, Gelderland, Netherlands Contact: L Massuger, Prof l.massuger@obgyn.umcn.nl Erasmus MC Not yet recruiting Rotterdam, Netherlands Contact: I Boere, MD., PhD. i.boere@erasmusmc.nl 收起 << |
NCT03518138 | Vasomotor Symptoms (VMS) | Phase 2 | Recruiting | August 2019 | United States, Massachusetts ... 展开 >> Brighams and Women's Hospital Recruiting Boston, Massachusetts, United States, 02115 Contact: Aleta Wiley 617-525-9627 awiley1@bwh.hardvard.edu Principal Investigator: Hadine Joffe Australia Royal Adelaide Hospital Not yet recruiting Adelaide, Australia, 5000 Contact: Lisa Leopardi 61 0882226759 lisa.leopardi@sa.gov.au Principal Investigator: Robert Whitfield School of Public Health and Preventive Medicine, Monash University Recruiting Melbourne, Australia, 3004 Contact: Corallee Morrow 61 0399030836 corallee.morrow@monash.edu Principal Investigator: Susan Davis Keogh Institute for Medical Research Recruiting Nedlands, Australia, 6009 Contact: Lee Mahoney 61 0893464402 lee@kimr.org Contact: Smilja Gragovic 61 0864572475 smilja@kimr.org Principal Investigator: Bronwyn Stuckey The Royal Women's Hospital Not yet recruiting Parkville, Australia, 3052 Contact: Shona Darby 61 0383452217 shona.darby@thewomens.org.au Contact: Soula Krejany 61 0383453719 soula.krejany@thewomens.org.au Principal Investigator: Martha Hickey Royal North Shore Hospital Not yet recruiting Saint Leonards, Australia, 2065 Contact: Liza Nery 61 0294631864 liza.nery@health.nsw.gov.au Contact: Rhonda Siddall Principal Investigator: Rodney Baber Women's Health Research Institute of Australis Recruiting Sydney, Australia, 2000 Contact: Jinzhu Liu 61 0293826278 jz.liu@unsw.ed.au Principal Investigator: John Eden 收起 << |
NCT01239745 | - | Terminated(See termination rea... 展开 >>son in detailed description.) 收起 << | - | - | |
NCT01758146 | Breast Cancer | Phase 3 | Unknown | June 2017 | India ... 展开 >> Department of Radiotherapy, Post Graduate Institute of Medical Education & Research Recruiting Chandigarh, India, 91 160012 Contact: Budhi S Yadav, MD 91 0172-275 ext 6390 drbudhi@gmail.com Principal Investigator: Dr Budhi S Yadav, MD 收起 << |
NCT02278120 | Advanced Metastatic Breast Can... 展开 >>cer 收起 << | Phase 3 | Active, not recruiting | September 27, 2019 | - |
NCT02467686 | Sexuality | Phase 4 | Recruiting | December 2017 | Brazil ... 展开 >> Carolina Furtado Macruz Recruiting Sao Paulo, Brazil, 01225001 Contact: Carolina Macruz +5511999141447 carolmacruz@gmail.com 收起 << |
NCT01272037 | Ductal Breast Carcinoma In Sit... 展开 >>u Estrogen Receptor and/or Progesterone Receptor Positive HER2/Neu Negative Invasive Breast Carcinoma Multicentric Breast Carcinoma Multifocal Breast Carcinoma Synchronous Bilateral Breast Carcinoma 收起 << | Phase 3 | Active, not recruiting | - | - |
NCT00026286 | Breast Cancer ... 展开 >> Hot Flashes Menopausal Symptoms 收起 << | Phase 3 | Completed | - | - |
NCT00016432 | Breast Cancer | Phase 3 | Completed | - | - |
NCT00866554 | Prostate Cancer ... 展开 >> Erectile Dysfunction Lower Urinary Tract Symptoms 收起 << | Phase 2 | Unknown | December 2015 | Canada ... 展开 >> CHUQ- Hotel-Dieu de Quebec Quebec, Canada, G1R 2J6 收起 << |
NCT00601900 | Estrogen Receptor Positive ... 展开 >> Invasive Breast Carcinoma Progesterone Receptor Positive Recurrent Breast Carcinoma Stage IIIB Breast Cancer AJCC v7 Stage IV Breast Cancer AJCC v6 and v7 收起 << | Phase 3 | Active, not recruiting | - | - |
NCT02395627 | Breast Neoplasms | Phase 2 | Recruiting | August 1, 2019 | United States, California ... 展开 >> University of California, San Francisco Medical Center Recruiting San Francisco, California, United States, 94115 Contact: Amy DeLuca 877-827-3222 cancertrials@ucsf.edu Principal Investigator: Pamela Munster, MD 收起 << |
NCT00038103 | Breast Neoplasms | Phase 2 | Completed | - | United States, Texas ... 展开 >> Pfizer Investigational Site Dallas, Texas, United States, 75204 Belgium Pfizer Investigational Site Antwerpen, Belgium, 2020 Pfizer Investigational Site Bruxelles, Belgium, 1000 Pfizer Investigational Site Leuven, Belgium, 3000 Pfizer Investigational Site Namur, Belgium, 5000 Pfizer Investigational Site Wilrijk, Belgium, 2610 Brazil Pfizer Investigational Site Porto Alegre, RS, Brazil, 90610-000 Pfizer Investigational Site Sao Paulo, SP, Brazil, 01509-900 Canada, Nova Scotia Pfizer Investigational Site Sydney, Nova Scotia, Canada, B1P 1P3 Colombia Pfizer Investigational Site Bogota, Bogota . DC, Colombia Pfizer Investigational Site Cali, Colombia India Pfizer Investigational Site Hyderabad, Andhra Pradesh, India, 500 082 Pfizer Investigational Site Bangalore, Karnataka, India, 560 029 Pfizer Investigational Site Mumbai, Maharashtra, India, 400 012 Pfizer Investigational Site Pune, Maharashtra, India, 41101 Mexico Pfizer Investigational Site Mexico, Distrito Federal, Mexico, 07760 Pfizer Investigational Site Guadalajara, Jalisco, Mexico, 44280 Peru Pfizer Investigational Site Lima, Peru, 11 Pfizer Investigational Site Lima, Peru, 34 Philippines Pfizer Investigational Site Manila, Philippines, 1000 收起 << |
NCT00038103 | - | Completed | - | - | |
NCT00897065 | - | Unknown | - | United States, Massachusetts ... 展开 >> Massachusetts General Hospital Recruiting Boston, Massachusetts, United States, 02114 Contact: Clinical Trials Office - Massachusetts General Hospital 877-726-5130 收起 << | |
NCT00649090 | Breast Neoplasms | Phase 4 | Completed | - | - |
NCT00001378 | Breast Cancer ... 展开 >> Breast Neoplasms 收起 << | Phase 1 | Completed | - | United States, Maryland ... 展开 >> National Cancer Institute (NCI) Bethesda, Maryland, United States, 20892 收起 << |
NCT00601900 | - | Active, not recruiting | - | - | |
NCT00001504 | Breast Cancer ... 展开 >> Breast Neoplasm 收起 << | Phase 1 | Completed | - | United States, Maryland ... 展开 >> National Cancer Institute (NCI) Bethesda, Maryland, United States, 20892 收起 << |
NCT00003140 | Breast Cancer | Phase 3 | Completed | - | - |
NCT01612871 | Breast Cancer | Phase 4 | Completed | - | France ... 展开 >> Centre Val d'Aurelle - Paul Lamarque Montpellier, France, 34298 Institut Claudius REGAUD Toulouse Toulouse, France, 31052 收起 << |
NCT00893061 | Breast Cancer | Phase 3 | Unknown | - | France ... 展开 >> Centre Oscar Lambret Recruiting Lille, France, 59020 Contact: Emilie Le Rhun 33-32-029-5959 收起 << |
NCT03381963 | - | Recruiting | May 2019 | Switzerland ... 展开 >> Geneva University Hospitals Recruiting Geneva, Switzerland Contact: Marc Blondon +41.22.372.92.92 marc.blondon@hcuge.ch 收起 << | |
NCT00963417 | Breast Cancer ... 展开 >> Osteoporosis 收起 << | Not Applicable | Active, not recruiting | December 2018 | Australia ... 展开 >> Royal Brisbane and Women's Hospital Brisbane, Australia Peter MacCallum Cancer Center East Melbourne, Australia Box Hill Hospital Melbourne, Australia Maroondah Hospital Melbourne, Australia Royal Perth Hospital Perth, Australia Belgium Centre Hospitalier Regional de Huy Huy, Belgium UZ Leuven Leuven, Belgium C.H.U. Sart Tilman Liège, Belgium CHR Citadelle Liège, Belgium C.H.P.L.T. de Verviers Verviers, Belgium Switzerland Oncology Institute of Southern Switzerland Bellinzona, Switzerland, CH-6500 Inselspital Bern Bern, Switzerland Kantonsspital St.Gallen St.Gallen, Switzerland 收起 << |
NCT00005886 | Breast Cancer | Phase 1 | Completed | - | United States, Alabama ... 展开 >> University of Alabama at Birmingham Comprehensive Cancer Center Birmingham, Alabama, United States, 35294-3300 United States, California Jonsson Comprehensive Cancer Center, UCLA Los Angeles, California, United States, 90095-1781 Comprehensive Cancer Centers of the Desert Palm Springs, California, United States, 92262 United States, Illinois Loyola University Medical Center Maywood, Illinois, United States, 60153 United States, Kansas University of Kansas Medical Center Kansas City, Kansas, United States, 66160-7357 United States, Ohio Cleveland Clinic Taussig Cancer Center Cleveland, Ohio, United States, 44195 Arthur G. James Cancer Hospital - Ohio State University Columbus, Ohio, United States, 43210-1240 United States, Pennsylvania Kimmel Cancer Center of Thomas Jefferson University - Philadelphia Philadelphia, Pennsylvania, United States, 19107-5541 United States, Texas U.S. Oncology Research Inc. Dallas, Texas, United States, 75246 收起 << |
NCT00002646 | Breast Cancer | Phase 3 | Completed | - | - |
NCT00814125 | Breast Cancer | Phase 3 | Completed | - | - |
NCT00233610 | Prostate Cancer | Phase 3 | Completed | - | Italy ... 展开 >> Research Site Bari, BA, Italy Research Site Bologna, BO, Italy Research Site Catania, CT, Italy Research Site Bagno a Ripoli, FI, Italy Research Site Firenze, FI, Italy Research Site Genova, GE, Italy Research Site Pisa, PI, Italy Research Site Parma, PR, Italy Research Site Udine, UD, Italy Research Site Como, Italy Research Site Roma, Italy 收起 << |
NCT00897091 | - | Completed | - | United States, Illinois ... 展开 >> Cardinal Bernardin Cancer Center at Loyola University Medical Center Maywood, Illinois, United States, 60153 收起 << | |
NCT00246961 | - | Completed | - | Netherlands ... 展开 >> Research Site 'S-Gravenhage, Netherlands Research Site 's-Hertogenbosch, Netherlands Research Site Alkmaar, Netherlands Research Site Antwerpen, Netherlands Research Site Apeldoorn, Netherlands Research Site Bergen op Zoom, Netherlands Research Site Boxmeer, Netherlands Research Site Breda, Netherlands Research Site Doetinchem, Netherlands Research SIte Dordrecht, Netherlands Research Site Ede, Netherlands Research Site Eindhoven, Netherlands Research Site Enschede, Netherlands Research Site Geldrop, Netherlands Research Site Groningen, Netherlands Research Site Harderwijk, Netherlands Research Site Helmond, Netherlands Research Site Hoogeveen, Netherlands Research Site Hoorn, Netherlands Research Site Leiden, Netherlands Research Site Oosterhout, Netherlands Research Site Purmerend, Netherlands Research Site Roermond, Netherlands Research Site Roosendaal, Netherlands Research Site Rotterdam, Netherlands Research Site Schiedam, Netherlands Research Site Terneuzen, Netherlands Research Site Tiel, Netherlands Research Site Venray, Netherlands Research Site Vlissingen, Netherlands Research Site Winterswijk, Netherlands Research Site Zoetermeer, Netherlands Research Site Zutphen, Netherlands 收起 << | |
NCT00002542 | Breast Cancer | Phase 3 | Completed | - | - |
NCT00002967 | Breast Cancer | Phase 3 | Completed | - | - |
NCT02228681 | Advanced, Persistent, or Recur... 展开 >>rent Endometrial Cancer 收起 << | Phase 2 | Active, not recruiting | - | - |
NCT03280563 | Breast Neoplasms | Phase 1 Phase 2 | Recruiting | October 7, 2022 | - |
NCT00001193 | Breast Neoplasms ... 展开 >> Neoplasm Metastasis 收起 << | Phase 2 | Completed | - | United States, Maryland ... 展开 >> National Cancer Institute (NCI) Bethesda, Maryland, United States, 20892 收起 << |
NCT02863900 | Breast Cancer | Not Applicable | Not yet recruiting | December 2019 | France ... 展开 >> Institut Claudius Regaud Not yet recruiting Toulouse, France, 31059 Contact: FLORENCE DALENC, MD 0033 5 31 15 51 04 dalenc.florence@iuct-oncopole.fr 收起 << |
NCT00003032 | Breast Cancer | Phase 3 | Completed | - | Canada, Alberta ... 展开 >> Tom Baker Cancer Center - Calgary Calgary, Alberta, Canada, T2N 4N2 Canada, British Columbia BC Cancer Agency Vancouver, British Columbia, Canada, V5Z 4E6 Canada, Manitoba CancerCare Manitoba Winnipeg, Manitoba, Canada, R3E 0V9 Canada, New Brunswick Moncton Hospital Moncton, New Brunswick, Canada, E1C 6ZB Saint John Regional Hospital Saint John, New Brunswick, Canada, E2L 4L2 Canada, Newfoundland and Labrador Newfoundland Cancer Treatment and Research Foundation St. Johns, Newfoundland and Labrador, Canada, A1B 3V6 Canada, Nova Scotia Nova Scotia Cancer Centre Halifax, Nova Scotia, Canada, B3H 1V7 Canada, Ontario William Osler Health Centre Brampton, Ontario, Canada, L6W 2Z8 Cancer Care Ontario-Hamilton Regional Cancer Centre Hamilton, Ontario, Canada, L8V 5C2 Cancer Care Ontario-London Regional Cancer Centre London, Ontario, Canada, N6A 4L6 Ottawa Regional Cancer Centre - General Campus Ottawa, Ontario, Canada, K1H 1C4 Hotel Dieu Hospital - St. Catharines St. Catharines, Ontario, Canada, L2R 5K3 Northeastern Ontario Regional Cancer Centre, Sudbury Sudbury, Ontario, Canada, P3E 5J1 Northwestern Ontario Regional Cancer Centre, Thunder Bay Thunder Bay, Ontario, Canada, P7A 7T1 Toronto Sunnybrook Regional Cancer Centre Toronto, Ontario, Canada, M4N 3M5 Toronto General Hospital Toronto, Ontario, Canada, M5G 2C4 Princess Margaret Hospital Toronto, Ontario, Canada, M5G 2M9 Humber River Regional Hospital Weston, Ontario, Canada, M9N 1N8 Cancer Care Ontario - Windsor Regional Cancer Centre Windsor, Ontario, Canada, N8W 2X3 Canada, Prince Edward Island Queen Elizabeth Hospital, PEI Charlottetown, Prince Edward Island, Canada, C1A 8T5 Canada, Quebec L'Hotel Dieu de Levis Levis, Quebec, Canada, G6V 3Z1 Centre Hospitalier de l'Universite de Montreal Montreal, Quebec, Canada, H2L-4M1 McGill University Department of Oncology Montreal, Quebec, Canada, H2W 1S6 Hotel Dieu de Montreal Montreal, Quebec, Canada, H2W 1T8 Centre Hospitalier Universitaire de Quebec, Pavillion de Quebec Quebec City, Quebec, Canada, G1R 2J6 收起 << |
NCT00193726 | Breast Cancer | Phase 3 | Terminated(The accrual was ver... 展开 >>y slow and there were many competing studies ongoing/initiated .) 收起 << | - | India ... 展开 >> Tata Memorial Hospital Mumbai, Maharashtra, India, 400012 收起 << |
NCT00433589 | Breast Cancer | Phase 3 | Active, not recruiting | - | Netherlands ... 展开 >> Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital Amsterdam, Netherlands, 1066 CX 收起 << |
NCT00906321 | High Risk for Breast Cancer ... 展开 >> Risk Reduction Behavior 收起 << | Not Applicable | Completed | - | United States, Maryland ... 展开 >> National Cancer Institute (NCI), 9000 Rockville Pike Bethesda, Maryland, United States, 20892 收起 << |
NCT00916162 | - | Completed | - | United States, Massachusetts ... 展开 >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02115 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 收起 << | |
NCT00711529 | Breast Cancer ... 展开 >> Hot Flashes 收起 << | Phase 3 | Completed | - | United States, Rhode Island ... 展开 >> Breast Health Center, Program in Women's Oncology, Women & Infants' Hospital of Rhode Island Providence, Rhode Island, United States, 02905 收起 << |
NCT02290782 | Breast Cancer | Phase 4 | Recruiting | July 2018 | Germany ... 展开 >> Department of Radiotherapy University Hospital Mannheim Recruiting Mannheim, Germany, 68167 Contact: Frederik Wenz, Prof. Dr. 00496213834960 frederik.wenz@medma.uni-heidelberg.de 收起 << |
NCT00711529 | - | Completed | - | - | |
NCT00735215 | - | Completed | - | Belgium ... 展开 >> Research Site Antwerp, Belgium Research Site Brugge, Belgium Research Site Brussels, Belgium Research Site Gent, Belgium Research Site Kortrijk, Belgium Research Site Leuven, Belgium Research Site Liege, Belgium Research Site Namur, Belgium Research Site Ostende, Belgium Research Site Roeselare, Belgium Research Site Turnhout, Belgium Research Site Wilrijk, Belgium 收起 << | |
NCT02771938 | Breast Cancer | Not Applicable | Recruiting | April 1, 2019 | United Kingdom ... 展开 >> The Royal Marsden NHS Foundation Trust Recruiting London, United Kingdom, SW3 6JJ Contact: Fiona MacNeill +442078082782 fiona.macneill@rmh.nhs.uk Contact: Lone Gothard +442086613460 lone.gothard@icr.ac.uk 收起 << |
NCT01501656 | - | Completed | - | United States, Texas ... 展开 >> UT Southwestern Medical Center Dallas, Texas, United States, 75204 收起 << | |
NCT03115593 | Endometrial Cancer | Not Applicable | Not yet recruiting | March 2020 | Belgium ... 展开 >> CHU Brugmann Not yet recruiting Brussels, Belgium, 1020 Contact: André Nazac, MD 32 2 4772660 Andre.NAZAC@chu-brugmann.be Principal Investigator: André Nazac, MD Hôpitaux Iris Sud - Site Ixelles Not yet recruiting Brussels, Belgium, 1050 Contact: Frédéric Buxant, MD 00 32 2 739 85 85 fbuxant@his-izz.be Principal Investigator: Frédéric Buxant CHR Citadelle Not yet recruiting Liege, Belgium, 4000 Contact: Laurent de Landsheere, MD 00 32 4 321 65 15 ldelandsheere@chu.ulg.ac.be Principal Investigator: Laurent de Landsheere, MD France Hôpital Bicêtre Not yet recruiting Le Kremlin Bicêtre, France, 94275 Contact: Hervé Fernandez, MD 01-45-21-77-01 herve.fernandez@bct.aphp.fr Principal Investigator: Hervé Fernandez, MD 收起 << |
NCT02297230 | - | Terminated(PI Left Institution... 展开 >> prior to reaching accrual goal and analyzing data.) 收起 << | - | - | |
NCT01499160 | Breast Neoplasms ... 展开 >> Endocrine Breast Diseases Neoplasm Metastasis 收起 << | Phase 2 | Terminated(low accrual) | - | United States, Maryland ... 展开 >> University of Maryland Marlene & Stewart Greenebaum Cancer Center Baltimore, Maryland, United States, 21201 收起 << |
NCT02455453 | Breast Cancer | Phase 2 | Recruiting | October 31, 2019 | United States, Missouri ... 展开 >> Washington University School of Medicine Recruiting Saint Louis, Missouri, United States, 63110 Contact: Farrokh Dehdashti, M.D. 314-747-1604 dehdashtif@wustl.edu Contact: Jennifer Frye, CNMT, PET, CCRC 314-747-1604 fryej@wustl.edu Principal Investigator: Farrokh Dehdashti, M.D. Sub-Investigator: Michael Naughton, M.D. Sub-Investigator: Cynthia Ma, M.D., Ph.D. Sub-Investigator: Barry Siegel, M.D. 收起 << |
NCT02297230 | Breast Cancer | Phase 1 Phase 2 | Terminated(PI Left Institution... 展开 >> prior to reaching accrual goal and analyzing data.) 收起 << | - | United States, New York ... 展开 >> Weill Medical College of Cornell University New York, New York, United States, 10065 收起 << |
NCT00310180 | Breast Adenocarcinoma ... 展开 >> Estrogen Receptor and/or Progesterone Receptor Positive HER2/Neu Negative Stage IA Breast Cancer AJCC v7 Stage IB Breast Cancer AJCC v7 Stage IIA Breast Cancer AJCC v6 and v7 Stage IIB Breast Cancer AJCC v6 and v7 Stage IIIB Breast Cancer AJCC v7 收起 << | Phase 3 | Active, not recruiting | - | - |
NCT01303679 | First Line Metastatic Breast C... 展开 >>ancer 收起 << | Phase 3 | Terminated(Not reveal any sign... 展开 >>ificant difference between the 2 treatment arms) 收起 << | - | France ... 展开 >> BACHELOT Lyon, France, 69000 收起 << |
NCT01499160 | - | Terminated(low accrual) | - | - | |
NCT00010010 | Breast Cancer | Phase 2 | Completed | - | United States, New York ... 展开 >> NYU School of Medicine's Kaplan Comprehensive Cancer Center New York, New York, United States, 10016 收起 << |
NCT03314688 | Breast Neoplasms | Not Applicable | Recruiting | December 31, 2022 | United States, Connecticut ... 展开 >> Yale University Recruiting New Haven, Connecticut, United States, 06510 收起 << |
NCT00762294 | - | Completed | - | United States, Connecticut ... 展开 >> University of Connecticut HEalth Center Farmington, Connecticut, United States, 06030 收起 << | |
NCT01771458 | Reccurent/Metastatic Solid Tum... 展开 >>or Disease 收起 << | Phase 2 | Unknown | December 2016 | France ... 展开 >> Centre régional de lutte contre le cancer de Bourgogne Georges François Leclerc Dijon, France, 21079 Centre Leon Berard Lyon, France, 69373 Institut Paoli Calmettes Marseille, France, 13009 Insitut Curie Paris, France, 75248 Institut Curie Hopital Rene Huguenin Saint-cloud, France, 92210 Institut de cancérologie de l'Ouest Centre René Gauducheau Saint-herblain, France, 44000 Institut Claudius Régaud Toulouse, France, 31052 Centre Alexis Vautrin Vandoeuvre Les Nancy, France, 54500 收起 << |
NCT00005822 | Breast Cancer | Phase 1 | Completed | - | United States, Ohio ... 展开 >> Ireland Cancer Center at University Hospitals Case Medical Center Cleveland, Ohio, United States, 44106-5065 收起 << |
NCT02095184 | Breast Cancer | Not Applicable | Recruiting | March 2019 | United States, Maryland ... 展开 >> University of Maryland Greenebaum Cancer Center Recruiting Baltimore, Maryland, United States, 21201 Contact: Nancy Tait, R.N. 410-328-3546 ntait@umm.edu Principal Investigator: Susan Kesmodel, M.D. 收起 << |
NCT01176916 | Breast Neoplasms | Phase 4 | Recruiting | November 28, 2018 | - |
NCT00488722 | Breast Cancer | Not Applicable | Unknown | - | China, Tianjin ... 展开 >> Tianjin Cancer Hospital Recruiting Tianjin, Tianjin, China, 300060 Contact: ZHANG SHENG, DOCTOR 86-022-23340123 ext 2901 Contact: ZHANG SHENG, DORTOR 86-022-23340123 ext 2901 Principal Investigator: ZHANG JIN, PROFESSOR 收起 << |
NCT00332709 | Osteoporosis ... 展开 >>Postmenopausal 收起 << | Phase 3 | Completed | - | Germany ... 展开 >> Novartis Investigative Site Deggendorf, Germany Novartis Investigative Site Frankfurt/Main, Germany Novartis Investigative Site Freiburg, Germany Novartis Investigative Site Georgsmarienhutte, Germany Novartis Investigative Site Gottingen, Germany Novartis Investigative Site Halle, Germany Novaertis Investigative Site Hamein, Germany Novartis Investigative Site Hannover, Germany Novartis Investigative Site Hoxter, Germany Novartis Investigative Site Ilsede, Germany Novartis Investigative Site Jena, Germany Novartis Investigative Site Karlsruhe, Germany Novartis Investigative Site Koln, Germany Novartis Investigative Site Leer, Germany Novartis Investigative Site Lubeck, Germany Novartis Investigative Site Mannheim, Germany Novartis Investigative Site Munster, Germany Novartis Investigative Site Rostock, Germany Novartis Investigative Site Salzgitter, Germany Novartis Investigative Site Schwenningen, Germany Novartis Investigative Site Stendal, Germany Novartis Investigative Site Volklingen, Germany Novartis Investigative Site Witten, Germany 收起 << |
NCT01791829 | - | Active, not recruiting | July 2023 | Canada, Alberta ... 展开 >> Tom Baker Cancer Centre Calgary, Alberta, Canada, T2N 4N2 Canada, British Columbia Abbotsford Centre Abbotsford, British Columbia, Canada, V2S 0C2 BC Cancer Agency, Centre for the North Prince George, British Columbia, Canada, V2M 7E9 BCCA - Vancouver Centre Vancouver, British Columbia, Canada, V5Z 4E6 BC Cancer Agency Victoria, British Columbia, Canada, V9R 6V5 Canada, Manitoba Cancer Care Manitoba Winnipeg, Manitoba, Canada, R3E 0V9 Canada, Ontario Royal Victoria Regional Health Centre Barrie, Ontario, Canada, L4M 6M2 Juravinski Cancer Centre Hamilton, Ontario, Canada, L8V 1C3 Cancer Centre of Southern Ontario at Kingston Kingston, Ontario, Canada Grand River Regional Cancer Centre Kitchener, Ontario, Canada, N2G 1G3 London Regional Cancer Centre London, Ontario, Canada, N6A 4L6 R.S. McLaughlin Durham Regional Cancer Centre Oshawa, Ontario, Canada, L1G 2B9 Ottawa Regional Cancer Centre Ottawa, Ontario, Canada, K1H 8L6 Algoma District Cancer Program Sault Ste. Marie, Ontario, Canada, P6B 0A8 Niagara Health System St. Catharines, Ontario, Canada, L2S 0A9 Northeastern Ontario Regional Cancer Centre Sudbury, Ontario, Canada, P3E 5J1 Thunder Bay Regional Health Sciences Thunder Bay, Ontario, Canada, P7B 6V4 Sunnybrook Health Sciences Centre Toronto, Ontario, Canada, M4N 3M5 Princess Margaret Cancer Centre Toronto, Ontario, Canada, M5G 1Z6 Canada, Quebec Centre integre de sante et de services sociaux de laval (CISSS de Laval) Laval, Quebec, Canada, H7M 3L9 CHUM - Hopital Notre Dame Montreal, Quebec, Canada, H2L 4M1 The Jewish General Hospital Montreal, Quebec, Canada, H3T1E2 McGill University Health Centre Montreal, Quebec, Canada, H4A 3J1 CHUQ - Pavillon Hotel-Dieu de Quebec Quebec city, Quebec, Canada, G1R 2J6 CHUS - Hopital Fleurimont Sherbrooke, Quebec, Canada, J1H 5N4 Canada, Saskatchewan The Allan Blair Cancer Centre Regina, Saskatchewan, Canada, S4T 7T1 Saskatoon Cancer Centre Saskatoon, Saskatchewan, Canada, S7N 4H4 收起 << | |
NCT00332709 | - | Completed | - | - | |
NCT00857012 | - | Completed | - | - | |
NCT00322647 | - | Completed | - | United States, New Mexico ... 展开 >> University of New Mexico Albuquerque, New Mexico, United States, 87114 收起 << | |
NCT01658176 | Breast Neoplasms | Phase 2 | Withdrawn | April 2015 | - |
NCT00256230 | Stage IV Melanoma | Phase 1 Phase 2 | Completed | - | United States, California ... 展开 >> Chao Family Comprehensive Cancer Center Orange, California, United States, 92868 收起 << |
NCT01167192 | - | Terminated | - | - | |
NCT03063619 | Mammographically Dense Breast | Phase 2 | Recruiting | May 15, 2019 | United States, Florida ... 展开 >> Moffitt Cancer Center Not yet recruiting Tampa, Florida, United States, 33612 Contact: Nagi B. Kumar 813-745-6885 nagi.kumar@moffitt.org Principal Investigator: Nagi B. Kumar United States, Illinois Northwestern University Not yet recruiting Chicago, Illinois, United States, 60611 Contact: Seema A. Khan 312-503-4236 s-khan2@northwestern.edu Principal Investigator: Seema A. Khan United States, Massachusetts Dana-Farber Cancer Institute Not yet recruiting Boston, Massachusetts, United States, 02215 Contact: Judy E. Garber 617-632-5770 Judy_Garber@dfci.harvard.edu Principal Investigator: Judy E. Garber United States, New York Columbia University/Herbert Irving Cancer Center Not yet recruiting New York, New York, United States, 10032 Contact: Katherine D. Crew 212-305-1732 kd59@cumc.columbia.edu Principal Investigator: Katherine D. Crew United States, Texas M D Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Powel H. Brown 713-792-4509 phbrown@mdanderson.org Principal Investigator: Powel H. Brown 收起 << |
NCT01167192 | Breast Neoplasms | Phase 2 | Terminated | - | United States, Missouri ... 展开 >> Washington University School of Medicine St. Louis, Missouri, United States, 63110 收起 << |
NCT01530373 | Hot Flashes B... 展开 >>reast Cancer 收起 << | Phase 2 | Recruiting | September 2021 | United States, Arkansas ... 展开 >> Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences Recruiting Little Rock, Arkansas, United States, 722205 Contact: Allen C Sherman, PhD 501-686-8700 shermanallenc@uams.edu Sub-Investigator: Issam Makhoul, MD Sub-Investigator: Laura Hutchins, MD Sub-Investigator: Rhonda Henry-Tillman, MD 收起 << |
NCT00129389 | Breast Cancer | Phase 3 | Unknown | December 2013 | Spain ... 展开 >> Spanish Breast Cancer Research Group (GEICAM) San Sebastián de los Reyes, Madrid, Spain, 28700 收起 << |
NCT03621904 | - | Not yet recruiting | February 1, 2023 | - | |
NCT00555477 | - | Terminated(The study was stopp... 展开 >>ed after 69 subjects were enrolled because of poor accrual.) 收起 << | - | - | |
NCT00555477 | Breast Cancer | Phase 2 | Terminated(The study was stopp... 展开 >>ed after 69 subjects were enrolled because of poor accrual.) 收起 << | - | United States, Maryland ... 展开 >> Sidney Kimmel Comprehensive Center at Johns Hopkins Baltimore, Maryland, United States, 21231-2410 United States, Massachusetts Dana-Farber Cancer Center Boston, Massachusetts, United States, 02115 United States, Michigan University of Michigan Ann Arbor, Michigan, United States, 48109 收起 << |
NCT03058939 | Breast Cancer ... 展开 >> Breast Cancer Stage II Breast Cancer Stage III 收起 << | Phase 2 | Withdrawn(Study never activate... 展开 >>d to enrollment.) 收起 << | June 2019 | Nigeria ... 展开 >> Lagos State University College of Medicine Ikeja, Lagos State, Nigeria 收起 << |
NCT00129935 | Breast Cancer | Phase 3 | Active, not recruiting | January 2019 | - |
NCT00376740 | Breast Cancer | Phase 3 | Completed | - | Israel ... 展开 >> Soroka University Medical Center Beer Sheva, Israel Tel Aviv Sourasky Medical Center Tel Aviv, Israel 收起 << |
NCT00615524 | Hormone-receptor Positive Brea... 展开 >>st Cancer 收起 << | Phase 2 | Withdrawn(Cancelled Before Enr... 展开 >>ollment) 收起 << | November 2012 | United States, California ... 展开 >> GSK Clinical Trials Call Center San Francisco, California, United States, 94115 收起 << |
NCT00999804 | - | Active, not recruiting | - | - | |
NCT00590785 | High Risk Bre... 展开 >>ast Cancer Positive Nodes Cyclophosphamide Doxorubicin 收起 << | Phase 3 | Completed | - | United States, New York ... 展开 >> Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 收起 << |
NCT00999804 | Breast Cancer | Phase 2 | Active, not recruiting | January 2018 | United States, Alabama ... 展开 >> University of Alabama - Birmingham Birmingham, Alabama, United States, 35294 United States, Illinois University of Chicago Chicago, Illinois, United States, 60637 United States, Indiana Indiana University Indianapolis, Indiana, United States, 46202 United States, Maryland Johns Hopkins Baltimore, Maryland, United States, 21231 United States, Massachusetts Dana Farber Cancer Institute Boston, Massachusetts, United States, 02130 United States, North Carolina Duke University Durham, North Carolina, United States, 27705 United States, Tennessee Vanderbilt University Medical Center Nashville, Tennessee, United States, 37212 United States, Texas Baylor College of Medicine Lester and Sue Smith Breast Center Houston, Texas, United States, 77030 收起 << |
NCT02406794 | Breast Neoplasms | Phase 1 Phase 2 | Completed | - | Spain ... 展开 >> Regional University Hospital Virgen de la Victoria Malaga, Spain 收起 << |
NCT03761420 | - | Not yet recruiting | January 1, 2022 | - | |
NCT02181101 | Breast Neoplasms | Phase 3 | Completed | - | Germany ... 展开 >> Klinikum der Universität München, Klinik und Poliklinik für Frauenheilkunde und Geburtshilfe, Campus Innenstadt Munich, Bavaria, Germany, 80337 收起 << |
NCT01313039 | - | Completed | - | - | |
NCT00653718 | - | Completed | - | Canada, Quebec ... 展开 >> Centre hospitalier de l'Université de Montréal Montréal, Quebec, Canada, H2W 1T8 收起 << | |
NCT02118636 | - | Completed | - | United States, Michigan ... 展开 >> University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States, 48109 收起 << | |
NCT02291913 | Breast Cancer | Phase 2 | Active, not recruiting | January 2019 | United States, Florida ... 展开 >> Florida Cancer Specialists-South Fort Myers, Florida, United States, 33916 Memorial Cancer Center Hollywood, Florida, United States, 33021 Woodlands Medical Specialists Pensacola, Florida, United States, 32503 Florida Cancer Specialists-East West Palm Beach, Florida, United States, 33401 United States, Indiana Hope Cancer Center Terre Haute, Indiana, United States, 47802 United States, Tennessee Tennessee Oncology Chattanooga, Tennessee, United States, 37404 Tennessee Oncology PLLC Nashville, Tennessee, United States, 37203 United States, Texas Center for Cancer and Blood Disorders Fort Worth, Texas, United States, 76104 收起 << |
NCT01908556 | is to Identify Biomarkers That... 展开 >> Could Predict the Efficacy of an Adjuvant Letrozol Treatment in Postmenopausal Breast Cancer Patients. 收起 << | Phase 4 | Unknown | - | Germany ... 展开 >> Frauenklinik University Hospital Erlangen, Bavaria, Germany, 91054 收起 << |
NCT01313039 | Breast Cancer | Early Phase 1 | Completed | - | United States, Florida ... 展开 >> University of Miami Sylvester Comprehensive Cancer Center Miami, Florida, United States, 33136 收起 << |
NCT01773551 | - | Withdrawn(Not NIH defined clin... 展开 >>ical trial study) 收起 << | April 2018 | United States, California ... 展开 >> Pacific Breast Care Medical Clinic Costa Mesa, California, United States, 92627 Beckman Laser Institute Medical Clinic Irvine, California, United States, 92612 Chao Family Comprehensive Cancer Center Orange, California, United States, 92868 Helen Diller Family Comprehensive Cancer Center/ UCSF San Francisco, California, United States, 94143 收起 << | |
NCT00240071 | Metastatic Breast Cancer | Phase 2 | Completed | - | United States, Alabama ... 展开 >> University of Alabama at Birmingham Birmingham, Alabama, United States, 35294 收起 << |
NCT02513329 | Hot Flushes H... 展开 >>ot Flashes 收起 << | Phase 2 | Recruiting | July 2019 | United States, Illinois ... 展开 >> Northwestern University Feinberg School of Medicine Recruiting Chicago, Illinois, United States, 60611 收起 << |
NCT00007904 | Breast Cancer | Phase 2 | Completed | - | United States, Ohio ... 展开 >> Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44106-5065 UH-LUICC Mentor, Ohio, United States, 44060 UH-Chagrin Highlands Orange Village, Ohio, United States, 44122 收起 << |
NCT00003042 | Breast Cancer | Phase 2 | Active, not recruiting | March 2019 | United States, California ... 展开 >> City of Hope Comprehensive Cancer Center Duarte, California, United States, 91010-3000 收起 << |
NCT00003992 | Breast Cancer | Phase 2 | Completed | - | - |
NCT00240071 | - | Completed | - | - | |
NCT03555877 | Breast Cancer Metastatic | Phase 2 | Recruiting | October 2019 | Germany ... 展开 >> Studienzentrum Onkologie Ravensburg Recruiting Ravensburg, Germany, 88212 Contact: Thomas Decker, Prof. Dr. +49 (0) 7513661970 ext 0 thomas.decker@onkonet.eu 收起 << |
NCT03161353 | Breast Cancer | Phase 2 | Recruiting | December 2021 | - |
NCT03238703 | HER2/Neu Negative ... 展开 >> Invasive Breast Carcinoma Postmenopausal Stage 0 Breast Cancer Stage IA Breast Cancer 收起 << | Phase 4 | Withdrawn(Administrative closu... 展开 >>re based on sponsor recommendation, prior to subject enrollment) 收起 << | March 14, 2025 | United States, Washington ... 展开 >> Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 收起 << |
NCT03592771 | Breast Neoplasm Female | Not Applicable | Recruiting | September 2022 | United States, Tennessee ... 展开 >> West Cancer Center, MIDTOWN, 1588 Union Ave. Recruiting Memphis, Tennessee, United States, 38104 Contact: Greg Vidal, MD 901-683-0055 gvidal@westclinic.com West Cancer Center, EAST MEMPHIS, 7945 Wolf River Blvd Recruiting Memphis, Tennessee, United States, 38138 Contact: Greg Vidal, MD 901-683-0055 gvidal@westclinic.com 收起 << |
NCT01293032 | - | Completed | - | - | |
NCT00002784 | Breast Cancer | Phase 3 | Completed | - | Australia, New South Wales ... 展开 >> Newcastle Mater Misericordiae Hospital Newcastle, New South Wales, Australia, NSW 2310 Royal Prince Alfred Hospital, Sydney Sydney, New South Wales, Australia, 2050 Australia, South Australia Royal Adelaide Hospital Adelaide, South Australia, Australia, 5000 Queen Elizabeth Hospital Adelaide, South Australia, Australia, 5011 Australia, Victoria Royal Melbourne Hospital Parkville, Victoria, Australia, 3050 Switzerland Swiss Institute for Applied Cancer Research Bern, Switzerland, CH-3008 Inselspital, Bern Bern, Switzerland, CH-3010 Centre Hospitalier Universitaire Vaudois Lausanne, Switzerland, CH-1011 Istituto Oncologico della Svizzera Italiana Lugano, Switzerland, CH-6900 Kantonsspital - Saint Gallen Saint Gallen, Switzerland, CH-9007 Universitaetsspital Zurich, Switzerland, CH-8091 收起 << |
NCT00084344 | Breast Cancer | Not Applicable | Completed | - | United States, Illinois ... 展开 >> Robert H. Lurie Comprehensive Cancer Center at Northwestern University Chicago, Illinois, United States, 60611 收起 << |
NCT01293032 | Ductal Breast Carcinoma in Sit... 展开 >>u Lobular Breast Carcinoma in Situ Stage II Breast Cancer Stage IIA Breast Cancer Stage IIB Breast Cancer Stage IIIA Breast Cancer Stage IIIB Breast Cancer 收起 << | Not Applicable | Completed | - | United States, District of Col... 展开 >>umbia Washington Cancer Institute Washington, District of Columbia, United States, 20010 United States, North Carolina Carolinas Medical Center Charlotte, North Carolina, United States, 28203 Forsyth Regional Cancer Center Charlotte, North Carolina, United States, 28204 Cone Health Cancer Center Greensboro, North Carolina, United States, 27403 United States, Texas Methodist Cancer Center Houston, Texas, United States, 77030 United States, Virginia Lynchburg Hematology Oncology Clinic, Inc Lynchburg, Virginia, United States, 24501 Virginia Commonwealth University Richmond, Virginia, United States, 23298 Canada, Quebec Centre Hospitalier de l'Université de Montréal , Hôtel-Dieu Hospital Montreal, Quebec, Canada, H2W 1T8 收起 << |
NCT02753686 | - | Recruiting | December 2, 2019 | Canada, British Columbia ... 展开 >> Novartis Investigative Site Recruiting Burnaby, British Columbia, Canada, V5G 2X6 Novartis Investigative Site Recruiting Richmond, British Columbia, Canada, V7C 5L9 Novartis Investigative Site Recruiting Vancouver, British Columbia, Canada, V5Z 4E6 Canada, New Brunswick Novartis Investigative Site Recruiting Moncton, New Brunswick, Canada, E1C 8X3 Canada, Ontario Novartis Investigative Site Recruiting Cambridge, Ontario, Canada, N1R 3G2 Novartis Investigative Site Recruiting Kingston, Ontario, Canada, K7L 5P9 Novartis Investigative Site Recruiting Kitchener, Ontario, Canada, N2G 1G3 Novartis Investigative Site Recruiting Newmarket, Ontario, Canada, L3Y 2P9 Novartis Investigative Site Recruiting Ottowa, Ontario, Canada, K1H 8L6 Novartis Investigative Site Recruiting Sault Ste-Marie, Ontario, Canada, P6A 2C4 Novartis Investigative Site Recruiting Windsor, Ontario, Canada, N8W 2X3 Canada, Quebec Novartis Investigative Site Recruiting Greenfield Park, Quebec, Canada, J4V 2H1 Novartis Investigative Site Recruiting Montreal, Quebec, Canada, H3A 1A1 Novartis Investigative Site Recruiting Montreal, Quebec, Canada, H3T 1E2 Novartis Investigative Site Recruiting Montreal, Quebec, Canada, H4J 1C5 Canada, Saskatchewan Novartis Investigative Site Recruiting Saskatoon, Saskatchewan, Canada, S7N 4H4 Canada Novartis Investigative Site Recruiting Quebec, Canada, G1S 4L8 收起 << | |
NCT02269670 | Estrogen Receptor-positive Bre... 展开 >>ast Cancer HER2-negative Breast Cancer Progesterone Receptor-positive Breast Cancer Recurrent Breast Cancer Stage IIIA Breast Cancer Stage IIIB Breast Cancer Stage IIIC Breast Cancer Stage IV Breast Cancer 收起 << | Phase 2 | Active, not recruiting | October 2020 | United States, Georgia ... 展开 >> Emory University Hospital Midtown Atlanta, Georgia, United States, 30308 Emory University/Winship Cancer Institute Atlanta, Georgia, United States, 30322 Emory Saint Joseph's Hospital Atlanta, Georgia, United States, 30342 收起 << |
NCT02188745 | Metastatic Breast Cancer | Phase 2 | Recruiting | March 2019 | United States, Massachusetts ... 展开 >> Baystate Medical Center Recruiting Springfield, Massachusetts, United States, 01199 United States, New Hampshire Dartmouth Hitchcock Medical Center Recruiting Lebanon, New Hampshire, United States, 03756 Contact: Gary N Schwartz, MD 800-639-6918 gary.n.schwartz@hitchcock.org Contact: Research Nurse 800-639-6918 cancer.research.nurse@dartmouth.edu 收起 << |
NCT00005908 | - | Completed | - | - | |
NCT00808522 | Breast Cancer | Phase 3 | Unknown | December 2009 | United States, New York ... 展开 >> New York Downtown Hospital Recruiting New York, New York, United States, 10038 Contact: Giuseppe Del Priore, MD, MPH 212-312-5268 nydresearch@downtownhospital.org Sub-Investigator: Alan S Klapper, MD Sub-Investigator: Steven Freidman, MD Sub-Investigator: Joseph Bottino, MD Sub-Investigator: Raffi Chalian, MD 收起 << |
NCT03184090 | Metastatic Breast Cancer | Phase 2 | Recruiting | March 2019 | Italy ... 展开 >> Ospedale Antonio Perrino Not yet recruiting Brindisi, Italy Contact: Saverio Cinieri Principal Investigator: Saverio Cinieri Istituto Europeo di Oncologia Not yet recruiting Milan, Italy Contact: Giuseppe Curigliano Principal Investigator: Giuseppe Curigliano Azienda Sanitaria Universitaria Integrata di Udine Not yet recruiting Udine, Italy Contact: Allesandro Minisini Principal Investigator: Allesandro Minisini Spain ICO Badalona Recruiting Badalona, Barcelona, Spain Contact: Vanesa Quiroga Principal Investigator: Vanesa Quiroga ICO l'Hospitalet Recruiting L'Hospitalet de Llobregat, Barcelona, Spain, 08007 Contact: Miguel Gil Principal Investigator: Miguel Gil Clinico Universitario A Coruña Recruiting A Coruña, Spain Contact: Lourdes Calvo Principal Investigator: Lourdes Calvo Hospital del Mar Recruiting Barcelona, Spain, 08003 Contact: Joan Albanell Principal Investigator: Joan Albanell Hospital Reina Sofia Recruiting Cordoba, Spain Contact: Juan De La Haba Principal Investigator: Juan De La Haba Hospital de Leon Recruiting Leon, Spain Contact: Andrés Garcia-Palomo Principal Investigator: Andres Garcia-Palomo Hospital 12 de Octubre Recruiting Madrid, Spain Contact: Eva Ciruelos Principal Investigator: Eva Ciruelos Hospital Clinico San Carlos Recruiting Madrid, Spain Contact: Jose Angel Garcia-Saenz Principal Investigator: Jose Angel Garcia-Saenz Hospital La Paz Recruiting Madrid, Spain Contact: Enrique Espinosa Principal Investigator: Enrique Espinosa Hospital Virgen del Rocío Recruiting Sevilla, Spain Contact: Manuel Ruiz Principal Investigator: Manuel Ruiz Hospital Clinico Universitario de Valencia Recruiting Valencia, Spain Contact: Begoña Bermejo Principal Investigator: Begoña Bermejo Hospital Universitari i Politecnic La Fe Recruiting Valencia, Spain Contact: Ana Santaballa Principal Investigator: Ana Santaballa Hospital Miguel Servet Recruiting Zaragoza, Spain Contact: Antonio Antón Principal Investigator: Antonio Antón 收起 << |
NCT00499083 | Breast Cancer | Phase 2 | Completed | - | United States, Florida ... 展开 >> H. Lee Moffitt Cancer Center and Research Institute at University of South Florida Tampa, Florida, United States, 33612-9497 United States, Nebraska UNMC Eppley Cancer Center at the University of Nebraska Medical Center Omaha, Nebraska, United States, 68198-6805 收起 << |
NCT00499083 | - | Completed | - | - | |
NCT01050634 | - | Completed | - | - | |
NCT03024580 | Breast Neoplasm | Phase 2 | Recruiting | September 2018 | Brazil ... 展开 >> Hospital do Cancer III Recruiting Rio de Janeiro, Brazil, 20560120 Contact: Renata Obadia, RN 552132073810 robadia@inca.gov.br 收起 << |
NCT02476786 | Breast Cancer ... 展开 >> Cancer of Breast Breast Neoplasms Cancer of the Breast 收起 << | Phase 2 | Recruiting | July 31, 2024 | United States, Missouri ... 展开 >> Washington University School of Medicine Recruiting Saint Louis, Missouri, United States, 63110 Contact: Rebecca L Aft, M.D., Ph.D. 314-747-0063 aftr@wustl.edu Contact: Tracey Guthrie 314-747-4404 guthriet@wustl.edu Principal Investigator: Rebecca L Aft, M.D., Ph.D. Sub-Investigator: Foluso Ademuyiwa, M.D. Sub-Investigator: Ron Bose, M.D., Ph.D. Sub-Investigator: Amy Cyr, M.D. Sub-Investigator: Timothy Eberlein, M.D. Sub-Investigator: William Gillanders, M.D. Sub-Investigator: Cynthia X Ma, M.D., Ph.D. Sub-Investigator: Julie Margenthaler, M.D. Sub-Investigator: Michael Naughton, M.D. Sub-Investigator: Rama Suresh, M.D. Sub-Investigator: Katherine N Weilbaecher, M.D. Sub-Investigator: Leonel Hernandez-Aya, M.D. Sub-Investigator: Peter Oppelt, M.D. Sub-Investigator: Antonella Rastelli, M.D. Sub-Investigator: Caron Rigden, M.D. 收起 << |
NCT01050634 | - | Completed | - | - | |
NCT00903162 | Breast Cancer | Phase 2 | Completed | - | United States, Colorado ... 展开 >> University of Colorado Denver, Colorado, United States, 80217 United States, Massachusetts Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02115 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02215 Newton Wellesley Hospital Newton, Massachusetts, United States, 02462 收起 << |
NCT00903162 | - | Completed | - | - | |
NCT00005908 | Breast Cancer ... 展开 >> Breast Neoplasm 收起 << | Phase 2 | Completed | - | United States, Maryland ... 展开 >> National Naval Medical Center Bethesda, Maryland, United States, 20889 收起 << |
NCT00002529 | Breast Cancer | Phase 3 | Completed | - | Australia, New South Wales ... 展开 >> Newcastle Mater Misericordiae Hospital Newcastle, New South Wales, Australia, NSW 2310 Royal Prince Alfred Hospital, Sydney Sydney, New South Wales, Australia, 2050 Australia, South Australia Royal Adelaide Hospital Adelaide, South Australia, Australia, 5000 Australia, Victoria Anti-Cancer Council of Victoria, Melbourne Carlton South, Victoria, Australia, 3053 Australia, Western Australia Sir Charles Gairdner Hospital, Perth Perth, Western Australia, Australia, 6009 Italy Centro di Riferimento Oncologico - Aviano Aviano, Italy, 33081 Universita di Brescia Brescia, Italy, 25124 Istituto Europeo Di Oncologia Milano, Italy, 20141 Ospedale Civile Rimini Rimini, Italy, 47037 Ospedale San Eugenio Rome, Italy, 00144 New Zealand Auckland Adventist Hospital Auckland, New Zealand, 5 Slovenia Institute of Oncology, Ljubljana Ljubljana, Slovenia, Sl-1000 South Africa Groote Schuur Hospital, Cape Town Cape Town, South Africa, 7925 Sweden Sahlgrenska University Hospital Gothenburg (Goteborg), Sweden, S-413 45 Switzerland University Hospital Basel, Switzerland, CH-4031 Inselspital, Bern Bern, Switzerland, CH-3010 Centre Hospitalier Universitaire Vaudois Lausanne, Switzerland, CH-1011 Hopital des Cadolles, Neuchatel Neuchatel, Switzerland, 2000 Kantonsspital - Saint Gallen Saint Gallen, Switzerland, CH-9007 Universitaetsspital Zurich, Switzerland, CH-8091 收起 << |
NCT00899288 | Breast Cancer ... 展开 >> Osteoporosis 收起 << | Phase 3 | Terminated(Insufficient accrua... 展开 >>l) 收起 << | - | - |
NCT00002707 | Breast Cancer | Phase 3 | Completed | - | - |
NCT00369850 | Breast Cancer ... 展开 >> Osteoporosis 收起 << | Phase 3 | Completed | - | Australia, New South Wales ... 展开 >> Institute of Oncology at Prince of Wales Hospital Randwick, New South Wales, Australia, 2031 Australia, Queensland Royal Brisbane and Women's Hospital Brisbane, Queensland, Australia, 4029 France Institut Bergonie Bordeaux, France, 33076 Italy Centro di Riferimento Oncologico - Aviano Aviano, Italy, 33081 Ospedali Riuniti di Bergamo Bergamo, Italy, 24100 European Institute of Oncology Milano, Italy, 20141 New Zealand Dunedin Hospital Dunedin, New Zealand Peru Instituto Nacional de Enfermedades Neoplasicas Lima, Peru, 34 South Africa Groote Schuur Hospital Cape Town, South Africa, 7925 Spain Hospital Ruber Internacional Madrid, Spain, 28034 Switzerland Kantonspital Aarau Aarau, Switzerland, CH-5001 Inselspital Bern Bern, Switzerland, CH-3010 Centre Hospitalier Universitaire Vaudois Lausanne, Switzerland, CH-1011 Ospedale Beata Vergine Mendrisio, Switzerland, CH-6850 Kantonsspital - St. Gallen St. Gallen, Switzerland, CH-9007 Regionalspital Thun, Switzerland, 3600 收起 << |
NCT00343616 | Breast Cancer ... 展开 >> Cognitive/Functional Effects Fatigue Psychosocial Effects of Cancer and Its Treatment 收起 << | Phase 3 | Completed | - | Australia, New South Wales ... 展开 >> Institute of Oncology at Prince of Wales Hospital Randwick, New South Wales, Australia, 2031 Australia, Victoria Peter MacCallum Cancer Centre East Melbourne, Victoria, Australia, 3002 St. Vincent's Hospital - Melbourne Fitzroy, Victoria, Australia, 3065 Cabrini Hospital Malvern, Victoria, Australia, 3144 Belgium Institut Jules Bordet Brussels, Belgium, 1000 Italy European Institute of Oncology Milan, Italy, 20141 New Zealand Auckland City Hospital Auckland, New Zealand, 1 Switzerland Universitaetsspital-Basel Basel, Switzerland, CH-4031 Oncology Institute of Southern Switzerland Bellinzona, Switzerland, CH-6500 International Breast Cancer Study Group Bern, Switzerland, CH-3008 Kantonsspital - St. Gallen St. Gallen, Switzerland, CH-9007 United Kingdom Ninewells Hospital Dundee, Scotland, United Kingdom, DD1 9SY 收起 << |
NCT03219476 | Breast Cancer ... 展开 >> Invasive Breast Cancer 收起 << | Phase 2 | Recruiting | December 1, 2020 | United States, Wisconsin ... 展开 >> Froedtert Hospital Recruiting Milwaukee, Wisconsin, United States, 53226 Contact: Lubna Chaudhary, MD 414-805-4600 lchaudhary@mcw.edu Contact: Medical College of Wisconsin Cancer Center Clinical Trials Office 414-805-8900 cccto@mcw.edu 收起 << |
NCT00382070 | Breast Cancer | Phase 3 | Active, not recruiting | October 2018 | - |
NCT00040014 | Breast Neoplasms | Phase 2 | Terminated | - | United Kingdom ... 展开 >> Pfizer Investigational Site Leicester, United Kingdom 收起 << |
NCT00107263 | Breast Cancer ... 展开 >> Osteoporosis 收起 << | Phase 3 | Completed | - | - |
NCT02517593 | Breast Cancer | Phase 1 Phase 2 | Active, not recruiting | June 2021 | United States, Minnesota ... 展开 >> Mayo Clinic in Rochester Rochester, Minnesota, United States, 55905 Canada, Manitoba CancerCare Manitoba Winnipeg, Manitoba, Canada 收起 << |
NCT00754845 | Breast Cancer | Phase 3 | Completed | - | - |
NCT00754845 | - | Completed | - | - | |
NCT01391689 | Stage IA Breast Cancer ... 展开 >> Stage IB Breast Cancer Stage II Breast Cancer Stage IIIA Breast Cancer 收起 << | Not Applicable | Completed | - | United States, Arizona ... 展开 >> Arizona Cancer Center Tucson, Arizona, United States, 85012 收起 << |
NCT03355157 | Metastatic Breast Cancer | Phase 4 | Recruiting | December 31, 2021 | Germany ... 展开 >> Agaplesion Markus Krankenhaus - Klinik für Gynäkologie und Geburtshilfe Recruiting Frankfurt am Main, Germany, 60431 Contact: Marc Thill, MD, PhD marc.thill@fdk.info 收起 << |
NCT02995772 | Breast Cancer | Phase 3 | Recruiting | January 2019 | Indonesia ... 展开 >> Dharmais National Cancer Center Hospital Recruiting Jakarta, Indonesia, 11420 Contact: Ramadhan Ramli, PhD +62-812-1045-970 ramadhan@dharmais-surgonc.com 收起 << |
NCT01564056 | Breast Cancer | Phase 3 | Active, not recruiting | March 2026 | - |
NCT01073865 | Breast Cancer | Phase 3 | Completed | - | - |
NCT01073865 | - | Completed | - | - | |
NCT03664895 | Breast Cancer Invasive | Phase 3 | Recruiting | October 2, 2023 | Korea, Republic of ... 展开 >> Seoul National University Hospital Recruiting Seoul, Korea, Republic of, 110-744 Contact: Wonshik Han, MD PhD 82-2-2072-1958 hanw@snu.ac.kr Contact: Eun-Shin Lee, MD silvershoe99@gmail.com Principal Investigator: Eun-Shin Lee, MD 收起 << |
NCT03554044 | Anatomic Stage III Breast Canc... 展开 >>er AJCC v8 Anatomic Stage IIIA Breast Cancer AJCC v8 Anatomic Stage IIIB Breast Cancer AJCC v8 Anatomic Stage IIIC Breast Cancer AJCC v8 Anatomic Stage IV Breast Cancer AJCC v8 Estrogen Receptor Positive HER2/Neu Negative Invasive Breast Carcinoma Prognostic Stage III Breast Cancer AJCC v8 Prognostic Stage IIIA Breast Cancer AJCC v8 Prognostic Stage IIIB Breast Cancer AJCC v8 Prognostic Stage IIIC Breast Cancer AJCC v8 Prognostic Stage IV Breast Cancer AJCC v8 Recurrent Breast Carcinoma 收起 << | Phase 1 | Not yet recruiting | December 1, 2021 | United States, California ... 展开 >> University of California, San Francisco Not yet recruiting San Francisco, California, United States, 94115 Contact: Amy J. Chien, MD 877-827-3222 cancertrials@ucsf.edu Principal Investigator: Amy J. Chien 收起 << |
NCT00814034 | - | Completed | - | Greece ... 展开 >> Hellenic Breast Surgeons Society Athens, Attica, Greece, 11523 Hellenic Breast Surgeons Society Athens, Greece, 11527 收起 << | |
NCT01612728 | Breast Cancer ... 展开 >> Arthralgia Joint Pain 收起 << | Phase 2 | Withdrawn(The grant applicatio... 展开 >>n for this project was rejected.) 收起 << | October 2014 | - |
NCT01234532 | Estrogen Receptor-negative Bre... 展开 >>ast Cancer HER2-negative Breast Cancer Progesterone Receptor-negative Breast Cancer Stage I Breast Cancer Stage II Breast Cancer Stage IIIA Breast Cancer Triple-negative Breast Cancer 收起 << | Phase 2 | Terminated(low accrual) | - | United States, Maryland ... 展开 >> University of Maryland Baltimore Baltimore, Maryland, United States, 21201 收起 << |
NCT00005970 | Breast Adenocarcinoma ... 展开 >> HER2 Positive Breast Carcinoma Stage IA Breast Cancer AJCC v7 Stage IB Breast Cancer AJCC v7 Stage IIA Breast Cancer AJCC v6 and v7 Stage IIB Breast Cancer AJCC v6 and v7 Stage IIIA Breast Cancer AJCC v7 收起 << | Phase 3 | Active, not recruiting | - | - |
NCT02630693 | Breast Cancer | Phase 2 | Active, not recruiting | February 2019 | Canada, Alberta ... 展开 >> Cross Cancer Institute Edmonton, Alberta, Canada, T6G 1Z2 Canada, British Columbia BCCA - Abbotsford Centre Abbotsford, British Columbia, Canada, V2S 0C2 BCCA - Fraser Valley Cancer Centre Surrey, British Columbia, Canada, V3V 1Z2 BCCA - Vancouver Cancer Centre Vancouver, British Columbia, Canada, V5Z 4E6 Canada, New Brunswick The Moncton Hospital Moncton, New Brunswick, Canada, E1C 6Z8 Canada, Newfoundland and Labrador Dr. H. Bliss Murphy Cancer Centre St. John's, Newfoundland and Labrador, Canada, A1B 3V6 Canada, Nova Scotia QEII Health Sciences Centre Halifax, Nova Scotia, Canada, B3H 1V7 Canada, Ontario Royal Victoria Regional Health Centre Barrie, Ontario, Canada, L4M 6M2 Juravinski Cancer Centre at Hamilton Health Sciences Hamilton, Ontario, Canada, L8V 5C2 Cancer Centre of Southeastern Ontario at Kingston Kingston, Ontario, Canada, K7L 5P9 Stronach Regional Health Centre at Southlake Newmarket, Ontario, Canada, L3Y 2P9 Lakeridge Health Oshawa Oshawa, Ontario, Canada, L1G 2B9 Ottawa Hospital Research Institute Ottawa, Ontario, Canada, K1H 8L6 Niagara Health System St. Catharines, Ontario, Canada, L2S 0A9 University Health Network Toronto, Ontario, Canada, M5G 2M9 Windsor Regional Cancer Centre Windsor, Ontario, Canada, N8W 2X3 Canada, Quebec CHUM - Hopital Notre-Dame Montreal, Quebec, Canada, H2L 4M1 The Jewish General Hospital Montreal, Quebec, Canada, H3T 1E2 Hopital du Sacre-Coeur de Montreal Montreal, Quebec, Canada, H4J 1C5 CHA-Hopital Du St-Sacrement Quebec City, Quebec, Canada, G1S 4L8 Centre hospitalier universitaire de Sherbrooke Sherbrooke, Quebec, Canada, J1H 5N4 Canada, Saskatchewan Allan Blair Cancer Centre Regina, Saskatchewan, Canada, S4T 7T1 收起 << |
NCT02823262 | Breast Cancer ... 展开 >> Estrogen Receptor Positive Breast Cancer Node-negative Breast Cancer Human Epidermal Growth Factor 2 Negative Carcinoma of Breast 收起 << | Not Applicable | Recruiting | July 2024 | United States, Massachusetts ... 展开 >> Beth Israel Deaconess Medical Center Recruiting Boston, Massachusetts, United States, 02115 Contact: Mara Schonberg, MD MPH 617-754-1414 Principal Investigator: Mara Schonberg, MD MPH Dana Farber Cancer Institute Not yet recruiting Boston, Massachusetts, United States, 02115 Contact: Faina Nakhlis, MD 617-983-7777 Principal Investigator: Faina Nakhlis, MD 收起 << |
NCT03493854 | Early Breast Cancer | Phase 3 | Recruiting | April 4, 2024 | - |
NCT03168074 | Breast Cancer | Phase 2 | Recruiting | March 28, 2021 | Singapore ... 展开 >> Nationa University Hospital Recruiting Singapore, Singapore Contact: Soo Chin Lee, MBBS, MRCP +65 6779 5555 Soo_Chin_Lee@nuhs.edu.sg Principal Investigator: Soo Chin Lee, MBBS, MRCP 收起 << |
NCT01864746 | Breast Cancer ... 展开 >> Hormonreceptor Positive Her2-normal Postneoadjuvant Treatment With CDK 4/6 Inhibitor CPS-EG Score 收起 << | Phase 3 | Active, not recruiting | November 2023 | United States, Pennsylvania ... 展开 >> NSABP Foundation Pittsburgh, Pennsylvania, United States, 15212 Australia, New South Wales Contact: Australia and New Zealand Breast Cancer Trials Group Newcastle, New South Wales, Australia, PO Box 155 Austria Contact: Austrian Breast & Colorectal Cancer Study Group Vienna, Austria, 1090 Canada Contact: NSABP Foundation Multiple Locations, Canada France Contact: UNICANCER Paris, France, 75654 Germany Contact: German Breast Group Neu-Isenburg, Germany, 63263 Ireland Contact: Cancer Trials Ireland Dublin, Ireland, 2 Japan Contact: Japan Breast Cancer Research Group Tokyo, Japan, 103-0016 Korea, Republic of Contact: Korea Cancer Study Group Seoul, Korea, Republic of, 138-736 Spain GEICAM San Sebastián de los Reyes, Spain, 28703 United Kingdom Contact: Institute of Cancer Research London, United Kingdom, SW7 3RP 收起 << |
NCT00869466 | - | Completed | - | United Kingdom ... 展开 >> Wellcome Trust Clinical Research Facility Manchester, England, United Kingdom, M13 9WL Christie Hospital Manchester, England, United Kingdom, M20 4BX Nightingale Centre and Genesis Prevention Centre at Wythenshawe Hospital Manchester, England, United Kingdom, M23 9LT South Manchester University Hospital Manchester, England, United Kingdom, M23 9LT Cancer Care Research Centre at University of Stirling Stirling, England, United Kingdom, FK9 4NF 收起 << | |
NCT03317405 | BRCA1 Gene Mutation ... 展开 >> BRCA2 Gene Mutation Ductal Breast Carcinoma In Situ Lobular Breast Carcinoma In Situ Prophylactic Mastectomy Patient Stage 0 Breast Cancer AJCC v6 and v7 Stage I Breast Cancer AJCC v7 Stage IA Breast Cancer AJCC v7 Stage IB Breast Cancer AJCC v7 Stage II Breast Cancer AJCC v6 and v7 Stage IIA Breast Cancer AJCC v6 and v7 Stage IIB Breast Cancer AJCC v6 and v7 Stage III Breast Cancer AJCC v7 Stage IIIA Breast Cancer AJCC v7 Stage IIIB Breast Cancer AJCC v7 Stage IIIC Breast Cancer AJCC v7 收起 << | Phase 1 | Recruiting | September 1, 2019 | United States, California ... 展开 >> Cedars Sinai Medical Center Recruiting Los Angeles, California, United States, 90048 Contact: Scott R. Karlan 310-423-9331 KarlanS@cshs.org Principal Investigator: Scott R. Karlan United States, Illinois Northwestern University Recruiting Chicago, Illinois, United States, 60611 Contact: Seema A. Khan 312-472-0585 skhan@nm.org Principal Investigator: Seema A. Khan United States, New York Memorial Sloan Kettering Cancer Center Not yet recruiting New York, New York, United States, 10065 Contact: Melissa L. Pilewskie 646-888-4590 pilewskm@mskcc.org Principal Investigator: Melissa L. Pilewskie 收起 << |
NCT00381927 | - | Completed | - | United States, Massachusetts ... 展开 >> Comprehensive Breast Center Springfield, Massachusetts, United States, 01199 收起 << | |
NCT03719495 | - | Recruiting | December 1, 2021 | United States, North Carolina ... 展开 >> Duke University Medical Center Recruiting Durham, North Carolina, United States, 27710 Contact: Duke Breast Oncology Research 919-660-1278 Principal Investigator: Sarah Sammons, MD 收起 << | |
NCT00498901 | Breast Cancer | Phase 2 | Terminated | - | United States, Washington ... 展开 >> Seattle Cancer Care Alliance Seattle, Washington, United States, 98109-1023 University Cancer Center at University of Washington Medical Center Seattle, Washington, United States, 98195-6043 收起 << |
NCT02734615 | Advanced or Metastatic ER+ Bre... 展开 >>ast Cancer 收起 << | Phase 1 | Recruiting | October 30, 2020 | United States, Maryland ... 展开 >> Novartis Investigative Site Recruiting Baltimore, Maryland, United States, 21287 United States, Massachusetts Massachusetts General Hospital Massachusetts General Hospital Recruiting Boston, Massachusetts, United States, 02114 Contact: Dejan Juric, MD 617-726-6500 Juric.Dejan@mgh.harvard.edu Contact: Meghan Miles 617-726-6500 MEMILES@mgh.harvard.edu Principal Investigator: Dejan Juric, MD United States, New York Novartis Investigative Site Recruiting New York, New York, United States, 10021 Contact: Alexandra Burleigh 646-422-4394 burleiga@mskcc.org Principal Investigator: Komal Jhaveri United States, Texas Novartis Investigative Site Recruiting Houston, Texas, United States, 77030 Contact: Daniela Westerhold diwesterhold@mdanderson.org Principal Investigator: Rachel M Layman Belgium Novartis Investigative Site Recruiting Bruxelles, Belgium, 1200 Canada, Ontario Novartis Investigative Site Recruiting Toronto, Ontario, Canada, M5G 2M9 France Novartis Investigative Site Recruiting Lyon Cedex, France, 69373 Italy Novartis Investigative Site Recruiting Milano, MI, Italy, 20133 Novartis Investigative Site Recruiting Milano, MI, Italy, 20141 Japan Novartis Investigative Site Recruiting Koto-ku, Tokyo, Japan, 135 8550 Singapore Novartis Investigative Site Recruiting Singapore, Singapore, 169610 Spain Novartis Investigative Site Recruiting Barcelona, Catalunya, Spain, 08036 Novartis Investigative Site Recruiting Madrid, Spain, 28007 收起 << |
NCT01399359 | - | Completed | - | United States, Texas ... 展开 >> MD Anderson Cancer Center Houston, Texas, United States, 77030 收起 << | |
NCT02415790 | Healthy Participants | Phase 1 | Completed | - | United States, California ... 展开 >> Paraxel International Glendale, California, United States 收起 << |
NCT01831076 | Breast Cancer ... 展开 >> Stage II Breast Cancer Stage III Breast Cancer 收起 << | Phase 2 | Active, not recruiting | December 2018 | United States, Colorado ... 展开 >> University of Colorado Cancer Center Aurora, Colorado, United States, 80045 收起 << |
NCT03018106 | - | Terminated(Obstacles with recr... 展开 >>uitment) 收起 << | - | - | |
NCT03018106 | Sexual Dysfunction, Physiologi... 展开 >>cal 收起 << | Phase 4 | Terminated(Obstacles with recr... 展开 >>uitment) 收起 << | - | United States, Georgia ... 展开 >> Emory Midtown Hospital Atlanta, Georgia, United States, 30308 Emory Clinic Atlanta, Georgia, United States, 30322 Emory Hospital Atlanta, Georgia, United States, 30322 Emory St. Joseph's Hospital Atlanta, Georgia, United States, 30342 收起 << |
NCT02345785 | - | Unknown | December 2015 | Korea, Republic of ... 展开 >> Department of Anesthesiology and Pain Medicine, Yonsei University College of Medicine Not yet recruiting Seoul, Korea, Republic of, 120-752 Contact: Hae Keum Kil, MD 82-2-2228-2420 hkkil@yuhs.ac 收起 << | |
NCT00349011 | Menopause | Not Applicable | Completed | - | United States, Connecticut ... 展开 >> Yale Cancer Genetic Counseling, Yale Cancer Center, Yale University School of Medicine New Haven, Connecticut, United States, 06510 收起 << |
NCT00887380 | Breast Cancer | Phase 3 | Active, not recruiting | December 2024 | - |
NCT00053911 | Breast Cancer | Phase 3 | Terminated | - | France ... 展开 >> Clinique Claude Bernard Albi, France, 81000 Centre Paul Papin Angers, France, 49036 Centre Hospitalier d'Annecy Annecy, France, 74011 Cedex Institut Sainte Catherine Avignon, France, 84082 Institut Bergonie Bordeaux, France, 33076 C.H. Bourg En Bresse Bourg En Bresse, France, 01012 CHU Hopital A. Morvan Brest, France, 29609 Centre Hospitalier General Brive, France, 19101 Centre Regional Francois Baclesse Caen, France, 14076 Centre Jean Perrin Clermont-Ferrand, France, 63011 Centre Hospitalier Compiegne Compiegne, France, 60321 Clinique du Petit Colmouilins Harfleur, France, 76700 Centre Oscar Lambret Lille, France, 59020 Institut J. Paoli and I. Calmettes Marseille, France, 13273 Hopital Notre-Dame de Bon Secours Metz, France, 57038 C.H. General Andre Boulloche Montbeliard, France, 25209 Centre Regional de Lutte Contre le Cancer - Centre Val d'Aurelle Montpellier, France, 34298 Centre Hospitalier de Mulhouse Mulhouse, France, 68051 Centre Regional Rene Gauducheau Nantes-Saint Herblain, France, 44805 Clinique Saint - Pierre Perpignan, France Centre Eugene Marquis Rennes, France, 35042 Clinique Armoricaine De Radiologie Saint Brieux, France, F-22015 Polyclinique de L'Ormeau Tarbes, France, 65000 Institut Claudius Regaud Toulouse, France, 31052 Hopital J. Ducuing Toulouse, France Institut Gustave Roussy Villejuif, France, F-94805 收起 << |
NCT00002755 | Breast Cancer | Phase 3 | Completed | - | Ireland ... 展开 >> St. Vincent's Hospital Dublin, Ireland, 4 United Kingdom Addenbrooke's NHS Trust Cambridge, England, United Kingdom, CB2 2QQ Cheltenham General Hospital Cheltenham, England, United Kingdom, GL53 7AN Royal Devon and Exeter Hospital Exeter, England, United Kingdom, EX2 5DW Royal Free Hospital Hampstead, London, England, United Kingdom, NW3 2QG Northwick Park Hospital Harrow, England, United Kingdom, HA1 3UJ Huddersfield Royal Infirmary Huddersfield, West Yorks, England, United Kingdom, HD3 3EA St. James's Hospital Leeds, England, United Kingdom, LS9 7TF St. George's Hospital London, England, United Kingdom, SW17 0QT Middlesex Hospital- Meyerstein Institute London, England, United Kingdom, W1N 8AA Newcastle General Hospital Newcastle Upon Tyne, England, United Kingdom, NE4 6BE Nottingham City Hospital NHS Trust Nottingham, England, United Kingdom, NG5 1PB Derriford Hospital Plymouth, England, United Kingdom, PL6 8DH Weston Park Hospital Sheffield, England, United Kingdom, S1O 2SJ Royal South Hants Hospital Southampton, England, United Kingdom, SO14 0YG Aberdeen Royal Infirmary Aberdeen, Scotland, United Kingdom, AB25 2ZN Royal Infirmary Edinburgh, Scotland, United Kingdom, EH3 9YW Western General Hospital Edinburgh, Scotland, United Kingdom, EH4 9NQ Beatson Oncology Centre Glasgow, Scotland, United Kingdom, G11 6NT Royal Infirmary Glasgow, Scotland, United Kingdom, G4 0SF Velindre Hospital Cardiff, Wales, United Kingdom, CF4 7XL 收起 << |
NCT01831076 | - | Active, not recruiting | - | - | |
NCT00629278 | Breast Cancer | Phase 3 | Unknown | - | Italy ... 展开 >> Ospedale Santa Croce Recruiting Cuneo, Italy, 12100 Contact: Contact Person 39-0171-441-309 Ospedale Civile di Ivrea Recruiting Ivrea, Italy, 10015 Contact: Contact Person 39-0125-4141 Azienda Ospedaliera - Universitaria di Modena Recruiting Modena, Italy, 41100 Contact: Pier Franco Conte, MD 39-059-422-4538 conte.pierfranco@unimo.it Piacenza Hospital Recruiting Piacenza, Italy, 29100 Contact: Contact Person 39-052-330-3123 Azienda Sanitaria Ospedale San Giovanni Battista Molinette di Torino Recruiting Turin, Italy, 10126 Contact: Contact Person 39-011-633-1633 Ospedal San Andrea Recruiting Vercelli, Italy, 13100 Contact: Contact Person 39-161-593-418 收起 << |
NCT03684005 | Cancer | Not Applicable | Recruiting | December 2019 | United States, Michigan ... 展开 >> Barbara Ann Karmanos Cancer Institute Recruiting Detroit, Michigan, United States, 48201 Principal Investigator: Felicity Harper, Ph.D. Sub-Investigator: Elisabeth I. Heath, M.D. Sub-Investigator: Louis Penner, Ph.D. 收起 << |
NCT00002772 | Breast Cancer | Phase 3 | Terminated(poor accrual) | - | United States, New York ... 展开 >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 收起 << |
NCT00033683 | Breast Cancer | Phase 2 | Unknown | - | - |
NCT00003972 | Breast Cancer | Phase 3 | Completed | - | United States, Washington ... 展开 >> Fred Hutchinson Cancer Research Center Seattle, Washington, United States, 98109 收起 << |
NCT00398489 | Breast Cancer | Phase 2 | Unknown | - | Germany ... 展开 >> Klinikum Bayreuth Bayreuth, Germany, D 95448 Universitaetsfrauenklinik - Koeln Cologne, Germany, D-50391 Klinikum Deggendorf Deggendorf, Germany, 94469 Klinikum der Friedrich-Schiller Universitaet Jena Jena, Germany, D-07743 Klinikum Rechts Der Isar - Technische Universitaet Muenchen Munich, Germany, D-81675 收起 << |
NCT02139982 | Upper Limb Nerve Block | Phase 1 | Completed | - | China, Zhejiang ... 展开 >> The Second Affiliated Hospital & Yuying Children hospital of Wenzhou Medical University Wenzhou, Zhejiang, China, 325027 收起 << |
NCT02139982 | - | Completed | - | - | |
NCT00003013 | Breast Cancer | Phase 3 | Completed | - | Austria ... 展开 >> Kaiser Franz Josef Hospital Vienna, Austria, A-1100 Czech Republic Radiotherapy Institute Ostrava-Poruba, Czech Republic, 70852 Estonia University of Tartu Tartu, Estonia, 51003 Germany Frauenklinik Vom Roten Kreuz Munich, Germany, 80637 Hungary Semmelweis University Budapest, Hungary, 1082 Uzsoki Hospital Budapest, Hungary, 1145 Italy Policlinico Monteluce Perugia, Italy, 06122 Ospedale St. Santa Chiara Pisa, Italy, 56100 Centro di Riferimento Oncologico - Aviano Trento, Italy, 38100 Universita Degli Studi di Udine Udine, Italy, 33100 Ospedale San Bortolo Vicenza, Italy, 36100 Latvia Latvian Cancer Center Riga, Latvia, 1079 Poland Regional Center of Oncology Bydgoszcz, Poland, 85-796 Jagiellonian University Krakow (Cracow), Poland, 31-826 Szpital Kliniczny NR 1 Poznan, Poland, PL-61-878 Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology Warsaw, Poland, 02-781 Russian Federation Russian Academy of Medical Sciences Cancer Research Center Moscow, Russian Federation, 115478 Moscow Clinical Dispenser Moscow, Russian Federation, 129128 N. A. Semashko Central Clinical Hospital Moscow, Russian Federation, 129128 Regional Oncology Clinic Murmansk, Russian Federation, 183047 Petrov Research Institute of Oncology Saint Petersburg, Russian Federation, 197758 Slovakia St. Elizabeth Cancer Institute Hospital Bratislava, Slovakia, SK-81250 Spain Hospital de la Santa Cruz I Sant Pau Barcelona, Spain, 08025 Hospital General Universitari Vall d'Hebron Barcelona, Spain, 08035 Hospital Universitario 12 de Octubre Madrid, Spain, 28041 Hospital Clinico Universitario - Malaga Malaga, Spain, 29010 Instituto Valenciano De Oncologia Valencia, Spain, 46009 Hospital Clinico Universitario de Valencia Valencia, Spain, 46010 收起 << |
NCT00002680 | Breast Cancer | Phase 2 | Completed | - | United States, Connecticut ... 展开 >> Yale Comprehensive Cancer Center New Haven, Connecticut, United States, 06520-8028 收起 << |
NCT03081234 | Breast Cancer | Phase 3 | Withdrawn(Withdrawn due to cha... 展开 >>nge in plan for this study and not due to safety reasons.) 收起 << | November 17, 2025 | - |
NCT01503905 | Breast Cancer Nos Premenopausa... 展开 >>l 收起 << | Not Applicable | Recruiting | December 2021 | China, Guangdong ... 展开 >> The first People's Hospital of Foshan Recruiting Foshan, Guangdong, China, 528000 Contact: Jie Yang 86-13902805191 Guangdong Women and Children Hospital Recruiting Guangzhou, Guangdong, China, 510010 Contact: Antai Zhang 86-13925115929 Guangzhou Army General Hospital Recruiting Guangzhou, Guangdong, China, 510010 Contact: Chenfang Zhang 86-13889908978 Sun Yat-Sen University Cancer Center Recruiting Guangzhou, Guangdong, China, 510060 Contact: Siyu Wang 86-18688464714 The First Affiliated Hospital of Sun Yat-Sen University Recruiting Guangzhou, Guangdong, China, 510080 Contact: Zhuanghong Wu 86-13602722502 Tumor Hospital of Guangzhou Recruiting Guangzhou, Guangdong, China, 510095 Contact: Hongsheng Li 86-13725111258 The Second Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine Recruiting Guangzhou, Guangdong, China, 510100 Contact: Pengxi Liu 86-13560333752 Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University Recruiting Guangzhou, Guangdong, China, 510120 Contact: Fengxi Su fengxisu@vip.163.com Guangzhou Women and Children Hospital Recruiting Guangzhou, Guangdong, China, 510180 Contact: Hongmin Ma 86-13922723808 The first People's Hospital of Guangzhou Recruiting Guangzhou, Guangdong, China, 510180 Contact: Li Zhao gdzhaoli@163.com The Second Affiliated Hospital of Guangzhou Medical University Recruiting Guangzhou, Guangdong, China, 510260 Contact: Lehong Zhang 86-13719150959 Zhujiang Hospital of Nanfang Medical University Recruiting Guangzhou, Guangdong, China, 510282 Contact: Aiguo Wu wagtyz@sina.com Nanfang Hospital of Nanfang Medical University Recruiting Guangzhou, Guangdong, China, 510515 Contact: Changsheng Ye 86-13802954097 The First Affiliated Hospital of Jinan University Recruiting Guangzhou, Guangdong, China, 510630 Contact: Ningxia Wang Twnx@Jnu.edu.cn The Third Affiliated Hospital of Sun Yat-Sen University Recruiting Guangzhou, Guangdong, China, 510630 Contact: Renbin Liu 86-13570073298 Shenzhen People's Hospital Recruiting Shenzhen, Guangdong, China, 518020 Contact: Dongxian Zhou 86-13510363636 The first Affiliated Hospital of Shenzhen University Recruiting Shenzhen, Guangdong, China, 518035 Contact: Xianming Wang 86-13500056238 收起 << |
NCT00009997 | Breast Cancer | Phase 1 | Completed | - | United States, New York ... 展开 >> NYU School of Medicine's Kaplan Comprehensive Cancer Center New York, New York, United States, 10016 收起 << |
NCT00004125 | Breast Cancer | Phase 3 | Completed | - | - |
NCT00174707 | Breast Neoplasms | Phase 3 | Completed | - | Italy ... 展开 >> Sanofi-Aventis Administrative Office Milan, Italy 收起 << |
NCT00047099 | Breast Cancer | Phase 3 | Completed | - | Germany ... 展开 >> I. Frauenklinik und Hebammenschule der Ludwig-Maximillians Universitaet Muenchen Munich, Germany, D-80337 Klinikum Rechts Der Isar - Technische Universitaet Muenchen Munich, Germany, D-81675 收起 << |
NCT00415571 | Hypogonadism ... 展开 >>Erectile Dysfunction 收起 << | Phase 2 | Completed | - | United States, Alabama ... 展开 >> Radiant Research Birmingham, Alabama, United States, 35209 United States, Arizona Genova Clinical Research Tucson, Arizona, United States, 85741 United States, Arkansas HealthStar Research Hot Springs, Arkansas, United States, 71913 United States, Florida Genesis Research International Longwood, Florida, United States, 32779 Renstar Medical Research Ocala, Florida, United States, 34471 Radiant Research West Palm Beach, Florida, United States, 33407 United States, Louisiana Regional Urology Shreveport, Louisiana, United States, 71106 United States, Nevada Office of Stephen Miller Las Vegas, Nevada, United States, 89144 United States, New Jersey Hamilton Urology Hamilton, New Jersey, United States, 08690 United States, New York Center for Urologic Research of WNY, LLC Williamsville, New York, United States, 14221 United States, North Carolina Metrolina Urology Clinic Charlotte, North Carolina, United States, 28207 NorthEast Urology research Concord, North Carolina, United States, 28025 United States, Tennessee Urology Associates, P.C. Nashville, Tennessee, United States, 37209 United States, Texas Radiant Research San Antonio, Texas, United States, 78229 收起 << |
NCT01061970 | Hypogonadism ... 展开 >>Chronic Obstructive Pulmonary Disease 收起 << | Phase 2 | Completed | - | - |
NCT02624973 | Breast Cancer | Phase 2 | Active, not recruiting | June 2030 | Norway ... 展开 >> Akershus University Hospital Lørenskog, Akershus, Norway Haukeland University Hospital Bergen, Hordaland, Norway, 5021 Helse Fonna Haugesund, Rogaland, Norway Helse Stavanger Stavanger, Rogaland, Norway Helse Førde Førde, Sogn Og Fjordande, Norway St. Olavs Hospital Trondheim, Sør Trøndelag, Norway Helse Nord/UNN Tromsø, Troms, Norway 收起 << |
NCT00003050 | Breast Cancer | Phase 2 | Completed | - | United States, California ... 展开 >> USC/Norris Comprehensive Cancer Center Los Angeles, California, United States, 90033-0800 United States, Florida Mayo Clinic Jacksonville Jacksonville, Florida, United States, 32224 收起 << |
NCT01272570 | - | Completed | - | United States, Michigan ... 展开 >> Michigan Center for Oral Health Research Ann Arbor, Michigan, United States, 48106 收起 << | |
NCT00003680 | Breast Cancer | Phase 3 | Unknown | - | United Kingdom ... 展开 >> C.R.C. Beatson Laboratories Glasgow, Scotland, United Kingdom, G61 1BD 收起 << |
NCT01419197 | Breast Cancer | Phase 3 | Completed | - | - |
NCT00003035 | Breast Cancer | Phase 2 | Completed | - | United States, District of Col... 展开 >>umbia Lombardi Cancer Center Washington, District of Columbia, United States, 20007 收起 << |
NCT01107873 | - | Completed | - | - | |
NCT00728949 | - | Completed | - | - | |
NCT00728949 | Metastatic Breast Cancer | Phase 2 | Completed | - | United States, Arizona ... 展开 >> ImClone Investigational Site Scottsdale, Arizona, United States, 85259 United States, Illinois ImClone Investigational Site Chicago, Illinois, United States, 60611 United States, Kansas ImClone Investigational Site Westwood, Kansas, United States, 66205 United States, Minnesota ImClone Investigational Site Rochester, Minnesota, United States, 55905-0002 United States, New Hampshire ImClone Investigational Site Lebanon, New Hampshire, United States, 03756 United States, New York ImClone Investigational Site Bronx, New York, United States, 10461 ImClone Investigational Site New York, New York, United States, 10021 United States, Ohio ImClone Investigational Site Columbus, Ohio, United States, 43210 United States, Tennessee ImClone Investigational Site Nashville, Tennessee, United States, 37203 收起 << |
NCT00016276 | Cardiac Toxicity ... 展开 >> Inflammatory Breast Cancer Stage IIIA Breast Cancer Stage IIIB Breast Cancer Stage IV Breast Cancer 收起 << | Phase 3 | Terminated(Administratively co... 展开 >>mplete.) 收起 << | - | United States, Illinois ... 展开 >> Cancer and Leukemia Group B Chicago, Illinois, United States, 60606 收起 << |
NCT03229499 | Pulmonary Arterial Hypertensio... 展开 >>n 收起 << | Phase 2 | Recruiting | September 2021 | United States, California ... 展开 >> Stanford University Recruiting Stanford, California, United States, 94305 Contact: Patricia Del Rosario, RN 650-721-2408 pdelrosa@stanford.edu Principal Investigator: Roham Zamanian, MD United States, Colorado University of Colorado - Denver Recruiting Aurora, Colorado, United States, 80045 Contact: Colton Carter colton.carter@ucdenver.edu Principal Investigator: Todd Bull, MD United States, Maryland Johns Hopkins University Recruiting Baltimore, Maryland, United States, 21218 Contact: Blessing Enobun benobun1@jhu.edu Principal Investigator: Stephen Mathai, MD United States, Missouri Washington University Recruiting Saint Louis, Missouri, United States, 63130 Contact: Sharon Heuerman, RN 314-747-8174 sheuerman@wustl.edu Principal Investigator: Murali Chakinala, MD United States, Pennsylvania University of Pennsylvania Recruiting Philadelphia, Pennsylvania, United States, 19104 Contact: Kate Boyle 215-294-9755 Kathleen.Boyle@uphs.upenn.edu Contact: Diane Pinder 215-294-9757 pinder@pennmedicine.upenn.edu Principal Investigator: Steven Kawut, MD United States, Rhode Island Rhode Island Hospital Recruiting East Providence, Rhode Island, United States, 02914 Contact: Meghan Ahearn 401-444-2733 Meghan.Ahearn@Lifespan.org Contact: Amy Palmisciano, RN, BSN 401-444-4961 APalmisciano@Lifespan.org Principal Investigator: Corey Ventetuolo, MD United States, Tennessee Vanderbilt University Recruiting Nashville, Tennessee, United States, 37232 Contact: Shannon Cordell, RN 615-343-8277 shannon.eason@Vanderbilt.Edu Principal Investigator: Anna Hemnes, MD 收起 << |
NCT00119262 | Male Breast Cancer ... 展开 >> Stage II Breast Cancer Stage IIIA Breast Cancer Stage IIIB Breast Cancer 收起 << | Phase 2 | Completed | - | United States, Massachusetts ... 展开 >> Eastern Cooperative Oncology Group Boston, Massachusetts, United States, 02215 收起 << |
NCT00194779 | Estrogen Receptor-negative Bre... 展开 >>ast Cancer Estrogen Receptor-positive Breast Cancer HER2-positive Breast Cancer Progesterone Receptor-negative Breast Cancer Progesterone Receptor-positive Breast Cancer Stage IA Breast Cancer Stage IB Breast Cancer Stage II Breast Cancer Stage IIIA Breast Cancer 收起 << | Phase 2 | Completed | - | United States, Washington ... 展开 >> Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 收起 << |
NCT00194779 | - | Completed | - | - | |
NCT01925586 | - | Active, not recruiting | August 2019 | United States, Connecticut ... 展开 >> Yale University & Smilow Breast Center at Yale New Haven Hospital New Haven, Connecticut, United States, 06510 收起 << | |
NCT01745965 | Breast Cancer | Phase 2 | Active, not recruiting | October 2020 | Germany ... 展开 >> Breast Center of the University of Munich (LMU) Munich, Germany Ev. Krankenhaus Bethesda Brustzentrum Niederrhien Mönchengladbach, Germany 收起 << |
NCT00119262 | - | Completed | - | - | |
NCT00003199 | Estrogen Receptor-negative Bre... 展开 >>ast Cancer Estrogen Receptor-positive Breast Cancer Inflammatory Breast Cancer Male Breast Cancer Progesterone Receptor-negative Breast Cancer Progesterone Receptor-positive Breast Cancer Stage IIIB Breast Cancer Stage IV Breast Cancer 收起 << | Phase 2 | Completed | - | United States, Washington ... 展开 >> Fred Hutchinson Cancer Research Center/Puget Sound Oncology Consortium Seattle, Washington, United States, 98109 收起 << |
NCT03272477 | Breast Neoplasms | Phase 2 | Recruiting | November 15, 2024 | Germany ... 展开 >> Evangelisches Krankenhaus Bethesda Mönchengladbach Recruiting Mönchengladbach, Germany, 41061 Contact: Oleg Gluz, PD Dr. med. 00492161 ext 9812010 oleg.gluz@wsg-online.com 收起 << |
NCT00003199 | - | Completed | - | - | |
NCT00002679 | Breast Cancer | Phase 2 | Completed | - | United States, Connecticut ... 展开 >> Yale Comprehensive Cancer Center New Haven, Connecticut, United States, 06520-8028 收起 << |
NCT01788839 | - | Recruiting | February 2019 | United States, New Jersey ... 展开 >> Memorial Sloan Kettering Basking Ridge Recruiting Basking Ridge, New Jersey, United States, 07920 Contact: Shari Goldfarb, MD 646-888-5080 Memorial Sloan Kettering Monmouth Recruiting Middletown, New Jersey, United States, 07748 Contact: Shari Goldfarb, MD 646-888-5080 Memorial Sloan Kettering Bergen Recruiting Montvale, New Jersey, United States, 07645 Contact: Shari Goldfarb, MD 646-888-5080 United States, New York Memorial Sloan Kettering Commack Recruiting Commack, New York, United States, 11725 Contact: Shari Goldfarb, MD 646-888-5080 Memorial Sloan Kettering Westchester Recruiting Harrison, New York, United States, 10604 Contact: Shari Goldfarb, MD 646-888-5080 Memorial Sloan Kettering Cancer Center Recruiting New York, New York, United States, 10065 Contact: Shari Goldfarb, MD 646-888-5080 Contact: Jeanne Carter, MD 646-888-5076 Memorial Sloan Kettering Rockville Centre Recruiting Rockville Centre, New York, United States Contact: Shari Goldfarb, MD 646-888-5080 收起 << | |
NCT00003679 | Breast Cancer | Phase 3 | Unknown | - | United Kingdom ... 展开 >> C.R.C. Beatson Laboratories Glasgow, Scotland, United Kingdom, G61 1BD 收起 << |
NCT00003080 | Ovarian Cancer | Phase 1 | Completed | - | United States, Washington ... 展开 >> Fred Hutchinson Cancer Research Center Seattle, Washington, United States, 98109 收起 << |
NCT03204734 | Breast Cancer | Phase 2 | Recruiting | December 30, 2021 | China, Zhejiang ... 展开 >> Zhejiang Cancer Hospital Recruiting Hangzhou, Zhejiang, China, 310022 Contact: Xiaojia WANG, MD,PhD +86 13906500190 wxiaojia0803@163.com Contact: Ya-bing Zheng, MD +8613858065353 zhengyabing@sina.com 收起 << |
NCT01419197 | - | Completed | - | - | |
NCT00896857 | - | Completed | - | - | |
NCT00276094 | Atrophy Vagin... 展开 >>al Diseases 收起 << | Phase 3 | Completed | - | - |
NCT00482391 | Breast Cancer | Phase 2 | Completed | - | United States, Massachusetts ... 展开 >> Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, New York Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 收起 << |
NCT02788201 | Urothelial Carcinoma ... 展开 >> Bladder Cancer Urinary Bladder Neoplasms 收起 << | Phase 2 | Recruiting | July 1, 2020 | United States, Maryland ... 展开 >> National Institutes of Health Clinical Center Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact National Cancer Institute Referral Office 888-624-1937 收起 << |
NCT00566982 | Atrophy Vagin... 展开 >>al Diseases 收起 << | Phase 3 | Completed | - | - |
NCT00482391 | - | Completed | - | - | |
NCT00566982 | - | Completed | - | - | |
NCT00630539 | Atrophy Vagin... 展开 >>al Diseases 收起 << | Phase 2 | Completed | - | - |
NCT00003953 | Breast Cancer | Phase 2 | Completed | - | United States, Ohio ... 展开 >> Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44106-5065 Metro Health Medical Center Cleveland, Ohio, United States, 44109 收起 << |
NCT00729469 | Atrophy Vagin... 展开 >>al Diseases 收起 << | Phase 3 | Completed | - | - |
NCT00290134 | Hypogonadism | Phase 2 | Completed | - | United States, Alabama ... 展开 >> Clinical Research Site Huntsville, Alabama, United States, 35801 United States, California Clinical Research Site Modesto, California, United States, 95350 United States, Colorado Clinical Research Site Aurora, Colorado, United States, 80012 United States, Connecticut Clinical Research Site Waterbury, Connecticut, United States, 06708 United States, Florida Clinical Research Site New Port Richey, Florida, United States, 34652 Clinical Research Site Tallahassee, Florida, United States, 32308 United States, Illinois Clinical Research Site Peoria, Illinois, United States, 61614 United States, Maryland Clinical Research Site Greenbelt, Maryland, United States, 20770 United States, Nevada Clinical Research Site Las Vegas, Nevada, United States, 89109 United States, New York Clinical Research Site Garden City, New York, United States, 11530 Clinical Research Site Poughkeepsie, New York, United States, 12601 Clinical Research Site Williamsville, New York, United States, 14221 United States, Oklahoma Clinical Research Site Bethany, Oklahoma, United States, 73008 United States, South Carolina Clinical Research Site Greer, South Carolina, United States, 29650 United States, Texas Clinical Research Site San Antonio, Texas, United States, 78229 United States, Washington Clinical Research Site Seattle, Washington, United States, 98166 收起 << |
NCT01563211 | - | Completed | - | United Kingdom ... 展开 >> Charing Cross Hospital London, United Kingdom, W6 8RF 收起 << | |
NCT00729469 | - | Completed | - | - | |
NCT01327781 | Estrogen Receptor Positive ... 展开 >> HER2/Neu Positive Hot Flashes Recurrent Breast Carcinoma Stage IIIC Breast Cancer AJCC v7 Stage IV Breast Cancer AJCC v6 and v7 收起 << | Phase 1 | Active, not recruiting | - | United States, Arizona ... 展开 >> Mayo Clinic in Arizona Scottsdale, Arizona, United States, 85259 United States, Florida Mayo Clinic in Florida Jacksonville, Florida, United States, 32224-9980 United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55905 收起 << |
NCT01585558 | Atrophy Vagin... 展开 >>al Diseases 收起 << | Phase 3 | Completed | - | - |
NCT03541863 | - | Active, not recruiting | December 20, 2018 | China, Shanghai ... 展开 >> Fudan University Shanghai Cancer Center Shanghai, Shanghai, China, 200032 收起 << | |
NCT00630539 | - | Completed | - | - | |
NCT00379015 | Breast Cancer | Phase 2 | Completed | - | Japan ... 展开 >> Shikoku Cancer Center Matsuyama-shi, Ehime, Japan, 791-0288 National Kyushu Cancer Center Fukuoka-shi, Fukuoka, Japan, 811-1395 Niigata Cancer Center Hospital Niigata, Japan, 951-8566 Keio University Hospital Tokyo, Japan, 160-8582 Teikyo University School of Medicine Tokyo, Japan, 173-8605 收起 << |
NCT01586364 | - | Completed | - | - | |
NCT02443090 | Secondary Hypogonadism ... 展开 >> Sexual Dysfunction Erectile Dysfunction 收起 << | Phase 2 | Unknown | April 2016 | United States, Arkansas ... 展开 >> Baptist Health Center for Clinical Research Little Rock, Arkansas, United States, 72205 United States, California San Diego Clinical Trials San Diego, California, United States, 92120 Genesis Research LLC San Diego, California, United States, 92123 United States, Florida Meridien Research Bradenton, Florida, United States, 34208 Clinical Research of South Florida Coral Gables, Florida, United States, 33134 Well Pharma Medical Research Miami, Florida, United States, 33144 United States, Louisiana Regional Urology, LLC Shreveport, Louisiana, United States, 71106 United States, New Jersey Premier Urology Associates, LLC, dba AdvanceMed Research Lawrence Township, New Jersey, United States, 08648 United States, New York The Urological Institute of Northeastern New York Albany, New York, United States, 12208 AccuMed Research Associates Garden City, New York, United States, 11530 Bruce R. GIlbert, MD, PhD, PC Great Neck, New York, United States, 11022 Manhattan Medical Research Practice PLLC New York, New York, United States, 10016 United States, Tennessee Volunteer Research Knoxville, Tennessee, United States, 37920 Clinical Research Associates, Inc. Nashville, Tennessee, United States, 37203 United States, Utah Physicians' Research Options LLC Draper, Utah, United States, 84020 United States, Virginia Clinical Research Associates of Tidewater, Inc. Norfolk, Virginia, United States, 23507 收起 << |
NCT00276094 | - | Completed | - | - | |
NCT00134680 | Metastatic Breast Cancer | Phase 2 | Completed | - | United States, District of Col... 展开 >>umbia Lombardi Cancer Institute, Georgetown University Medical Center Washington, District of Columbia, United States, 20007 United States, Massachusetts Dana Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, Missouri Siteman Cancer Center, Washington University St. Louis, Missouri, United States, 63110 United States, North Carolina Duke University Medical Center Durham, North Carolina, United States, 27710 收起 << |
NCT02784613 | Vulvovaginal Atrophy ... 展开 >> Dyspareunia 收起 << | Phase 4 | Completed | - | United States, California ... 展开 >> San Diego Sexual Medicine San Diego, California, United States, 92120 收起 << |
NCT01586364 | Atrophy Vagin... 展开 >>al Diseases 收起 << | Phase 3 | Completed | - | - |
NCT01047358 | - | Completed | - | Korea, Republic of ... 展开 >> Soon Chun Hyang University Hospital Cheonan Cheonan, Chungcheongnam-do, Korea, Republic of, 330-721 Hallym University Sacred Heart Hospital Anyang, Gyeonggi-do, Korea, Republic of, 431-070 Soon Chun Hyang University Bucheon Hospital Bucheon, Gyeonggi-do, Korea, Republic of, 420-767 Myongji Hospital, Kwangdong Unversity College of Medicine Goyang, Gyeonggi-do, Korea, Republic of, 412-270 Wonkwang University School of Medicine and Hospital (WUH) Iksan -si, Jeollabuk-do, Korea, Republic of, 570-749 Asan Medical Center Seoul, Korea, Korea, Republic of, 138-736 Hwasun Hospital, Chonnam National University Cheonnam, South Jeolla Province, Korea, Republic of, 519-809 Inje University Busan Paik Hospital Busan, Korea, Republic of, 614-735 Yeung Nam University Hospital Daegu, Korea, Republic of, 705-717 Seoul National University Bundang Hospital Gyeonggi-do, Korea, Republic of, 463-707 Inha University Hospital Incheon, Korea, Republic of, 400-711 Cheil General Hospital & Women's Healthcare Center Seoul, Korea, Republic of, 100-380 Seoul National University Hospital (SNUH) Seoul, Korea, Republic of, 110-744 Seoul National University Hospital Seoul, Korea, Republic of, 110-744 Severance Hospital, Yonsei University Health System, Yonsei Cancer Center Seoul, Korea, Republic of, 120-752 Samsung Medical Center Seoul, Korea, Republic of, 135 710 Korea University Anam Hospital Seoul, Korea, Republic of, 136-705 Asan Medical Center, University of Ulsan Seoul, Korea, Republic of, 138-736 Korea University Medical Center (KUMC) - Korea University Guro Hospital Seoul, Korea, Republic of, 152-703 SMG-SNU Boramae Medical Center Seoul, Korea, Republic of, 156-707 Ewha Womans University Mokdong Hospital Seoul, Korea, Republic of, 158-710 Ajou University Hospital Suwon, Korea, Republic of, 443-380 收起 << | |
NCT02638337 | Vaginal Dryness | Phase 3 | Completed | - | - |
NCT01047358 | - | Completed | - | - | |
NCT03750396 | Breast Cancer ... 展开 >> Recurrent Breast Cancer Stereotactic Body Radiotherapy Estrogen Receptor Positive Tumor Her2-negative Tumor Surgery 收起 << | Phase 2 | Recruiting | July 31, 2025 | Korea, Republic of ... 展开 >> Gangnam Severance Hospital Recruiting Seoul, Korea, Republic of, 135720 Contact: Joon Jeong, M.D.,Ph.D. 82220193370 gsjjoon@yuhs.ac Contact: Sung Gwe Ahn, M.D. 82220193370 asg2004@yuhs.ac 收起 << |
NCT02366130 | Breast Cancer | Phase 2 | Active, not recruiting | February 2021 | United States, Texas ... 展开 >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 收起 << |
NCT02850939 | Breast Cancer | Not Applicable | Not yet recruiting | December 2021 | United States, Texas ... 展开 >> Cancer Therapy and Research Center - CTRC Not yet recruiting San Antonio, Texas, United States, 78229 Contact: Amelie G Ramirez, DrPH ramirezag@uthscsa.edu Contact: Patricial Chalela, DrPH chalela@uthscsa.edu Principal Investigator: Amelie G. Ramirez, DrPH Principal Investigator: Patricia Chalela, DrPH 收起 << |
NCT03065621 | Breast Cancer Female | Phase 2 | Recruiting | March 2020 | Belgium ... 展开 >> Institut Jules Bordet Recruiting Brussels, Belgium, 1000 Contact: Michail Ignatiadis, MD CHU Brugmann Recruiting Brussels, Belgium, 1090 Contact: Jacques Chapiro, MD CU Saint-Luc Recruiting Brussels, Belgium, 1200 Contact: Francois Duhoux, MD UZ Leuven Gasthuisberg Recruiting Leuven, Belgium, 3000 Contact: Patrick Neven, MD CHU UCL Namur Sainte-Elisabeth Recruiting Namur, Belgium, 5000 Contact: Peter Vuylsteke, MD 收起 << |
NCT02344472 | Metastatic Breast Cancer | Phase 3 | Recruiting | September 2021 | Germany ... 展开 >> University Hospital Ulm Gynecology/Obstetrics Recruiting Ulm, Germany 收起 << |
NCT00666822 | - | Completed | - | United States, Ohio ... 展开 >> Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44106 收起 << | |
NCT01712893 | Breast Cancer | Phase 3 | Completed | - | China, Shanghai ... 展开 >> FUSCC Shanghai, Shanghai, China, 200032 收起 << |
NCT00206466 | Breast Cancer | Phase 2 | Completed | - | United States, Texas ... 展开 >> Baylor Breast Center Houston, Texas, United States, 77030 收起 << |
NCT01937052 | - | Active, not recruiting | January 2022 | United States, Maryland ... 展开 >> Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States, 21287-0013 收起 << | |
NCT03029286 | Breast Density ... 展开 >> Breast Cancer Female 收起 << | Not Applicable | Active, not recruiting | August 2020 | United States, Washington ... 展开 >> Kaiser Permanente Washington Health Research Institute Seattle, Washington, United States, 28124 收起 << |
NCT02971748 | Inflammatory Breast Cancer ... 展开 >> Malignant Neoplasm of Breast 收起 << | Phase 2 | Recruiting | January 2021 | United States, Texas ... 展开 >> The University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: MD Anderson Health Information Specialist 877-632-6789 Contact: Breast Medical Oncology 713-792-2817 收起 << |
NCT01619306 | - | Unknown | - | Singapore ... 展开 >> Nationa University Hospital Recruiting Singapore, Singapore Contact: Andrea Wong, MRCP +65 6779 5555 andrea_la_wong@nuhs.edu.sg Principal Investigator: Andrea Wong, MRCP 收起 << | |
NCT02627703 | - | Unknown | - | Canada, British Columbia ... 展开 >> BC Cancer Agency - Vancouver Centre Recruiting Vancouver, British Columbia, Canada, V5Z4E6 Contact: Stephen Chia, MD 604-877-6000 schia@bccancer.bc.ca 收起 << | |
NCT00016549 | Breast Cancer | Phase 2 | Completed | - | United States, Maryland ... 展开 >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 收起 << |
NCT02382094 | Prostate Cancer | Phase 3 | Completed | - | - |
NCT00851110 | High-Risk Breast Cancer | Phase 2 | Terminated | - | Netherlands ... 展开 >> Free University Hospital Amsterdam, Netherlands, 1007 MB The Netherlands Cancer Institute Amsterdam, Netherlands, 1066 CX Academic Medical Center Amsterdam, Netherlands, 1105 AZ Medisch Spectrum Twente Enschede, Netherlands, 7511 JX University Medical Centre Groningen Groningen, Netherlands, 9713 GZ Leiden University Medical Centre Leiden, Netherlands, 2333 JS University Hospital Maastricht Maastricht, Netherlands, 6202 AZ University Medical Centre Nijmegen St. Radboud Nijmegen, Netherlands, 6525 GA Erasmus MC, Daniel den Hoed Cancer Center Rotterdam, Netherlands, 3075 EA University Medical Centre Utrecht Utrecht, Netherlands, 3584 CX 收起 << |
NCT00418236 | - | Completed | - | - | |
NCT00001250 | Breast Neoplasm ... 展开 >> Neoplasm Metastasis 收起 << | Phase 2 | Completed | - | United States, Maryland ... 展开 >> National Cancer Institute (NCI) Bethesda, Maryland, United States, 20892 收起 << |
NCT01372618 | - | Terminated(PI has passed away.... 展开 >> Requested by department to terminate study.) 收起 << | - | - | |
NCT01585558 | - | Completed | - | - | |
NCT02774395 | - | Completed | - | France ... 展开 >> CHU de Nice Nice, France, 06200 收起 << | |
NCT01372618 | Ductal Carcinoma in Situ | Phase 1 Phase 2 | Terminated(PI has passed away.... 展开 >> Requested by department to terminate study.) 收起 << | - | United States, New York ... 展开 >> NYU School of Medicine New York, New York, United States, 10016 收起 << |
NCT00393406 | - | Completed | - | United States, North Carolina ... 展开 >> NIEHS, Research Triangle Park Research Triangle Park, North Carolina, United States, 27709 收起 << | |
NCT00954135 | Breast Cancer | Phase 2 | Unknown | December 2010 | Italy ... 展开 >> Breast Unit Azienda Ospedaliera Istituti Ospitalieri Cremona, Italy Azienda Ospedaliera S.Luigi Orbassano Orbassano, Italy 收起 << |
NCT02476305 | Desmoid Tumors | Not Applicable | Completed | - | France ... 展开 >> Service d'Imagerie Interventionnelle Strasbourg, Alsace, France, 67091 收起 << |
尊敬的 Ambeed 客户您好,
请您选择所在区域,我们将转接对应客服为您服务!